Académique Documents
Professionnel Documents
Culture Documents
Module 2
Cells use a large number of clearly defined signalling pathways to regulate their activity. In this module,
attention is focused on the On mechanisms responsible for transmitting information into the cell. These
signalling pathways fall into two main groups depending on how they are activated. Most of them are
activated by external stimuli and function to transfer information from the cell surface to internal effector
systems. However, some of the signalling systems respond to information generated from within the
cell, usually in the form of metabolic messengers. For all of these signalling pathways, information is
conveyed either through protein--protein interactions or it is transmitted by diffusible elements usually
referred to as second messengers. Cells often employ a number of these signalling pathways, and
cross-talk between them is an important feature. In this section, attention is focused on the properties
of the major intracellular signalling pathways operating in cells to regulate their cellular activity.
During the processes of development, specific cell types select out those signalling systems that are
suitable to control their particular functions. One of the aims of this website is to understand how these
unique cell-specific signalsomes function to regulate different mammalian cell types.
Intracellular signalling pathways 1. Cyclic AMP signalling pathway. One of the first sig-
There are a large number of intracellular signalling path- nalling systems to be characterized was the cyclic
ways responsible for transmitting information within the AMP signalling pathway, which led to the second mes-
cell. They fall into two main categories. The majority re- senger concept that applies to many other signalling
spond to external stimuli arriving at the cell surface, usu- systems. The idea is that the external stimulus arriving
ally in the form of a chemical signal (neurotransmitter, at the cell surface is the first messenger, which is then
hormone or growth factor), which is received by recept- transformed at the cell surface by adenylyl cyclase
ors at the cell periphery that function as molecular an- (AC) into a second messenger, cyclic AMP, which is
tennae embedded in the plasma membrane. These recept- part of the signalling cascade that then activates down-
ors then transfer information across the membrane using stream effectors.
a variety of transducers and amplifiers that engage a di- 2. Cyclic ADP-ribose (cADPR) signalling and nicotinic
verse repertoire of intracellular signalling pathways (Path- acid–adenine dinucleotide phosphate (NAADP) sig-
ways 1--16 in Module 2: Figure cell signalling pathways). nalling systems function in Ca2 + signalling. An ADP--
The phosphoinositide signalling and Ca2 + signalling sys- ribosyl cyclase (ADP-RC) is responsible for generat-
tems (Pathways 2--6) have been grouped together because ing these two second messengers.
they contain a number of related signalling pathways that 3. Voltage-operated channels (VOCs) contribute to
often interact with each other. The other categories are Ca2 + signals by controlling the entry of external Ca2 +
the pathways that are activated by signals generated from in excitable cells.
within the cell (Pathways 17 and 18). There are a number of 4. Receptor-operated channels (ROCs) contribute to
metabolic messengers that act from within the cell to initi- Ca2 + signals by controlling Ca2 + entry in both excit-
ate a variety of signalling pathways. GTP-binding proteins able and non-excitable cells.
often play a central role in the transduction process re- 5. Stimuli that activate phospholipase C (PLC) to hy-
sponsible for initiating many of these signalling pathways. drolyse PtdIns4,5P2 (also known as PIP2 ) generate a
All of these signalling pathways generate an internal number of signalling pathways:
messenger that is responsible for relaying information to • Inositol 1,4,5-trisphosphate (InsP3 )/Ca2 + sig-
the sensors that then engage the effectors that activate cel- nalling cassette
lular responses. The main features of the signalling path- • Diacylglycerol (DAG)/protein kinase C (PKC) sig-
ways summarized in Module 2: Figure cell signalling path- nalling cassette
ways are outlined below: • PtdIns4,5P2 signalling cassette
• Multipurpose inositol polyphosphate signalling
Green text indicates links to content within this module; blue text
indicates links to content in other modules.
pathway
Please cite as Berridge, M.J. (2012) Cell Signalling Biology; 6. PtdIns 3-kinase signalling is activated by stimuli
doi:10.1042/csb0001002 that stimulate PtdIns 3-kinase to phosphorylate PIP2
C
2012 Portland Press Limited www.cellsignallingbiology.org
Licensed copy. Copying is not permitted, except with prior permission and as allowed by law.
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r2
to form the lipid second messenger PtdIns3,4,5P3 ation. The ligand Hedgehog (Hh) acts through the
(PIP3 ). transcription factor GLI.
7. Nitric oxide (NO)/cyclic GMP signalling pathway. 17. Hippo signalling pathway. This pathway has a core
Nitric oxide (NO) synthase (NOS) generates the gas protein kinase cascade that has some similarities to the
NO that acts both through cyclic GMP and nitrosyla- MAP kinase cascade in that a series of serine/threonine
tion reactions. NO has a particularly important role protein kinases function to regulate the transcription
in modulating the activity of other pathways such as of a number of genes that function in cell growth,
Ca2 + signalling. proliferation and apoptosis.
8. Redox signalling. Many receptors act through 18. Notch signalling pathway. This is a highly conserved
NADPH oxidase (NOX) to form reactive oxygen signalling system that functions in developmental pro-
species, such as the superoxide radical (O2 − • ) and cesses related to cell-fate determination particularly in
hydrogen peroxide (H2 O2 ), which act to regulate the stem cells. The notch receptor generates the transcrip-
activity of specific signalling proteins such as tyrosine tion factor NICD (Notch intracellular domain).
phosphatases, transcription factors and ion channels. 19. Endoplasmic reticulum (ER) stress signalling. The en-
The O2 − • participates in the nitrosylation reaction in doplasmic reticulum (ER) stress signalling pathway
Pathway 7. concerns the mechanisms used by the ER to transmit
9. Mitogen-activated protein kinase (MAPK) signalling. information to the nucleus about the state of protein
This is a classical example of a protein phosphoryla- processing within the lumen of the ER.
tion cascade that often begins with Ras and consists of 20. AMP signalling pathway. This pathway is regulated
a number of parallel pathways that function to control by adenosine monophosphate (AMP), which func-
many cellular processes and particularly those related tions as a metabolic messenger to activate an important
to cell proliferation, cell stress and apoptosis. pathway for the control of cell proliferation.
10. Nuclear factor κB (NF-κB) signalling pathway. This
signalling system has a multitude of functions. It is Not included in Module 2: Figure cell signalling path-
particularly important in initiating inflammatory re- ways are some additional signalling pathways that have
sponses in macrophages and neutrophils as part of an specific functions in regulating various aspects of cell meta-
innate immune response to invading pathogens. bolism, such as sterol sensing and cholesterol biosynthesis,
11. Phospholipase D (PLD) signalling pathway. This is a that control the level of cholesterol in cell membranes. An-
lipid-based signalling system that depends upon the other example is found in the NAD signalling pathways,
hydrolysis of phosphatidylcholine by phospholipase where NAD + functions to regulate a number of cellular
D (PLD) to give phosphatidic acid (PA), which func- processes, including energy metabolism, gene transcrip-
tions as a second messenger to control a variety of tion, DNA repair and perhaps ageing as well.
cellular processes. These cassettes then engage a variety of effectors that
12. Sphingomyelin signalling pathway. Certain growth are responsible for activating cellular responses. All of
factors and cytokines hydrolyse sphingomyelin to these mechanisms (Module 1: Figure signal transmission
generate two second messengers that appear to have mechanisms) depend upon information transfer mechan-
opposing effects in the cell. Ceramide seems to pro- isms whereby information is transferred along an orderly
mote apoptosis, whereas sphingosine 1-phosphate sequence of events to activate the internal effectors re-
(S1P) stimulates cell proliferation. S1P may also re- sponsible for inducing a great variety of cellular responses.
lease Ca2 + from internal stores. The action of S1P is
complicated in that it is released from the cell, where
it can act as a hormone to stimulate external receptors. Cyclic AMP signalling pathway
13. Janus kinase (JAK)/signal transducer and activator of Cyclic AMP is a ubiquitous second messenger that
transcription (STAT) signalling pathway. This is a fast- regulates a multitude of cellular responses. Cyclic
track signal transduction pathway for transferring in- AMP formation usually depends upon the activation of
formation from cell-surface receptors into the nucleus. G-protein-coupled receptors (GPCRs) that use heterotri-
The Janus kinases (JAKs) are tyrosine kinases that meric G proteins to activate the amplifier adenylyl cyc-
phosphorylate the signal transducers and activators lase (AC), which is a large family of isoforms that dif-
of transcription (STATs), which carry the information fer considerably in both their cellular distribution and
into the nucleus. the way they are activated. There are a number of cyclic
14. Smad signalling pathway. This pathway mediates the AMP signalling effectors such as protein kinase A (PKA),
action of the transforming growth factor β (TGF-β) the exchange proteins activated by cyclic AMP (EPACs)
superfamily, which controls transcription through the that activate the small GTP-binding protein Rap1 and the
Smad transcription factors. cyclic nucleotide-gated channels (CNGCs). These various
15. Wnt signalling pathways. These pathways play an im- effectors are then responsible for carrying out the cyclic
portant role in both development and cell prolifera- AMP signalling functions that include control of metabol-
tion. ism, gene transcription and ion channel activity. In many
16. Hedgehog signalling pathway. This pathway re- cases, these functions are modulatory in that cyclic AMP
sembles the Wnt signalling pathway in that it also often acts to adjust the activity of other signalling path-
functions to regulate development and cell prolifer- ways and thus has a central role to play in the cross-talk
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r3
1 AC cAMP
2 ADP-RC NAADP
cADPR
3 VOC Ca 2+
4 ROC
IP 3
DAG
5 PLC
PIP2
CELLULAR RESPONSES
cGMP
7 NOS NO
Nitrosylation
8 NOX O + H O2
EFFECTORS
2 2
SENSORS
STIMULI
JNK
9 Ras Erk1/2
p38
10 IkBs
NF-kB
11 PLD PA
13 JAK STAT
14 TGF- Smad
15 Wnt b-catenin
16 Hh GLI
18 Notch NICD
ATF6, PERK
ER 19
SCAP, bHLH
Metabolism 20 AMP AMPK
Summary of the major signalling pathways used by cells to regulate cellular processes.
Cells have a number of signalling systems that are capable of responding either to external stimuli or to internal stimuli. In the case of the former, external
stimuli acting on cell-surface receptors are coupled to transducers to relay information into the cell using a number of different signalling pathways
(Pathways 1--17). Internal stimuli derived from the endoplasmic reticulum (ER) or from metabolism activate signalling pathways independently of
external signals (Pathways 18 and 19). All of these pathways generate an internal messenger that then acts through an internal sensor to stimulate
the effectors that bring about different cellular responses. As described in the text, the names of these signalling pathways usually reflect a major
component(s) of the pathway.
between signalling pathways. This modulatory function is zyme adenylyl cyclase (AC) (Module 2: Figure heterotri-
particularly evident in the case of Ca2 + signalling in both meric G protein signalling). In the case of AC stimulation,
neuronal and muscle cells. Many of the functions of cyclic the external stimulus binds to the GPCR that functions
AMP depend upon the precise location of PKA relative as a guanine nucleotide exchange factor (GEF) to replace
to both its upstream and downstream effectors. A family GDP with GTP, which dissociates the heterotrimeric com-
of A-kinase-anchoring proteins (AKAPs) determines this plex into their Gβγ and Gα subunits (Module 2: Figure
cellular localization of PKA as well as a number of other cyclic AMP signalling). The GαS ·GTP complex activates
signalling components. The OFF reactions responsible for AC, whereas Gαi ·GTP inhibits AC. The Gα subunits have
removing cyclic AMP are carried out by either cyclic AMP GTPase activity that hydrolyses GTP to GDP, thus ter-
hydrolysis or by cyclic AMP efflux from the cell. minating their effects on AC. The endogenous GTPase of
GαS ·GTP is inhibited by cholera toxin and this causes the
persistent activation of the intestinal fluid secretion that
Cyclic AMP formation results in the symptoms of cholera.
The formation of cyclic AMP can be activated by a
very large number of cell stimuli, mainly neurotrans-
mitters and hormones (Module 1: Figure stimuli for Adenylyl cyclase (AC)
cyclic AMP signalling). All these stimuli are detec- The adenylyl cyclase (AC) family is composed of ten iso-
ted by G-protein-coupled receptors (GPCRs) that use forms: nine of them are membrane-bound (AC1--AC9),
heterotrimeric G proteins, which are the transducers that while one of them is soluble (AC10) (Module 2: Table
are responsible for either activating or inhibiting the en- adenylyl cyclases). The domain structure of AC1--AC9 is
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r4
TM 1-6 TM 7-12
C1 C2 AC 1 - 9
C1 C2 AC 10
Plasma membrane
1 2 3 4 5 6 7 8 9 10 11 12
C1 C2
O O
O P O P O
O O Pyrophosphate
NH 2 NH 2
N N
N N
H H O O O H H
N C O P O P O P O N C
N O N O O
O O O
O P
ATP OH OH Cyclic AMP OH O O
characterized by having two regions where there are six tein kinase A (PKA)]. Of the two types of PKA, protein
transmembrane regions (Module 2: Figure adenylyl cy- kinase A (PKA) I is found mainly free in the cytoplasm
clase structure). The large cytoplasmic domains C1 and and has a high affinity for cyclic AMP, whereas protein
C2, which contain the catalytic region, form a heterodimer kinase A (PKA) II has a much more precise location by be-
and co-operate with each other to convert ATP into cyclic ing coupled to the A-kinase-anchoring proteins (AKAPs).
AMP. The AKAPs are examples of the scaffolding proteins that
function in the spatial organization of signalling pathways
Cyclic AMP signalling effectors by bringing PKA into contact with its many substrates.
Cyclic AMP is a highly versatile intracellular messen- The scaffolding function of the AKAPs is carried out by
ger capable of activating a number of different effectors various domains such as the conserved PKA-anchoring
(Module 2: Figure cyclic AMP signalling). An example of domain [yellow region in Module 2: Figure protein kinase
such effectors is the exchange proteins activated by cyc- A (PKA)], which is a hydrophobic surface that binds to
lic AMP (EPACs), which act to stimulate Rap. Another an extended hydrophobic surface on the N-terminal di-
group of effectors are the cyclic nucleotide-gated channels merization region of the R subunits. At the other end of
(CNGCs) (Module 3: Figure Ca2 + entry mechanisms) that the molecule, there are unique targeting domains (blue)
play a particularly important role in the sensory systems that determine the way AKAPs identify and bind specific
responsible for smell and taste. Most of the actions of cyclic cellular targets in discrete regions of the cell.
AMP are carried out by protein kinase A (PKA).
Protein kinase A (PKA) I
Protein kinase A (PKA) Type I protein kinase A (PKA) associates with the RI iso-
Many of the actions of cyclic AMP are carried out by pro- forms. As for all isoforms, the R subunits form dimers
tein kinase A (PKA), which phosphorylates specific sites through their N-terminal dimerization/docking domains
on downstream effector processes (Module 2: Figure cyc- [yellow bar in Module 2: Figure protein kinase A (PKA)].
lic AMP signalling). PKA is composed of two regulatory In addition to holding two R subunits together, this N-
(R) subunits and two catalytic (C) subunits. The way in terminal region is also responsible for docking to the A-
which cyclic AMP activates PKA is to bind to the R sub- kinase-anchoring proteins (AKAPs), as occurs for PKA
units, which then enables the C subunits to phosphorylate II. However, the RI isoforms have a very low affinity for
a wide range of different substrates [Module 2: Figure pro- the AKAPs and are thus mainly soluble. Cyclic AMP acts
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r5
by binding to the tandem cyclic AMP-binding domains to to free fatty acids and glycerol in both white fat cells
release active C subunits that then phosphorylate specific (Module 7: Figure lipolysis and lipogenesis) and in
substrates. Since the RI subunits have a higher cyclic AMP- brown fat cells (Module 7: Figure brown fat cell).
binding affinity, PKA I will be able to respond to the lower • PKA phosphorylates the phosphorylase kinase that
cyclic AMP concentrations found globally within the bulk converts inactive phosphorylase b into active phos-
cytoplasm. phorylase a in skeletal muscle (Module 7: Figure skeletal
muscle E-C coupling) and in liver cells (Module 7: Fig-
Protein kinase A (PKA) II ure glycogenolysis and gluconeogenesis).
A characteristic feature of Type II protein kinase A (PKA) • PKA activates the transcription factor cyclic AMP re-
is that the regulatory dimer is made up of RII sub- sponse element-binding protein (CREB) (Module 4:
units. Since this RII subunit has a much higher affin- Figure CREB activation). This activation is a critical
ity for the A-kinase-anchoring proteins (AKAPs), PKA event in the induction of gluconeogenesis in liver cells
II is usually docked to this scaffolding protein and thus (Module 7: Figure liver cell signalling).
has a much more precise localization to specific cellular • PKA inhibits the salt-inducible kinase 2 (SIK2) that nor-
targets. mally acts to phosphorylate TORC2, thereby prevent-
The substrates phosphorylated by cyclic AMP (Module ing it from entering the nucleus to facilitate the activity
2: Figure cyclic AMP signalling) fall into two main groups: of CREB (Module 7: Figure liver cell signalling).
the cyclic AMP substrates that regulate specific cellular • PKA phosphorylates inhibitor 1 (I1), which assists the
processes and the cyclic AMP substrates that are compon- protein phosphorylation process by inactivating protein
ents of other signalling systems. phosphatase 1 (PP1) .
Cyclic AMP substrates that regulate specific cellular • PKA contributes to the translocation and fusion of ves-
processes: icles with the apical membrane during the onset of acid
secretion by parietal cells (Module 7: Figure HCl secre-
• In neurons, cyclic AMP acts through PKA to phos- tion).
phorylate Ser-845 on the AMPA receptor (Module 3: • PKA phosphorylates the regulatory (R) domain on the
Figure AMPA receptor phosphorylation). cystic fibrosis transmembrane conductance regulator
• Cyclic AMP acting through PKA stimulates the (CFTR) to enable it to function as an anion channel
fructose-2,6-bisphosphatase component to lower the (Module 3: Figure CFTR channel).
level of fructose 2,6-bisphosphate, which reduces glyco- • In the small intestine, PKA phosphorylates the cystic
lysis and promotes gluconeogenesis (Module 2: Figure fibrosis transmembrane conductance regulator (CFTR)
AMPK control of metabolism). channel (Module 3: Figure CFTR channel) that is re-
• In insulin-secreting β-cells, the salt-inducible kinase 2 sponsible for activating fluid secretion (Module 7: Fig-
(SIK2) that phosphorylates transducer of regulated cyc- ure intestinal secretion). Uncontrolled activation of
lic AMP response element-binding protein (TORC) cyclic AMP formation by cholera toxin results in
is inhibited by a cyclic AMP/PKA-dependent phos- cholera.
phorylation (Module 7: Figure β-cell signalling). • In kidney collecting ducts, cyclic AMP acts through
• PKA phosphorylates the hormone-sensitive lipase PKA to phosphorylate Ser-256 on the C-terminal cyto-
(HLS) that initiates the hydrolysis of triacylglycerol plasmic tail of aquaporin 2 (AQP2), enabling this water
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r6
GDP
S i
Cholera GDP
toxin
- GTP
S + - i
GTP
ABCC4
HCO + Cyclic
3
Soluble adenylyl cyclase AMP PDE 5’AMP
EPAC + + CNGC
Rap1 PKA
PLC
+ Ca2+
+ P
InsP 3
DAG
+ + CFTR
+ + + +
P
Cyclic
GMP P + + Ca2+
AMPAR
P P
cGMP PDE
P P P RYR
CREB P
5’GMP P CaV1.1
F-2,6-P2 P
phosphatase Lipase Phosphorylase PLN Ca V1.2
kinase ER/SR
SERCA
channel to fuse with the apical membrane to allow wa- • The ryanodine receptor 2 (RYR2) is modulated by phos-
ter to enter the cell (Module 7: Figure collecting duct phorylation through PKA, which is associated with the
function). cytoplasmic head through an AKAP (Module 3: Figure
• In blood platelets, cyclic AMP activates the ryanodine receptor structure).
phosphorylation of vasodilator-stimulated phos- • Sarco/endo-plasmic reticulum Ca2 + -ATPase 2a
phoprotein (VASP), which is a member of the (SERCA2a) increases its Ca2 + -pumping activity when
Ena/vasodilator-stimulated phosphoprotein (VASP) the inhibitory effect of phospholamban (PLN) is
family resulting in a decrease in the actin-dependent removed following its phosphorylation by PKA on
processes associated with clotting (Module 11: Figure Ser-16 (Module 5: Figure phospholamban mode of
platelet activation). action).
Cyclic AMP substrates that are components of other Salt-inducible kinase 2 (SIK2)
signalling systems: The salt-inducible kinase 2 (SIK2) functions to phos-
• Phosphorylation of the cyclic GMP phosphodiesterase phorylate the transducer of regulated CREB (TORC2),
PDE1A by PKA results in a decrease in its sensitivity thereby preventing it from entering the nucleus to facil-
to Ca2 + activation. itate the activity of the transcriptional factor cyclic AMP
• Entry of Ca2 + through the L-type CaV 1.1 channel response element-binding protein (CREB) (Module 4: Fig-
(Module 3: Figure CaV 1.1 L-type channel) and the L- ure CREB activation). It functions to regulate TORC2
type CaV 1.2 channel (Module 3: Figure CaV 1.2 L-type in liver cells (Module 7: Figure liver cell signalling) and
channel) is enhanced through PKA-dependent phos- in insulin-secreting β-cells (Module 7: Figure β-cell sig-
phorylation. nalling).
• PKA-dependent phosphorylation of dopamine- and
cyclic AMP-regulated phosphoprotein of apparent mo- Exchange proteins activated by cyclic
lecular mass 32 kDa (DARPP-32) functions as a molecu- AMP (EPACs)
lar switch to regulate the activity of protein phosphatase Other targets for the second messenger cyclic AMP are the
1 (PP1). exchange proteins activated by cAMP (EPACs). One of the
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r7
PKA I PKA II
RI RI RII RII
C Tandem C
C C
AKAP
cyclic AMP-binding
domains
Substrate Substrate
Cellular target
Cyclic AMP
RI RI
Cyclic AMP
RII RII
AKAP
C
P
C P P
Substrate Substrate
Substrate Substrate
Cellular target
functions of EPACs is to activate Rap1 and Rap2B, which lar mass 32 kDa (DARPP-32) co-ordinates the activ-
have many functions, many of which are related to con- ity of the dopamine and glutamate signalling pathways
trolling actin dynamics. In addition, the EPAC/Rap path- in medium spiny neurons (Module 10: Figure medium
way can activate phospholipase Cε (PLCε) and this mech- spiny neuron signalling).
anism has been implicated in the control of autophagy • Adrenaline-induced glycogenolysis in skeletal muscle
(Module 11: Figure autophagy signalling mechanisms). cells depends upon a cyclic AMP-dependent phos-
phorylation of phosphorylase kinase (Module 7: Figure
Cyclic AMP signalling functions skeletal muscle E-C coupling).
The cyclic AMP signalling pathway functions in the con- • Activation of the cyclic AMP-dependent transcription
trol of a wide range of cellular processes: factor cyclic AMP response element-binding protein
(CREB) contributes to the regulation of glucagon bio-
• Cyclic AMP suppresses spontaneous Ca2 + oscillations synthesis in glucagon-secreting α-cells (Module 7: Fig-
during oocyte maturation. ure α-cell signalling).
• Cyclic AMP has a potent anti-inflammatory action by
inhibiting the activity of macrophages (Module 11: Fig-
ure macrophage signalling) and mast cells (Module 11: Cyclic AMP hydrolysis
Figure mast cell inhibitory signalling). There are two OFF reactions of the cyclic AMP sig-
• Melanocortin 4 receptors (MC4Rs) on second-order nalling pathway, cyclic AMP efflux from the cell and cyclic
neurons use the cyclic AMP signalling pathway AMP hydrolysis. The latter is carried out by a family of
to induce the hypothalamic transcription factor phosphodiesterase enzymes that hydrolyse cyclic AMP to
Single-minded 1 (Sim1) to decrease food intake and AMP (Module 2: Figure cyclic AMP signalling).
weight loss (Module 7: Figure control of food intake).
• Cyclic AMP mediates the action of lipolytic hormones
in white fat cells by stimulating a hormone-sensitive Cyclic AMP efflux
lipase (Module 7: Figure lipolysis and lipogenesis). There are two OFF reactions for the cyclic AMP sig-
• Heat production by brown fat cells is controlled by nalling pathway, cyclic AMP hydrolysis and cyclic AMP
noradrenaline acting through cyclic AMP (Module 7: efflux from the cell (Module 2: Figure cyclic AMP sig-
Figure brown fat cell). nalling). The latter is carried out by ABCC4, which is one
• The phosphorylation of dopamine- and cyclic of the ATP-binding cassette (ABC) transporters (Module
AMP-regulated phosphoprotein of apparent molecu- 3: Table ABC transporters).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r8
Guanine nucleotide
exchange factors
GEFs
Signalling responses
GTP-binding proteins elements, and both the Gα subunit and the Gβγ subunit
There are a large number of GTP-binding proteins, which are able to relay information to downstream components
usually are referred to as G proteins, which play a cent- (Module 2: Figure heterotrimeric G protein signalling).
ral role in cell signalling as molecular switches (Module These heterotrimeric G proteins exist in two states.
2: Figure G protein binary switching). These G proteins When the Gα subunit is bound to GDP, it forms a com-
are also GTPases, and the switching is driven by both the plex with Gβγ subunits to form the inactive heterotri-
binding of GTP and its hydrolysis to GDP. The G protein meric complex. When the GPCRs, which are sensitive to a
is inactive when bound to GDP, but when the GDP is ex- wide range of stimuli (Module 1: Figure stimuli for cyclic
changed for GTP, the G protein/GTP complex is active and AMP signalling), are activated, they function as a guan-
transfers information down the signalling pathway until ine nucleotide exchange factor (GEF) to replace the GDP
the endogenous GTPase activity hydrolyses GTP to GDP. with GTP. The binding of GTP not only activates the
The G proteins belong to two groups, the heterotrimeric Gα subunit, but also liberates the Gβγ subunit, both of
G proteins and the monomeric G proteins, which have which can activate a range of signalling systems. This signal
separate, but overlapping, functions. transduction process is switched off when the endogen-
ous GTPase activity of the Gα subunit hydrolyses GTP
Heterotrimeric G proteins to GDP and the Gα/GDP complex recombines with the
The heterotrimeric G proteins function as transducers for Gβγ subunit to reform the inactive heterotrimeric com-
the G-protein-coupled receptors (GPCRs) that activate a plex. The normal rate of GTPase activity is very low (four
number of cell signalling pathways (Module 1: Table G- to eight conversions per s), which means that the two sub-
protein coupled receptors). These G proteins are made up units have a long time to find their targets. However, there
from 16 Gα, five Gβ and 11 Gγ genes (Module 2: Table are two mechanisms for speeding up the GTPase activity.
heterotrimeric G proteins). These different subunits are Firstly, some of the targets can act to accelerate the GT-
characterized by having various lipid modifications that Pase activity. Secondly, a family of regulators of G protein
serve to insert them into the plasma membrane, where they signalling (RGS) proteins function as GTPase-activating
are positioned to detect information coming in from the proteins (GAPs) that accelerate the Gα subunit GTPase
GPCRs and to relay it to various amplifiers. The Gα sub- activity more than 1000-fold.
units are either palmitoylated or myristoylated near the N- There are G-protein receptor kinases (GRKs) such as
terminus, whereas the Gβγ subunits are prenylated. The β-adrenergic receptor kinase 1 (βARK1), which phos-
heterotrimeric G proteins are extremely versatile signalling phorylate active receptors to provide binding sites for
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r9
G protein β (Gβ) subunits; β1--β5 These β subunits combine with γ subunits to form βγ dimers that have a number of control functions
(for details see Module 2: Figure heterotrimeric G protein signalling)
G protein γ (Gγ) subunits; γ1--γ11 These γ subunits combine with β subunits to form βγ dimers that have a number of control functions
(for details see Module 2: Figure heterotrimeric G protein signalling)
arrestin that prevent the heterotrimeric proteins from (PTB), pleckstrin homology (PH) and phox homology
binding the receptor and this leads to receptor desensit- (PX) domains, indicating that, in addition to their GAP
ization (Module 1: Figure homologous desensitization). activity, they may have other functions. One of these might
The active Gα/GTP and Gβγ subunits are able to re- be the regulation of the G-protein-activated inwardly rec-
lay information to a large number of signalling pathways, tifying K + (GIRK) channel.
which are described in more detail for the different sig- The function of RGS proteins has been clearly defined
nalling pathways: in phototransduction, where RGS9 acts to accelerate GTP
hydrolysis by Gαt (step 6 in Module 10: Figure photo-
• The cyclic AMP signalling pathway (Module 2: Figure transduction).
cyclic AMP signalling).
• The activation of phospholipase Cβ (PLCβ) in the Monomeric G proteins
inositol 1,4,5-trisphosphate (InsP3 )/Ca2 + signalling The monomeric GTP-binding proteins (G proteins) be-
cassette (Module 2: Figure PLC structure and function). long to a large family of approximately 150 members. Ras
• Modulation of the CaV 2 family of N-type and P/Q-type was the founding member, and the family is often referred
channels (Module 3: Figure CaV 2 channel family). to as the Ras family of small G proteins. Within this family,
• Activation of the PtdIns 3-kinase signalling pathway it is possible to recognize five subfamilies: Ras, Rho, Rab,
(Module 2: Figure PtdIns 3-kinase signalling). Ran and ADP-ribosylation factor (Arf) (Module 2: Table
• Activation of phosphodiesterase 6 (PDE6) during pho- monomeric G protein toolkit). The Ran family plays a role
totransduction in photoreceptors (Module 10: Figure in nuclear transport, whereas the large Rab family func-
phototransduction). tions in membrane trafficking. The Ras and Rho family are
• Gαolf functions in sperm motility and chemotaxis. primarily involved in cell signalling, where they function as
• Gαgust , which is also known as gustudin, functions in binary switches to control a number of cell signalling sys-
taste cells and in the L cells that detect food components tems. This binary switch is driven by the binding of GTP,
in the lumen of the intestine L cells (Module 7: Figure which represents the ON reaction, and is followed by the
L cells). hydrolysis of the GTP by the endogenous GTPase activ-
Regulators of G protein signalling (RGS) ity. Most attention has focused on a small number of these
The regulators of G protein signalling (RGS) are a large signal transducers, and the following will be described in
family of approximately 30 proteins that function as detail to illustrate their role in cell signalling:
GTPase-activating proteins (GAPs) for the heterotrimeric
G proteins (Module 2: Figure heterotrimeric G protein sig- • Arf signalling mechanisms
nalling). The Gα subunit has a low intrinsic GTPase activ- • Cdc42 signalling mechanisms
ity and this is greatly increased by the RGS proteins. RGS • Rab signalling mechanisms
structure is defined by an RGS-box region that is respons- • Rac signalling mechanisms
ible for binding to Gα/GTP. However, many of the RGS • Ras signalling mechanisms
proteins contain a number of other protein--protein inter- • Rap signalling mechanisms
action domains, such as PDZ, phosphotyrosine-binding • Rho signalling mechanisms
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r10
InsP3 Ca 2+
G responses
PLC
Stimulus DAG
q
AC Cyclic AMP
s Cyclic AMP
AC
GPCR i
t PDE6 Cyclic GMP
P
GRK
12/13 Cytoskeleton
Rho A
Arrestins
GTP
GTP GDP + Rac Cytoskeleton
AC Cyclic AMP
InsP3 Ca 2+
PLC
DAG G responses
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r11
Glutamate Growth
factors
Ca2+
PTKR
Ras responses
NMDAR
2+ DAG
Ca
+ +
TK TK
RasGRP
RasGRF SOS Raf ERK1/2
Ca2+ CaM
PI 3-K PIP3
+
Ras GTP GDP Ras InsP3 Ca 2+
PLC
GDP GTP
DAG
Son-of-sevenless (SoS) and thus responds to the microdomain of Ca2 + near the
Son-of-sevenless (SoS) is a classical Ras guanine nucle- mouth of the channel. This signalling mechanism func-
otide exchange factor (RasGEF). Its mode of action is tions in neuronal gene transcription (Module 10: Figure
evident in the way the platelet-derived growth factor re- neuronal gene transcription).
ceptor (PDGFR) is linked to the mitogen-activated pro-
tein kinase (MAPK) signalling pathway (Module 1: Fig- Ras guanine nucleotide releasing proteins (RasGRPs)
ure PDGFR activation). SoS binds to the Src homology 3 The Ras guanine nucleotide releasing proteins (RasGRPs)
(SH3)-containing adaptor growth factor receptor-bound are mainly expressed in haematopoietic cells (Module 2:
protein 2 (Grb2), which is attached to the phosphotyr- Table monomeric G protein toolkit). These GRPs are also
osine residues of the activated receptor. Once it is associ- known as CalDAG-GEFs because they are sensitive to di-
ated with the receptor, SoS comes into contact with Ras acylglycerol (DAG) and Ca2 + . They contain a C1 domain
and can begin to facilitate the exchange of GDP for GTP, that binds DAG and they also have a pair of Ca2 + -binding
thus creating the active Ras/GTP complex that begins to EF-hands. The sensitivity to both DAG and Ca2 + sug-
stimulate the MAPK signalling pathway (for further de- gests that these RasGRPs may couple phosphoinositide
tails see Module 2: Figure ERK signalling). signalling to the activation of the various pathways that
are linked to Ras (Module 2: Figure Ras signalling).
Ras guanine nucleotide release-inducing factors
(RasGRFs) Rap signalling mechanisms
The Ras guanine nucleotide release-inducing factors The Ras-related protein (Rap) family are typical small
(RasGRFs) and Ras guanine nucleotide releasing proteins monomeric G-proteins that belong to the Ras superfam-
(RasGRPs) are also important GEFs that can relay inform- ily (Module 2: Table monomeric G-protein toolkit). The
ation to Ras. The RasGRFs, which are strongly expressed Rap family has four members Rap1A, Rap1B, Rap2A and
in brain, are particularly important for the activation of Rap2B. One of the guanine nucleotide-exchange factors
the MAPK signalling pathway in neurons, where they re- (GEFs) is the cyclic AMP-dependent GEF EPAC that
spond to activation of N-methyl-D-aspartate (NMDA) re- regulates the activation of Rap1 and Rap2B. This pathway
ceptors. One of the functions of the latter is to gate Ca2 + , can activate phospholipase Cε (PLCε) (Module 2: Figure
which then acts through calmodulin (CaM) to stimulate cyclic AMP signalling). Such a mechanism has been im-
RasGRF. This is a highly localized signalling event, be- plicated in the control of autophagy (Module 11: Figure
cause the RasGRF is associated with the NMDA receptor autophagy).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r12
Rab responses
Rab REP
GDP Rabankyrin-5
PKB PIP
3
REP SNARE Vesicle
PI 3-kinase p115 fusion
Rab
GDP Insulin
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r13
Rab1 Rab6
Rab1 functions in vesicle tethering and fusion especially During the process of COPII-mediated transport from
during both ER-to-Golgi and Golgi-to-ER transport (see ER to Golgi (Module 4: Figure COPII-coated vesicles),
steps 1 and 2 in Module 4: Figure membrane and protein Rab6 binds to Bicaudal D and thus provides a mechanism
trafficking). During the COPII-mediated transport from to attach the dynein motor complex to the vesicle for its
the ER to the Golgi (Module 4: Figure COPII-coated transfer between the ER and Golgi membranes (Module
vesicles), TRAPP1 is the guanine nucleotide-exchange 4: Figure dynein)
factor (GEF) that converts inactive Rab1.GDP into act-
ive Rab1.GTP during vesicle tethering prior to fusion Rab 7
to the Golgi membrane. The transport from the Golgi The two Rab7 proteins (Rab7A and Rab7B), which are
back to the ER begins with the golgin protein p115 re- expressed ubiquitously, play a role in regulating vesicle
cruiting Rab1b, which then activates the Golgi-specific trafficking between the endocytic and autophagic com-
brefeldin A resistant factor 1 (GBF1), which is a guan- partments. Rab7 is found on the acidic and degradative
ine nucleotide-exchange factor (GEF) for the small mono- organelles, such as the late endosomes, lysosomes, mul-
meric G-protein ADP-ribosylation factor 1 (Arf1) that has tivesicular bodies, phagosomes and autophagolysosomes.
an important role in controlling key events such as coat These mechanisms regulate the degradation of endocytic
formation, actin polymerization and Golgi vesicle bud- cargos such as EGF receptors and neurotrophic factor re-
ding during COPI-mediated transport from the Golgi to ceptors such as TrkA and internalized cholesterol. The role
the ER (Module 4: Figure COPI-coated vesicles). of RAB7 in lysosomal transport depends on the effector
protein Rab7-interacting lysosomal protein (RILP). Rab7
may also play a role in the retrograde trafficking of the
Rab3
signalling endosomes that supply trophic support to peri-
There are three Rab3 proteins (Rab3A, Rab3B, Rab3C and
pheral neurons.
Rab3D) that function in regulated exocytosis. These Rab3
Charcot-Marie-Tooth disease type 2B is caused by
members tend to be restricted to cells types with high rates
mutations in Rab7A.
of exocytosis such as neurons and neuroendocrine cells
(Rab3A and Rab3C). Rab3B is located on tight junctions Rab8
and secretory granules in epithelial cells. The more widely Rab8A interacts with myosin Vb to carry out non-
expressed Rab3D is located on the secretory granules of clathrin-dependent endocytosis. It also plays a role in the
non-neuronal cells such as fat cells, adipocytes, exocrine biogenesis of cilia by interacting with cenexin/ODF2.
glands and certain haematopoietic cells. Rab3A and Rab3C A defect in the transcriptional regulation of Rab8A has
tend to reduce exocytosis, whereas Rab3B and Rab3D have been linked to Microvillus inclusion disease.
a more positive role.
The activation of these Rabs is regulated by a Rab3GAP Rab11
which has two components: a catalytic RabGAP1 sub- There are three Rab11 proteins (Rab11A, Rab11B and
unit and a non-catalytic RabGAP2 subunit. Mutations in Rab11C), which function in both endocytic recycling and
RabGAP1 have been linked to Warburg Micro syndrome cytokinesis. Rab11 plays an important role in the trans-
whereas a milder form called Martsolf syndrome is cause port of synaptic vesicles where it is attached to myosin
by mutations in RabGAP2. Vb through the Rab11-family interacting proteins (FIPs)
(Module 4: Figure myosin motor). Such trafficking events
leading to receptor insertion are key components in the
Rab4
relationship between Ca2 + and synaptic plasticity during
Rab 4, together with myosin V, functions in early endo-
the process of learning (Module 10: Figure Ca2 + -induced
some to plasma membrane trafficking (Module 4: Figure
synaptic plasticity).
early endosome budding). Rab 4, together with myosin V,
Rab11, together with its effector FIP2, also plays a role
also functions in early endosome to trans-Golgi network
in the trafficking and insertion of aquaporin-2 (AQP2)
(TGN) trafficking (Module 4: Figure early endosome bud-
(Module 7: collecting duct function) and also plays a role
ding).
in controlling the trafficking and insertion of new vesicles
to form the cleavage furrow during cytokinesis (Module
Rab5 9: Figure cytokinesis).
Rab5 plays a role in endosome vesicle fusion to early endo-
somes by targeting vesicles to the early endosome (Module Rab27
4: Figure endosome vesicle fusion). Such a role is mani- There are two Rab27 proteins (Rab27A and Rab27B),
fest during phagosome maturation (Module 4: Figure pha- which function in intracellular transport of secretory gran-
gosome maturation). Rab5 also has a role in activating ules and melanosomes (Module 4: Figure myosin mo-
hVPS34 to promote vesicle nucleation during autophagy tor). Rab27 exerts its actions through various effectors
(Module 11: Figure autophagy signalling mechanisms). that fall into three families that have distinct functions.
Rabex-5 is the guanine nucleotide-exchange factor There are synaptotagmin-like proteins (Slps), Slp lacking
(GEFs) that activates Rab5, which then interacts with the C2 domains (Slac2s) and the Rab3-binding domain (RBD)
effector Rabaptin-5. Rab22 may play a role in recruiting family. They all have an N-terminal Rab27-binding do-
Rabex-5 to the early endosome. main known as the Slp-homology domain (SHD), which
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r14
binds to the GTP-bound form of Rab27. The Slp and RBD • Rab-coupling protein (RCP) is also known as FIP1C
families also have two C-terminal C2 domains, which
enables these effectors to bind to phospholipids at the ClassII (have typical Ca2 + -binding EF-hands)
plasma membrane and thus enables Rab27a to regulate
the secretory machinery at the vesicle docking step. The • FIP3, which is also known as Arfophilin and Eferin,
Slac2-a/Melanophilin and Slac2-c/MyRIP complexes link contributes to the role of Rab11 in trafficking and in-
Rab27a to molecular motors such as MyoVa (Module 4: sertion of membrane vesicles during formation of the
Figure myosin motor). The active Rab27.GTP carries out cleavage furrow responsible for cytokinesis (Module 9:
a number of functions: Figure cytokinesis).
• FIP4, which is also known as Arfophilin-2, functions
• One of the functions of RAB27A is to move melano-
like FIP3 to regulate cytokinesis.
somes along actin filaments in retinal pigment epithe-
lium cells and in melanocytes. A defect in the transport
of melanocytes results in choroideraemia. In the case Mutations in FIP2/optineurin have been linked to
of melanogensis, Rab27A interacting with melanophilin some forms of glaucoma and amyotrophic lateral sclerosis
that then uses myosin Va to move melanosomes to the (ALS).
cell periphery of the melanocytes (Module 7: Figure
melanogenesis). Rac signalling mechanisms
• Another function of Rab27A is to regulate the secre- The Rac signalling pathway has an important role in ac-
tion of perforin- and granzyme-containing cytotoxic tivating a number of signalling pathways (Module 2: Fig-
granules at the immunological synapse that forms when ure Rac signalling). Like other G proteins, Rac functions
cytotoxic T lymphocytes (CTLs) and natural killer as a binary switch. It is inactive when bound to GDP,
(NK) cells interacts with their target cells, such as virus- but when this GDP is exchanged for GTP, the Rac/GTP
infected cells and tumour cells. Interaction of the T complex becomes active. External stimuli can activate this
cell receptor (TCR) with an antigen-presenting target switch using different guanine nucleotide exchange factors
cell induces the rapid polarization of the microtubule- (GEFs) such as T cell lymphoma invasion and metastasis
organizing center (MTOC), which orchestrates secre- (Tiam), Kalirin, Vav, SoS and P-Rex. Arf6, which particip-
tion of the cytotoxic granules at the immunological syn- ates in the Arf signalling pathway, stimulates the Rac GEF
apse. The Rab27 effector hMunc13-4 contributes to the called downstream of Crk-180 homologue (DOCK180).
maturation and exocytosis of the perforin-containing Kalirin functions in the Ephrin (Eph) receptor signalling
granules. Several inherited conditions, which lead to pathway, where it links the EphB receptor to Rac and actin
functional impairment of this cytotoxic pathway result assembly (Module 1: Figure Eph receptor signalling). The
from defects in either Rab27A or hMunc13-4. Muta- lipid second messenger PtdIns3,4,5P3 , which is produced
tions in Rab27A have been linked to Griscelli syn- by the PtdIns 3-kinase signalling pathway, is particularly
drome type 2 (GS2), whereas mutations in hMunc13- effective in stimulating many of these GEFs.
4 cause familial hemophagocytic lymphohistiocytosis The activated Rac/GTP complex has a number of im-
type 3 (FHL3). portant actions:
• Insulin granules are tethered to the plasma membrane
using the effector Slp4-a/granuphilin-a to interact with A. Rac is responsible for mediating the action of the
both Rab27A and the SNARE protein syntaxin-1a. PtdIns 3-kinase signalling pathway in stimulating the
• In glucagon-secreting α-cells in the pancreas, glucagon NADPH oxidase to initiate the reactive oxygen species
granules are targeted to the plasma membrane by Slp2a. (ROS) signalling pathway (Module 2: Figure plasma
Rab11-family interacting proteins (FIPs) membrane ROS formation).
The Rab11-family interacting proteins (FIPs) serve as ef- B. It stimulates the JNK (c-Jun N-terminal kinase) sig-
fectors for a number of Rabs and ADP-ribosylation factors nalling pathway (Module 2: Figure JNK signalling).
(Arfs). There are five members, which all have a Rab11- C. It promotes actin stability by stimulating p21-activated
binding domain (RBD) at the C-terminus and are divided kinase (PAK) to phosphorylate LIM kinase, which
into two classes: phosphorylates cofilin to inhibit its ability to cut actin.
Class I (have a phospholipid-binding C2 domain) D. It contributes to focal adhesion integrin signalling
(Module 6: Figure integrin signalling).
• Rip11, which is also known as pp75 or FIP5, functions E. It promotes actin remodelling in several ways. It
in the transport of GLUT-4 vesicles to the cell surface stimulates PtdIns4P 5-kinase to increase the form-
when adipocytes are stimulated by insulin. ation of PtdIns4,5P2 to control actin remodelling
• FIP2, which is also known as optineurin (OPTN), func- (Module 4: Figure actin remodelling). It also acts
tions to couple Rab 11 to the AMPA-containing syn- through insulin receptor substrate p53 (IRSp53),
aptic vesicles (Module 4: Figure myosin motor). Such which activates Wiskott-Aldrich syndrome pro-
trafficking events leading to receptor insertion are key tein (WASP) to co-ordinate the activity of the
components in the relationship between Ca2 + and syn- actin-related protein 2/3 complex (Arp2/3 complex)
aptic plasticity during the process of learning (Module that initiates actin polymerization (Module 4: Figure
10: Figure Ca2 + -induced synaptic plasticity). actin remodelling). Such a role is evident in neurons
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r15
Rac responses
Stimulus Stimulus
PTKR GPCR
+ Ca2+
Arf6
PIP
3
Ca2+
TK
TK
CIB1 Cofilin
DOCK P
Vav1 Actin
CaMKII Kalirin 180 Sos GEFs disassembly
TIAM P-Rex Cofilin
PAK1 LIM-K1
P
Rac GTP GDP Rac
GDP GTP Actin
IRS p53 WAVE Arp2/3 assembly
Actin
3BP-1 GAPs polymerization
PtdIns4P
PtdIns4P Actin-Profilin
5-kinase Profilin
PtdIns4,5P2
during spine morphogenesis (Module 10: Figure post- p115-RhoGEF and PDZ-RhoGEF are specific for coup-
synaptic density) and during the Ca2 + and synaptic ling G-protein-coupled receptors (GPCRs) to Rho activa-
plasticity changes that occur during long-term poten- tion. Net-1, which appears to be sensitive to PtdIns3,4,5P3
tiation (LTP) (Module 10: Figure Ca2 + -induced syn- (PIP3 ), is normally found in the nucleus, but translocates
aptic plasticity). to the cytoplasm, where it functions to activate RhoA. An-
other important GEF is Ect2, which is also found in the
Rho signalling mechanisms nucleus during interphase, but then associates with micro-
The Rho (Ras homologue) signalling pathway has an im- tubules during mitosis, where it stimulates the activation
portant role in regulating a number of systems, in par- of Rho cytokinesis (Module 9: Figure cytokinesis).
ticular the operation of the cytoskeleton. It regulates the The activated Rho/GTP complex is able to stimulate a
function of actin in two main ways. Firstly, it controls number of signalling processes, many of which are directed
some of the processes that function in actin assembly and towards remodelling of actin and its contraction. Many of
it also operates one of the control mechanisms that regulate the actions of Rho are carried out through a Rho kinase
the myosin II--actin interaction responsible for contraction (ROK). Diaphanous-related forming 1 (Dia1) is one of
both in smooth muscle cells and non-muscle cells (Module the downstream effectors that responds to Rho/GTP by
2: Figure Rho signalling). Like other G proteins, Rho func- interacting with profilin to increase actin polymerization.
tions as a binary switch. It is inactive when bound to GDP, Oligophrenin-1 (OPHN1) is a Rho Gap that functions
but when this GDP is exchanged for GTP, the Rho/GTP to stabilize AMPA receptors at neuronal synapses and thus
complex becomes active. External stimuli can activate this plays an important role in both synapse formation and
switch using different Rho guanine nucleotide exchange synaptic plasticity. Mutations in the OPHN1 gene have
factors (RhoGEFs). There are a large number of such been linked to mental retardation.
RhoGEFs that are characterized by having a Dbl homo- The following are some examples of the function of Rho
logy (DH) domain. The term Dbl comes from diffuse B cell signalling:
lymphoma, which is the cell line where the first RhoGEF
was identified. The family of Dbl-containing GEFs has
now expanded to 69 members, some of which are shown • Activation of smooth muscle contraction (Module 7:
in Module 2: Table monomeric G protein toolkit. These Figure smooth muscle cell E-C coupling).
GEFs are not necessarily specific for Rho: some are rather • Assembly of the actomyosin contractile ring and
promiscuous and will also function as Rac and Cdc42 activation of the contraction during cytokinesis
GEFs. In the case of Rho, ephexin appears to be specific for (Module 9: Figure cytokinesis).
coupling ephrin receptors to Rho (Module 2: Figure Rho • Endothelial cell contraction to open the permeability
signalling). Also leukaemia-associated RhoGEF (LARG), barrier (Module 7: Figure endothelial cell contraction).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r16
Rho responses
CaM
MLCK
s
Stimulu Stimulus Myosin II
MLC P
Contraction
P
PPI
GPCR MYPT1
PTKR
PIP PPI
3 12/13 P
TK
MYPT1
TK
ROK
Net1 LARG p115-RhoGEF
Ephexin
PDZ-RhoGEF
LIM-K1 Cofilin
PtdIns4P Actin
GTP GDP assembly
P
Rho Rho PtdIns4P Cofilin
GDP GTP 5-kinase
Actin
PtdIns4,5P2 polymerization
DLC1 p190Rho
GAPs GAP
mDia
Profilin
Actin-Profilin
• Assembly of the actin ring in osteoclast podosomes of its main actions is to stimulate the Wiskott-Aldrich
(Module 7: Figure osteoclast podosome). syndrome protein (WASP) that acts on the actin-related
• Eph receptor-induced growth cone collapse in develop- protein 2/3 complex (Arp2/3 complex) to initiate actin
ing neurons (Module 1: Figure Eph receptor signalling). polymerization (Module 4: Figure actin remodelling). This
• Activation of uropod contraction during neutrophil action is facilitated by Cdc42 acting on profilin through in-
chemotaxis (Module 11: Figure neutrophil chemotactic sulin receptor substrate p53 (IRSp53) and Mena.
signalling). The Cdc42 signalling mechanism plays an important
• Physical interactions between endothelial cells and role in actin polymerization in synaptic spines as part of
the extracellular matrix (ECM) activate p190RhoGAP the events associated with Ca2 + and synaptic plasticity
that is responsible for the mechanosensitive control of (Module 10: Figure Ca2 + -induced synaptic plasticity).
VEGF receptor expression. Arf signalling mechanisms
Cdc42 signalling mechanisms The ADP-ribosylation factors (Arfs) are best known for
The Cdc42 signalling mechanism has an important role their role in membrane and protein trafficking. There are
in controlling the actin cytoskeleton. It regulates some of six mammalian Arfs that are divided into three classes
the processes that function in actin assembly (Module 2: (Module 2: Table monomeric G-protein toolkit). The Class
Figure Cdc42 signalling). Like other G proteins, Cdc42 I and Class II Arfs are found mainly at the Golgi and
functions as a binary switch. It is inactive when bound also on various endosomal membranes where they func-
to GDP, but when this GDP is exchanged for GTP, the tion in actin remodelling and formation of the coat pro-
Cdc42/GTP complex becomes active. External stimuli ac- tein complexes responsible for the vesicle budding that
tivate this switch using different guanine nucleotide ex- transfers cargo form one compartment to another. Such
change factors (GEFs), such as intersectin-long (ITSN- a role is evident in the case of COPI-mediated transport
L) and PAK-interacting exchange factor α (α-Pix). Just from Golgi to ER (Module 4: Figure COPI-coated ves-
how these Cdc42 RhoGEFs are activated is still not prop- icles). Class III has a single member Arf6, which func-
erly understood. In the case of the Ephrin (Eph) receptor tions at the plasma membrane where it can have marked
signalling pathway, intersectin is activated by binding to effects on actin polymerization. One action of Arf6 is to
the EphA receptor (Module 1: Figure Eph receptor sig- induce the trafficking of Rac1 to the plasma membrane
nalling). The activated Cdc42/GTP complex then stimu- where it is activated by the Rac GEF called downstream of
lates various elements that regulate actin polymerization. Crk-180 homologue (DOCK180) to increase membrane
It promotes actin stability by stimulating p21-activated ruffling and focal adhesion actin attachment (Module 6:
kinase (PAK) to phosphorylate LIM kinase, which phos- Figure integrin signalling). The DOCK180 acts as a com-
phorylates cofilin to inhibit its ability to cut actin. One plex in association with a protein called engulfment and
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r17
ulus Stimulus
Stim
PIP
3
TK
? Cofilin
TK
P
ITSN-L Dbs
-Pix GEFs
PAK4 LIM-K1 Cofilin
Actin-Profilin
Profilin
cell motility (ELMO). Arf6 has also been implicated in Another group of Arf GAPs with ANK repeats and PH
the endocytosis of AMPA receptors during the process domain (AZAPs) have 12 genes that fall into four groups
of Ca2 + -induced synaptic plasticity at synaptic endings and the ‘Z’ refers to the protein domain that characterizes
(See step 4 in Module 10: Figure Ca2 + -induced synaptic each subgroup:
plasticity). This function of Arf6 depends on the activity
of BRAG2, which is an Arf GEF that binds to the Glu2 • Arf GAP with coiled-coil, ANK repeats and PH domain
subunit of the AMPA receptor. (ACAP)
Like other monomeric GTP-binding proteins (G- • Arf GAP with GLD domain, ANK repeats and PH
proteins), Arf activity is regulated by a balance between domain (AGAP)
Arf guanine nucleotide-exchange factors (Arf GEFs) and • Arf GAP with Rho GAP, ANK repeats and PH domain
the Arf GTPase-activating proteins (Arf GAPs) (Module (ARAP)
2: Figure Arf signalling). Examples of Arf GEFs are Golgi- • Arf GAP with Src homology 3, ANK repeats and PH
specific brefeldin A resistant factor 1 (GBF1) and Arf domain (ASAP)
nucleotide-binding site opener (ARNO). These activation The ASAP family has three genes (ASAP1--3). The
mechanisms are counteracted by the Arf GAPs that facil- ASAP3--Arf6 complex is of interest because it is sensitive
itate the hydrolysis of GTP to GDP thus converting the to Ca2 + that binds to a specific region at the complex
complex back into its inactive Arf.GDP state. There are 24 interface. This sensitivity to Ca2 + suggests that there
human genes coding for Arf GAPs, which are character- may be cross-talk between the Arf and Ca2 + signalling
ized by having an Arf GAP domain, that can be separated pathways.
into two main groups: the Arf GAP1 type and the Arf GAP To carry out its role in vesicle trafficking, the Arfs have
with ANK repeats and PH domain (AZAPs) (Module 2: two main actions. First, they catalyse the nucleation and
Table monomeric G protein toolkit). assembly of coat protein complexes during the process
The Arf GAP1 group has three genes coding for Arf of vesicle budding. This role is particularly evident at the
GAP1-3, two genes for stromal membrane-associated pro- Golgi during the formation of COPI vesicles (Module 4:
tein 1 and 2 (SMAP1 and SMAP2) and two genes coding Figure COPI-coated vesicles). The Arfs also play a role in
for G-protein-coupled receptor kinase interactors 1 and recruiting various Arf-associated golgins, such as GMAP-
2 (Git1 and Git2). ArfGAP1 and ArfGAP2/3 inactivates 210, to the Golgi membrane.
Arf1.GTP resulting in the shedding of the COPI coat as The Arfs also function by activating the PtdIns4,5P2 sig-
the vesicles approach the endoplasmic reticulum (See step nalling cassette responsible for controlling multiple func-
7 in Module 4: Figure COPI-coated vesicles). tions (Module 2: Figure PtdIns4,5P2 signalling). The Arfs
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r18
Arf responses
Brefeldin A (BFA) Nucleation and assembly of
coat protein complexes
Rab1
GEFs Cortactin
GBF1 ARNO
PtdIns
PtdIns4K
II
Arf GTP GDP Arf
GTP Actin Vesicle
GDP PtdIns4P
polymerization budding
AGAPs
ACAPs
ASAPs PtdIns4P
Arf GAPs
Git1/2 ARAPs 5-kinase
GAPs PtdIns4,5P2
PC PLD PA
act by recruiting and stimulating both PtdIns 4 kinase p21-activated kinase (PAK)
IIIβ and the PtdIns4P 5-kinase (Module 2: Figure Arf sig- The p21-activated kinases (PAKs) are some of the major
nalling). All of the Arfs are responsible for phospholipase downstream targets of Rac and Rho (Module 2: Figure
D (PLD) activation (Module 2: Figure PLD signalling). Rho-regulated kinases). They have been implicated in a
The subsequent formation of phosphatidic acid (PA), large number of processes such as actin remodelling, cell
which is a bioactive lipid, has two actions: it acts syn- cycle control, transcription and apoptosis. There are six
ergistically to stimulate PtdIns4P 5-kinase and it alters isoforms (PAK1--PAK6) with slightly different functions.
membrane curvature during vesicle budding (Module 2: Rac acts through LIM kinase 1 (LIMK1) to phosphorylate
Figure Arf signalling). cofilin (Module 2: Figure Rac signalling). Rho acts through
PAK4 to phosphorylate the same LIMK1 (Module 2: Fig-
ure Cdc42 signalling). Another function of PAK1 is to
Dedicator of cytokinesis 8 (DOCK8)
phosphorylate myosin light chain kinase (MLCK), result-
There is a family of eleven dedicator of cytokinesis
ing in a decrease in the activity of the actin--myosin con-
(DOCK) proteins that are guanine nucleotide-exchange
tractile system. PAK1 can also be activated independently
factors (GEFs) that appear to act primarily on the Rac sig-
of Rac through the calcium and integrin-binding protein 1
nalling mechanism and the Cdc42 signalling mechanism.
(CIB1) that acts by stimulating PAK1 (Module 2: Figure
A typical example is DOCK8, which has an N-terminal
Rac signalling).
DOCK Homology Region-1 (DHR-1) responsible for the
The fragile X mental retardation protein 1 RMRP1,
guanine nucleotide-exchange reaction and a C-terminal
which is mutated in fragile X syndrome (FXS), may
DHR-2 domain that is thought to bind phospholipids.
act to inhibit the function of PAK particularly during
This family of DOCK proteins may act by remodelling
actin remodelling in neuronal spines (Module 10: Figure
actin to carry out a variety of cellular functions such as the
Ca2 + -dependent synaptic plasticity).
control of cell migration, morphology, adhesion and pro-
liferation. During the process of B-cell differentiation in
the lymph node, DOCK8 is activated following its inter- Myotonic dystrophy kinase-related Cdc42-binding
action with the integrin intercellular adhesion molecule 1 kinase (MRCK)
(ICAM1) (Module 8: Figure B cell maturation signalling). Myotonic dystrophy kinase-related Cdc42-binding kinase
Loss-of-function mutations in DOCK8 have been (MRCK) has a number of functional domains and be-
linked to variants of hyper-IgE syndromes (HIES) and longs to the same family as Rho kinase (ROK) (Module
mental retardation. 2: Figure Rho-regulated kinases). MRCK, which is
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r19
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r20
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r21
activated by Cdc42·GTP, may play a role in actin forma- stabilize actin by phosphorylating LIM, which then phos-
tion during the growth of neurites. One of the downstream phorylates cofilin to prevent it from severing actin. Rho
targets of MRCK is the MYPT1 subunit (Module 5: Table also acts on diaphanous-related formin protein (Dia),
PP1 regulatory and inhibitory subunits and proteins) that which belongs to a formin-related protein family that in-
binds protein phosphatase 1δ (PP1δ) and which dephos- teracts with profilin to promote actin polymerization.
phorylates the myosin light chain (MLC). The other major function of ROK is to control contrac-
tion by activating myosin II in smooth muscle cells and
in non-muscle cells. The activity of myosin II is regulated
Rho kinase (ROK) by the phosphorylation status of the myosin light chain
Rho kinase (ROK) is a serine/threonine kinase that phos- (MLC) that is associated with the myosin head. When
phorylates key regulators of actin and myosin function MLC is dephosphorylated, myosin is inactive, but when
(Module 2: Figure Rho-regulated kinases). ROK acts to it is phosphorylated by the Ca2 + -sensitive myosin light
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r22
PBD Kinase
P21-activated kinase (PAK)
Kinase PBD
Cdc42
MYPT1 GTP
CRD
LIMK1/2 Rho
FilGAP GTP
CRD
Kinase CC PBD PH
Rho kinase (ROK)
Kinase CC PBD PH
STIMULUS Time
domain
Exocytosis s
ON REACTIONS
Contraction ms
sec
Ca
2+ Ca2+ Metabolism
Gene
100 nM OFF REACTIONS
500nM
transcription min
Fertilization
Proliferation hr
Hypertrophy
chain kinase (MLCK), myosin can begin to interact with phatase targeting subunit 1 (MYPT1) (Module 5: Table PP1
actin to induce contraction. ROK can influence the phos- regulatory, targeting and inhibitory subunits).
phorylation of MLC by inhibiting the protein phosphatase ROK may also function to inhibit endocytosis by phos-
1 by phosphorylating the scaffolding protein myosin phos- phorylating endophilin.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r23
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r24
STIMULUS 2+
[ Ca ]
PMCA
2nd [Ca 2+ ]
messengers Resting
+ +
SERCA
ER
Na + Na +
Mitochondria
2+
[Ca 2+ ] Ca
Activated
Buffers
1. Agonists such as the neurotransmitters glutamate and DAG formation), which then diffuses into the cell
and ATP act directly on receptor-operated channels to activate the InsP3 receptor (InsP3 R) to release Ca2 +
(ROCs) in the plasma membrane to allow external from the ER.
Ca2 + to enter the cell.
2. Second messengers such as diacylglycerol (DAG), cyc- Ca2 + ON reactions
lic AMP, cyclic GMP and arachidonic acid acting from In response to external stimuli, channels in the plasma
the cytoplasmic side open second messenger-operated membrane or ER are opened, and Ca2 + flows into the
channels (SMOCs) in the plasma membrane. cytoplasm to bring about the elevation of cytosolic Ca2 +
3. Membrane depolarization (V) activates responsible for cell activation (Module 2: Figure Ca2 + sig-
voltage-operated channels (VOCs) in the plasma nalling dynamics). During these ON reactions, the cell
membrane to allow a rapid influx of external Ca2 + . employs a variety of both Ca2 + entry channels and Ca2 +
4. Membrane depolarization (V) activates a specific release channels to create Ca2 + signals with markedly dif-
VOC isoform, the CaV 1.1 L-type channel, that ac- ferent spatial and temporal properties.
tivates the ryanodine receptor 1 (RYR1) in skeletal The entry of Ca2 + across the plasma membrane is car-
muscle through a direct conformational-coupling ried out by many different channels whose names indicate
mechanism. how they are opened:
5. Membrane depolarization (V) activates voltage- • Voltage-operated channels (VOCs)
operated channels (VOCs) in the plasma membrane • Agonist-operated channels (AOCs)
to allow a rapid influx of external Ca2 + (see Mod- • Receptor-operated channels (ROCs)
ule 3) to provide a Ca2 + trigger that then activates the • Second messenger-operated channels (SMOCs)
ryanodine receptor 2 (RYR2) to release Ca2 + stored in • Store-operated channels (SOCs)
the sarcoplasmic reticulum (SR) through a process of
Ca2 + -induced Ca2 + release (CICR). This mechanism Release of Ca2 + from internal stores is carried out by
is found in cardiac muscle and neurons. different types of channels and control mechanisms:
6. Agonists acting on cell-surface receptors generate inos- • Ryanodine receptors (RYRs)
itol 1,4,5-trisphosphate (InsP3 ) (Module 2: Figure InsP3 • InsP3 receptors (InsP3 Rs)
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r25
• NAADP control of Ca2 + release Another classical process for releasing internal Ca2 +
is the inositol 1,4,5-trisphosphate (InsP3 )/Ca2 + signalling
One of the major problems in Ca2 + signalling has been cassette (Ca2 + module 6 in Module 2: Figure Ca2 + mod-
to determine how stimuli arriving at the cell surface gain ules). Other Ca2 + -mobilizing messengers have been de-
access to these internal stores. Two main mechanisms have scribed such as sphingosine 1-phosphate (S1P), cyclic ADP
been identified: ribose (cADPR) and nicotinic acid–adenine dinucleotide
phosphate (NAADP).
1. Conformational coupling through a protein--protein The channels responsible for these Ca2 + ON reactions
interaction. This is a very fast mechanism that depends usually have powerful inactivation mechanisms that rap-
upon a sensor in the plasma membrane interacting dir- idly curtail the entry or release processes to prevent the
ectly with an internal release channel. The receptor on cell being swamped with Ca2 + , which can result in cell
the cell surface is the CaV 1.1 L-type channel (a voltage stress and apoptosis. Once the ON reactions have been
sensor), which is coupled to the type 1 ryanodine re- curtailed, the Ca 2 + OFF reactions rapidly take over
ceptor 1 (RYR1) (Ca2 + module 4 in Module 2: Figure to return the activated level of Ca2 + back to its resting
Ca2 + modules). Information is transferred through a level.
process of conformational coupling. This mechanism is
restricted to skeletal muscle (Module 7: Figure skeletal
muscle E-C coupling) and perhaps also to some neur-
ons. Ca2 + -induced Ca2 + release (CICR)
2. Generation of diffusible second messengers. Activa- A process of Ca2 + -induced Ca2 + release (CICR) plays a
tion of receptors or channels on the cell surface gen- central role in the way Ca2 + signals are generated. This
erate second messengers that then diffuse into the cell positive-feedback mechanism whereby Ca2 + triggers its
to activate release channels. One of the most signific- own release has two important functions in cells. It en-
ant Ca2 + -mobilizing messengers is Ca2 + itself, which ables Ca2 + entering across the plasma membrane to func-
is a potent activator of the two main internal re- tion as a messenger to release Ca2 + from the internal store
lease channels, the ryanodine receptors (RYRs) and the (Module 2: Figure Ca2 + -induced Ca2 + release). This func-
inositol 1,4,5-trisphosphate receptors (InsP3 Rs). This tion of CICR was first described in cardiac cells, where the
Ca2 + -induced Ca2 + release (CICR) mechanism has CaV 1.2 L-type channel provides an influx of trigger Ca2 +
the unique property of being autocatalytic and plays that then diffuses into the cell to activate the ryanodine
a central role in generating those Ca2 + signals that receptor 2 (RYR2) (Ca2 + module 5 in Module 2: Figure
appear as regenerative Ca2 + waves (Module 2: Figure Ca2 + modules). A similar interaction is particularly evid-
Ca2 + -induced Ca2 + release). ent for neuronal Ca2 + entry and release channels.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r26
Adiponectin
+
RYR1 STIM1
Acidic Ca 2+ STIM2
Ca 2+
AdipoR1/2 stores
Ca 2+
PMCA1-4
NAADP InsP3
Ca 2+ TPC1 +
TPC2 +
InsP 3 R1-3
NCX1-3 ER buffers
Ca 2+
Calsequestrin
Na+ 2+ Calreticulin
+ + Ca GRP78
K+ & Na+ GRP94
Ca 2+ RYR2-3
NCKX1-4
SERCA1-3
Na+
cADPR
Ca 2+
Na/Ca + Cytosolic buffers
exchanger
Ca 2+ CalbindinD-28k
Calretinin
Mitochondrial Parvalbumin
Ca 2+ calcium SPCA1-2
uniporter
+ +
ATP Nucleus
synthesis
ROS
MTP
formation + + TRPML1 Chromatin Cell
Apoptosis remodelling remodelling
Ca 2+ Ca 2+
Cell
+ Gene
proliferation
C2 domain EF-hand transcription
Exocytosis Annexin 1-13
+
CaM NCS-1
Otoferin Hippocalcin
TnC
+ Protein kinase C Neurocalcin
Calpains
RASAL Recoverin
Miro1-2
Endocytosis SynaptotagminI-III VILIP1-3
S100A1-14
S100B GCAP1-3 +
KChIP1-4 Protein synthesis
S100C
CaBP1-5
+
S100P hVps34/mTOR
+ MICU1 +
Excitability and
fluid secretion + + + Metabolism
DAG kinase
K+ IP 3 Kinase
BK, SK,IK & TRESK Signalling crosstalk Cytoskeletal Phopho-
Motility diesterase
remodelling
Cl - Cyclic AMP NO ROS MAPK PI 3-K Actin Myosin
Phosphorylase
polymerization
Na+ Actin
TRPM4/5 Ras
TRPV4-6 AC NOS DUOX
Summary of the major components that contribute to the Ca2 + signalling signalsome.
There is an extensive Ca2 + signalling toolkit. The green boxes illustrate the membrane Ca2 + channels, whereas the red boxes are the pumps and
exchangers that move Ca2 + either out of the cell or back into the endoplasmic reticulum (ER). The purple boxes represent the buffers located in
the cytoplasm or in the endoplasmic reticulum (ER). To carry out its signalling function, Ca2 + binds to sensors with C2 or EF-hand domains that
then employ a range of effectors to stimulate cellular processes shown in the yellow boxes. These different components are mixed and matched to
construct various Ca2 + signalling modules (Module 2: Figure Ca2 + modules) that are then assembled to produce cell-specific signalsomes.
The other main function of CICR is to set up respectively. It is these unitary events that are used to gen-
intracellular Ca2 + waves where an elevated level of Ca2 + erate the regenerative waves that make up global Ca2 +
in one region of the cell (the initiation site) propagates signals.
throughout the rest of the cytoplasm as a regenerat-
ive Ca2 + wave. Waves can progress by recruiting either
RYRs or inositol 1,4,5-trisphosphate receptors (InsP3 Rs) Ca2 + OFF reactions
(Module 2: Figure Ca2 + -induced Ca2 + release). These Cells use a variety of mechanisms to remove Ca2 + from
Ca2 + waves are made up of elementary Ca2 + events such the cytoplasm (Module 2: Figure Ca2 + signalling dynam-
as the sparks and puffs produced by the RYRs and InsP3 Rs ics). The introduction of Ca2 + into the cell during the
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r27
CHANNELS
Plasma membrane channels
Voltage-operated channels (VOCs) See Module 3: Table VOC classification for further details
CaV 1.1 (L-type)
CaV 1.2 (L-type)
CaV 1.3 (L-type)
CaV 1.4 (L-type)
CaV 2.1 (P/Q-type)
CaV 2.2 (N-type)
CaV 2.3 (R-type)
CaV 3.1 (T-type)
CaV 3.2 (T-type)
CaV 3.3 (T-type)
Ca2 + -sensitive ion channels
Ca2 + -activated K + channels See Module 3: Table properties of Ca2 + -sensitive K + channels for
further information
SK (small conductance Ca2 + -sensitive channel)
IK (intermediate conductance Ca2 + -sensitive channel)
BK (large conductance Ca2 + -sensitive channel)
Ca2 + -activated chloride channel
HCLCA1 (human chloride channel, Ca2 + -activated)
Receptor-operated channels (ROCs) See Module 3: Table receptor-operated channel toolkit for further
details)
Nicotinic acetylcholine receptors
5-HT3 5-Hydroxytryptamine receptor
AMPA receptors α-Amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor
NMDA receptors N-methyl-D-aspartate receptor
P2X receptors
Second messenger-operated channels (SMOCs) Module 3: Figure Ca2 + entry mechanisms
Arachidonate-regulated Ca2 + channel (IARC )
Cyclic nucleotide-gated channels (CNGs) Module 3: Figure cyclic nucleotide-gated channels
CNGA1--CNGA4, CNGB1, CNGB3
Transient receptor potential (TRP) ion channel family Module 3: Figure TRP channel phylogeny
TRPC1--TRPC7 Canonical
TRPV1--TRPV6 Vanilloid
TRPM1--TRPM8 Melastatin
Polycystins Module 3: Figure polycystin domain structure
PC1
PC2
Endoplasmic reticulum (ER)/sarcoplasmic reticulum (SR) Ca2 +
release channels
InsP3 receptors (InsP3 Rs) Module 3: Figure InsP3 R structure
InsP3 R1
InsP3 R2
InsP3 R3
Ryanodine receptors (RYRs) Module 3: Figure ryanodine receptor structure
RYR1
RYR2
RYR3
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r28
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r29
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r30
Ca2 + ON reactions usually occurs for a relatively brief and the resting level (Module 5: Figure Ca2 + uptake and
period during which there is a rapid increase in the in- extrusion).
tracellular concentration of Ca2 + . In fact, the increase in Some of these OFF reactions interact with each other
free Ca2 + that can be measured in the cytoplasm using during the recovery period, and this is particularly evident
aequorin or fluorescent indicators is a very small propor- in the case of the ER/mitochondrial Ca2 + shuttle (Module
tion of the total amount of Ca2 + that enters during the 5: Figure ER/mitochondrial shuttle). When Ca2 + is re-
ON reactions. Much of this Ca2 + is rapidly bound by the leased from the ER, Ca2 + is rapidly taken up by the mi-
cytosolic buffers or is taken up by the mitochondria. As tochondria and this is then released slowly back to the ER
the Ca2 + concentration returns to its resting level, Ca2 + once Ca2 + has returned to the resting level.
leaves the buffers and the mitochondria and is returned to In addition to its role of returning the level of Ca2 +
the ER or is pumped out of the cell resulting in a brief to its resting level following a stimulus, the Ca2 + OFF
Ca2 + transient. reactions are in constant operation to maintain the rest-
The recovery process thus depends upon a complex in- ing level of Ca2 + within a fairly narrow range. This cal-
terplay between cytosolic Ca2 + buffers, mitochondria and ciostat is a dynamic system in that the OFF reactions
Ca2 + pumps and exchangers on the internal stores and on are operating continuously to reverse the constant basal
the plasma membrane (Module 2: Figure Ca2 + signalling rate of Ca2 + entry through various ‘Ca2 + leak pathways’
dynamics). These Ca2 + OFF reactions operate at different that remain poorly defined. There is increasing evidence
stages during the recovery phase of a typical Ca2 + spike. that presenilins may function as such a leak channel and
The buffers and mitochondria operate early, and the Ca2 + this has been incorporated into the calcium hypothesis of
pumps and exchangers are responsible for restoring the Alzheimer’s disease (see step 10 in Module 12: Figure amyl-
status quo by pumping Ca2 + out of the cell or back into oid processing and Ca2 + signalling). The latter can result
the ER. These pumps and exchangers operate at different in an elevation of cytosolic Ca2 + if the OFF reactions
times during the recovery process. The Na + /Ca2 + ex- are inhibited. For example, agents such as thapsigargin,
changers have low affinities for Ca2 + , but have very high which inhibit the SERCA pumps on the ER, will result
capacities and this enables them to function at the begin- in an increase in Ca2 + concentration. Indeed, the rate at
ning of the recovery process to rapidly remove large quant- which the Ca2 + concentration rises following pump in-
ities of Ca2 + . On the other hand, the plasma membrane hibition provides a measure of the activity of these leak
Ca2 + -ATPase (PMCA) and sarco/endo-plasmic reticulum pathways.
Ca2 + -ATPase (SERCA) pumps have lower capacities, but In pathological situations, the lack of oxygen reduces
their higher affinities mean that they can complete the re- the supply of energy, thus compromising the function of
covery process and can continue to pump at lower Ca2 + the OFF reactions, resulting in the rise of Ca2 + that is
levels, thus enabling them to maintain the internal stores so damaging during stroke or cardiac ischaemia. Under
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r31
AGONIST
2+
1 Ca
ROC
Second messengers
2 SMOC
2+
Ca
VOC
2+
Ca
3
V
RYR1
SR
4
V 2+
Ca
2+ RYR2
Ca
SR
5
2+
V Ca
InsP InsP R
3 3
AGONIST
ER
6 2+
Ca
normal circumstances, however, the fully energized OFF act as a buffer, and this applies to the sensors. However,
reactions can rapidly reduce the pulse of Ca2 + introduced the concentration of these sensors is usually rather low,
by the ON mechanisms, thus generating a brief Ca2 + so they have little buffering capacity. The role of Ca2 +
transient (Module 2: Figure Ca2 + transient mechanisms). buffering is carried out by the other major group of Ca2 + -
Such brief pulses of Ca2 + are a characteristic feature binding proteins. Cells have a number of buffers (Module
of the Ca2 + signalling pathway and contribute to the 2: Table Ca2 + signalling toolkit) that are capable of bind-
spatiotemporal aspects of Ca 2 + signalling. ing to Ca2 + both in the cytoplasm and within the lumen
of the endoplasmic reticulum (ER). The sole function of
Ca2 + buffers these Ca2 + buffers is to bind Ca2 + , and this has an im-
Cells express a large number of Ca2 + -binding proteins, portant function in shaping both the spatial and temporal
which fall into two main groups: Ca2 + sensors and Ca2 + properties of Ca2 + signals.
buffers. The Ca2 + sensors respond to changes in intracel- The major cytosolic buffers in cells are parvalbumin
lular Ca2 + by activating some downstream effector pro- (PV), calbindin D-28k (CB) and calretinin (CR). The
cess. In a sense, all proteins capable of binding Ca2 + will major buffers that operate within the lumen of the ER
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r32
Stimulus
VOC ROC
Ca2+ InsP3
Intracellular CICR
calcium wave
+
+
+
+
CICR CICR
+
+
+
Spark Puff
R R R I I I
Blink
+
+
+
+
+
Ca2+ ER
The role of Ca2 + -induced Ca2 + release (CICR) in mobilizing Ca2 + from internal stores.
The Ca2 + -sensitive channels are the ryanodine receptors (R) and the InsP3 receptors (I) located on the endoplasmic reticulum (ER). CICR has two
important functions. Firstly, it provides a mechanism for transferring information from the plasma membrane to these internal release channels. The
primary mechanism is based on the voltage-operated channels (VOCs) that open in response to membrane depolarization to allow a small amount
of Ca2 + to enter, which then diffuses into the cell to activate either R or I. The other important function of CICR is to link together these intracellular
channels so that the Ca2 + being released from one channel diffuses across to neighbouring channels that are excited to release further Ca2 + , thereby
setting up regenerative waves (yellow arrows).
Ca2+ entry
Ca2+ release
Ca 2+ buffers
Mitochondria
Na+ /Ca 2+ exchanger
Ca 2+ pumps
(SERCA/PMCA)
ON OFF
Reactions Reactions
CALCIUM TRANSIENT
The sequence of ON and OFF reactions during the generation of a typical Ca2 + transient.
The rising phase of the Ca2 + spike results from the activation of Ca2 + entry and release mechanisms (yellow bars), which are then terminated by
inactivation processes. Once the ON reactions have been inactivated, a series of OFF reactions operate in a sequential manner to restore Ca2 + to
its resting level (blue bars). During the rising phase of the Ca2 + transient, large amounts of Ca2 + are rapidly bound to the Ca2 + buffers (calbindin
D-28k and parvalbumin) and are taken up by the mitochondria. The mitochondria and cytosolic buffers help to shape the Ca2 + signal by reducing
the impact of the ON reactions. In effect, they enable the cell to generate very fast transients without running the risk of being overwhelmed by Ca2 + .
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r33
are calsequestrin (CSQ) in the sarcoplasmic reticulum of miniaturize the Ca2 + component of their signalling sys-
muscle cells and calreticulin (CRT) in the ER of non- tems.
muscle cells. The latter is unusual in that it functions both The ability of CB to buffer internal Ca2 + may play an
as a cytosolic and a luminal buffer. The role of calseques- important role in facilitating Ca2 + reabsorption by the
trin is discussed elsewhere and here we concentrate on the kidney tubule (Module 7: Figure kidney Ca2 + reabsorp-
function of the cytosolic buffers. The latter have subtly tion). In the case of Ca2 + reabsorption by the intestine,
different Ca2 + -binding properties and are expressed in the flux of Ca2 + is facilitated by calbindin D-9k (Module
cells in differing combinations and concentrations to cre- 7: Figure intestinal Ca2 + reabsorption).
ate Ca2 + signals that are tailored to carry out different An important aspect of the calcium hypothesis of
functions. For example, neurons such as Purkinje cells ex- Alzheimer’s disease is that there is a decrease in the ex-
press large amounts of PV and CB. As a consequence, pression of CB, which increases the sensitivity of neurons
Purkinje cells have a large endogenous Ca2 + buffering ca- to the enhanced Ca2 + signals that arise during the onset of
pacity, e.g. their buffers bind approximately 2000 Ca2 + Alzheimer’s disease (Module 12: Figure amyloid cascade
ions for each free ion. Lower capacities of 50--100:1 are hypothesis).
found in other cells. Motor neurons have a very low buf-
fering capacity and consequently have large Ca2 + signals
Calretinin (CR)
in both the soma and dendrites during normal physiolo-
Calretinin (CR) is an EF-hand Ca2 + -binding protein that
gical responses, and this makes them particularly suscept-
is closely related to calbindin D-28k (CB). It has six
ible to neurodegeneration. Buffer concentration is one of
EF-hand domains all of which can bind Ca2 + except for
the important parameters in determining buffer capacity.
domain VI. CR is usually located in the cytoplasm, but can
The other key parameters include affinity for Ca2 + and
also be found localized to specific sites in the cell where
other metal ions, the kinetics of Ca2 + binding, release and
it may function as a buffer to regulate microdomains of
mobility.
Ca2 + . This Ca2 + buffer is an excellent biochemical marker
Alterations in Ca2 + buffers have been linked to
for certain GABAergic inhibitory interneurons such as the
schizophrenia.
Cajal--Retzius neurons and double bouquet neurons in the
dorsolateral prefrontal cortex (DLPFC) (Module 10: Fig-
Parvalbumin (PV) ure dorsolateral prefrontal cortex).
Parvalbumin (PV) is a slow-onset buffer. It has relatively
low on and off rates, which means that it cannot respond
Calreticulin (CRT)
to the rapid onset of most Ca2 + signals. However, PV
Calreticulin (CRT) is a low-affinity Ca2 + -binding protein
can soak up Ca2 + once the signal has appeared and thus
that is located within the lumen of the endoplasmic retic-
influences the rate at which Ca2 + recovers. It is strongly
ulum (ER). It has also been detected in the nucleus and
expressed in skeletal muscle, where it plays an important
cytoplasm and it may also be secreted into the extracellu-
role in facilitating the rate of relaxation. In PV − / − mice,
lar environment during periods of cell stress. Its primary
there is a slowing in the recovery of the Ca2 + transient.
location, however, is within the lumen of the ER, where
Some of the effects of removing PV are compensated for by
it functions both as a chaperone protein and as the major
an increase in the volume of mitochondria that has a similar
ER Ca2 + buffer. CRT has three main domains; there is
ability to PV of removing free Ca2 + from the cytoplasm
a globular N-domain of unknown function followed by
during the recovery phase.
a proline-rich P-domain, which has sequences unique to
Reductions in the level of PV have been recorded in
CRT and its homologous proteins calnexin and calmegin.
schizophrenia.
Finally, there is a highly acidic C-terminal domain, which
has a large number of low-affinity Ca2 + -binding sites cap-
Calbindin D-28k (CB) able of binding 20--30 mol of Ca2 + /mol of protein. This
Calbindin D-28k (CB) is one of the major cytosolic buf- C-terminal region terminates in the KDEL sequence re-
fers, particularly in neurons. It is a fast buffer that can sponsible for retaining CRT in the lumen of the ER.
have a major effect on both the spatial and temporal prop- The chaperone function of CRT is carried out in
erties of Ca2 + transients. CB thus plays a major role in conjunction with a related chaperone calnexin. A cal-
restricting the size of the elementary Ca2 + events that nexin/calreticulin cycle ensures the correct folding and
form around Ca2 + channels. CB is thus of central im- subunit assembly of glycoproteins and is thus essential
portance for the ability of neurons to create the highly for protein trafficking and secretion. The proper folding
localized Ca2 + events that occur in spines. The existence and assembly of proteins is very dependent on a constant
of these buffers has enabled neurons to increase the num- level of Ca2 + within the ER lumen and the chaperones.
bers of their synaptic connections, and this neuronal mini- The ability of CRT to bind large amounts of Ca2 + en-
aturization greatly enhances the signal processing capacity ables it to function as an ER Ca2 + buffer to help maintain
of the brain. Some support for such a notion emerged this constancy of ER Ca2 + . In addition to functioning
from the finding of a remarkable compensatory mechan- as a passive buffer, CRT may play a more direct role in
ism whereby the volume of the spines increases markedly maintaining homoeostatic control of their working envir-
in neurons when these buffers are knocked out. In effect, onment by modulating the activity of the Ca2 + channels
the lack of these buffers reduces the capacity of neurons to and pumps. When the Ca2 + level within the lumen gets too
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r34
high, CRT and calnexin inhibit the sarco/endo-plasmic re- same enzyme that possesses both synthase and hydrolase
ticulum Ca2 + -ATPase (SERCA) pump and, when Ca2 + is activity. The cADPR control of Ca2 + release is somewhat
released, this inhibition is relieved and the SERCA pumps controversial, as its precise mode of action is still unclear.
can restore Ca2 + to its normal level. In addition to its role A cADPR working hypothesis has been put forward to
as an ER buffer, CRT may play an active role in ensur- provide a framework to understand some of the current
ing that the Ca2 + concentration within the ER lumen is information on how this messenger appears to operate. A
maintained at the optimal level for protein folding to occur. relationship between cADPR and cell regulation has been
established in a number of different cell types.
Ca2 + signalling function
The function of Ca2 + as an intracellular second messenger cADPR working hypothesis
is carried out by a combination of Ca2 + sensors and Ca2 + There is sufficient evidence to take seriously the possibility
effectors (Module 2: Figure Ca2 + signalling toolkit). The that cADPR functions to regulate Ca2 + signalling. What
major sensors are the EF-hand proteins troponin C (TnC), seems to be in question is exactly how it functions. This
calmodulin (CaM), neuronal Ca2 + sensor proteins (NCS) working hypothesis has two main components:
and the S100 proteins. However, there are a number of
other sensors (Module 2: Table Ca2 + signalling toolkit). • Firstly, the generation of cADPR is closely coupled to
These sensors are then responsible for relaying inform- cellular metabolism, as described in cADPR generation
ation through a range of effectors: and metabolism (Module 2: Figure cADPR/NAADP
function). The idea is that cADPR may function as a
• Ca2 + -sensitive K + channels
metabolic messenger responsible for relaying informa-
• Ca2 + -sensitive Cl − channels (CLCAs)
tion about the state of metabolism to various systems in
• Ca2 + /calmodulin-dependent protein kinases (CaMKs)
the cell, especially those that require a heavy expenditure
• Calcineurin
of energy. An example would be Ca2 + signalling and the
• Phosphorylase kinase
downstream elements regulated by Ca2 + . When energy
• Myosin light chain kinase (MLCK)
is abundant, an increase in cADPR will set the stage for
• Ca2 + -promoted Ras inactivator (CAPRI) (Module 2:
Ca2 + signalling to occur.
Figure Ras signalling)
• Secondly, the cADPR control of Ca2 + release
may occur indirectly through an activation of the
Spatiotemporal aspects of Ca2 + signalling sarco/endo-plasmic reticulum Ca2 + -ATPase (SERCA)
The use of Ca2 + as a universal signal for cell regulation is pump to increase the uptake of Ca2 + into the endoplas-
somewhat paradoxical because this ion can be very toxic mic reticulum/sarcoplasmic reticulum. This increased
to cells if its level remains high for a prolonged period. loading of the internal store will serve to sensitize re-
Such toxicity is avoided by presenting Ca2 + signals in a lease channels such as the RYRs, thus leading to an in-
pulsatile manner (Module 2: Figure temporal aspects). In crease in Ca2 + signalling. This messenger should thus
addition to this temporal aspect, the Ca2 + signal is also be considered as a modulator rather than a mediator of
highly organized in space. The elementary and global as- Ca2 + signalling.
pects of Ca2 + signalling greatly increase the versatility of
the Ca2 + signalling system in that it can act either locally
cADPR generation and metabolism
or globally. For example, muscle contraction is activated
The generation and metabolism of cADPR are described
by a global elevation in Ca2 + , whereas the release of neur-
together because both processes are carried out by the
otransmitters results from a minute punctate pulse of Ca2 +
same enzyme: the ADP-ribosyl cyclase (Module 2: Fig-
delivered directly to the docked vesicle by a Ca2 + sensor
ure cADPR metabolism). The hydrolysis of cADPR pro-
tightly associated with exocytotic machinery (Module 4:
duces ADPR, which has been implicated as a messenger
Figure Ca2 + -induced membrane fusion). In between these
regulating melastatin-related transient receptor potential 2
two extremes, there are many variations in the way the
(TRPM2), which is a Ca2 + channel in the plasma mem-
Ca2 + signal is presented to cells. Perhaps the most dra-
brane (Module 2: Figure cADPR/NAADP function). This
matic are the Ca2 + waves that initiate at fixed localities
is a highly versatile enzyme. In addition to synthesizing
and then process through the cytoplasm in a regenerative
and metabolizing cADPR, it is also responsible for syn-
manner through the process of CICR (Module 2: Figure
thesizing NAADP. In mammals, this bifunctional enzyme
Ca2 + -induced Ca2 + release).
appears to be the lymphocyte antigen CD38, which is ex-
These spatiotemporal aspects greatly enhance the ver-
pressed widely and is located both in the plasma membrane
satility of Ca2 + signalling, thus providing the flexibility to
and at internal sites. With regard to the former location, its
regulate so many cellular processes.
enzymatic region is located on the outside. This is unusual
because its substrate and its site of action are on the inside
Cyclic ADP-ribose (cADPR) signalling of the cell. It has been suggested that the enzyme might
Cyclic ADP-ribose (cADPR) is one of the messengers as- use NAD + derived from dying cells at sites of infections
sociated with the NAD + signalling pathways. cADPR has to generate cADPR, which is then transported into the
attracted considerable attention as a putative messenger to cell.
regulate the Ca2 + signalling pathway. cADPR generation The intracellular enzyme is more likely to be the one
and metabolism is unusual in that it is carried out by the that functions in most cells. Just how the cyclase is
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r35
CALCIUM TRANSIENT
ON OFF
Reaction Reaction
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r36
Ca 2+ Ca 2+ AGONISTS
VOC TRPM2
Ca 2+ Cellular Ca 2+
metabolism +
Ca2+
+
ATP
RYR NADH ADPR ?
NAD
NADP
+ +
+ Ca 2+ H S
ADP ribosyl cyclase
SERCA
Ca 2+ + cADPR
TPC1/2 + NAADP
Phosphatase
Ca 2+
Lysosome-related
+ NAAD
+ H organelle
H
activated is still unclear. One suggestion is that the forma- cADPR control of Ca2 + release
tion of cADPR and NAADP is sensitive to cellular meta- One of the major uncertainties about cADPR is its mode of
bolism (Module 2: Figure cADPR/NAADP function). In action in controlling the release of Ca2 + . There have been
other words, cADPR and NAADP might be metabolic suggestions that it is a Ca2 + -mobilizing second messenger
messengers that are capable of relaying information about that acts by stimulating the ryanodine receptors (RYRs) to
the state of cellular metabolism to the Ca2 + signalling release Ca2 + . However, direct evidence for this assertion is
pathways. Such a notion is supported by the fact that not particularly convincing. Early single channel record-
cADPR metabolism by the hydrolase is inhibited by either ings seemed to provide such evidence by showing that
ATP or NADH. Another suggestion is that it might be cADPR could open RYRs in lipid membranes, but these
activated by agonists acting through cell-surface recept- observations were challenged on the basis that the cADPR
ors, but the coupling mechanism remains to be established was acting through the ATP-binding site. When cADPR is
(Module 2: Figure cADPR/NAADP function). This ab- injected into cells, it usually fails to release Ca2 + , but after a
sence of a coupling mechanism might be explained by the period of time, it can begin to enhance the sensitivity of the
cADPR working hypothesis if the external agonist en- RYRs. An example of such an effect is shown in heart cells,
hanced cADPR formation indirectly by first increasing where there is a gradual increase in spark frequency fol-
cellular metabolism. Such a mechanism could explain the lowing addition of cADPR (Module 2: Figure cADPR ac-
ability of β-adrenergic agents to increase cADPR levels in tion in heart cells). This observation on cardiac cells forms
heart. Likewise, the glucose-dependent increase in cADPR the basis of the second part of the cADPR working hypo-
in β-cells can be directly linked to the metabolism of gluc- thesis, which argues that cADPR acts indirectly as a modu-
ose, with the resulting increase in ATP acting to reduce lator of Ca2 + release (Module 2: Figure cADPR/NAADP
the hydrolase activity (Module 2: Figure cADPR/NAADP function) by stimulating the sarco/endo-plasmic retic-
function). ulum Ca2 + -ATPase (SERCA) pump to increase the load
In CD38 − / − mice, there is a decrease in the amount of Ca2 + within the lumen of the store. This increase
of oxytocin (OT) released from hypothalamic neurons. in luminal Ca2 + then sensitizes the RYRs so that they
Such mice show defects in maternal nurturing and in social either begin to open spontaneously to give Ca2 + sparks
behaviour. (Module 2: Figure cADPR action in heart cells) or begin to
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r37
produce larger Ca2 + transients when activated by a pulse zyme synthesizes both messengers. The NAADP control
of trigger Ca2 + as occurs in neurons (Module 2: Figure of Ca2 + release depends upon this messenger acting on a
cADPR action in neurons). store that is different from that controlled by the inositol
1,4,5-trisphosphate receptors (InsP3 Rs) or the ryanodine
cADPR and cell regulation
receptors (RYRs). A relationship between NAADP and
A role for cADPR has been implicated in a number of
cell regulation seems to depend upon its interaction with
different cell types:
the other Ca2 + -mobilizing messenger systems.
• Insulin-secreting β-cells (Module 7: Figure β-cell sig-
nalling) NAADP generation and metabolism
• Hypothalamic neurons: in CD38 − / − mice, there is a NAADP (Module 2: Figure NAADP structure) is another
decrease in the amount of oxytocin (OT) released from member of the NAD signalling pathways. Its synthesis
hypothalamic neurons. Such mice show defects in ma- from NADP is closely linked to that of cADPR in that
ternal nurturing and in social behaviour. they both share the same enzyme: the ADP-ribosyl cyc-
lase (Module 2: Figure cADPR/NAADP function). This
Nicotinic acid--adenine dinucleotide enzyme uses NAD + to make cADPR through a cycliza-
phosphate (NAADP) signalling tion reaction, or it can use NADP as a substrate to produce
NAADP is one of the messengers associated with the NAADP through a base-exchange reaction during which
NAD signalling pathways. NAADP has attracted consid- the nicotinamide group is exchanged for nicotinic acid.
erable attention as a Ca2 + -mobilizing second messenger. Unlike cADPR, which is hydrolysed by the same en-
NAADP generation and metabolism is unusual in that it zyme, NAADP is degraded to NAAD by phosphatases
is closely allied to that of cADPR in that the same en- such as alkaline phosphatase.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r38
NAADP control of Ca2 + release the ryanodine receptors (RYRs), is still being defined. On
NAADP functions as a Ca2 + -mobilizing messenger to the basis of studies carried out in sea urchin eggs, this
release Ca2 + from an internal store (Module 2: Fig- novel store appears to reside in a lysosome-related or-
ure cADPR/NAADP function). This NAADP-sensitive ganelle. The receptors for NAADP appear to be a family
store, which is distinct from the endoplasmic retic- of two-pore channels (TPC), with TPC1 being located on
ulum/sarcoplasmic reticulum store that is regulated by the the endosomal membranes, whereas TPC2 is on lysosomal
inositol 1,4,5-trisphosphate receptors (InsP3 Rs) and membranes.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r39
NAADP and cell regulation the actin cytoskeleton, membrane trafficking, exocytosis,
The amount of Ca2 + released by NAADP is relatively ion channels and exchangers.
small and is unlikely to have a direct role in Ca2 + sig- Alterations in the activity of this phosphoinositide
nalling. However, there are suggestions that it may act lipid signalling pathway have been implicated in various
indirectly to trigger the release of Ca2 + by the other re- diseases such as manic-depressive illness, Lowe’s oculo-
lease channels [ryanodine receptors (RYRs) or the inositol cerebrorenal (OCRL) syndrome and Cowden’s disease.
1,4,5-trisphosphate receptors (InsP3 Rs) (Module 2: Figure
cADPR/NAADP function)]. Phosphoinositide metabolism
NAADP has been implicated in the control of insulin re- Phosphoinositide metabolism can be separated into two
lease by β-cells (Module 7: Figure β-cell signalling) and in main components (Module 2: Figure phosphoinositide
the control of secretion by pancreatic acinar cells (Module metabolism):
7: Figure control of pancreatic secretion).
• Inositol lipid metabolism concerns the pathways re-
sponsible for converting PtdIns into a variety of
ADP-ribosyl cyclase phosphoinositide lipid signalling molecules.
ADP-ribosyl cyclase is the enzyme responsible for syn- • Inositol phosphate metabolism is responsible for creat-
thesizing the Ca2 + mobilizing messengers cADPR and ing a large array of inositol phosphates, some of which
NAADP. During cADPR generation and metabolism it function in the multipurpose inositol polyphosphate
uses NAD + to make cADPR through a cyclization reac- signalling pathway. This metabolic pathway also forms
tion (Module 2: Figure cADPR/NAADP function). The the inositol that is used to resynthesize the lipid pre-
same enzyme is also responsible for the hydrolysis of cursor PtdIns.
cADPR to ADPR. This enzyme can also use NADP as a
substrate to produce NAADP through a base-exchange re- These two pathways are connected by the processes of
action during which the nicotinamide group is exchanged lipid hydrolysis and lipid synthesis. The hydrolysis occurs
for nicotinic acid. when external signals activate phospholipase C (PLC) to
In mammals, this bifunctional enzyme appears to be the hydrolyse PtdIns4,5P2 to form the second messengers in-
lymphocyte antigen CD38, which is expressed widely and ositol 1,4,5-trisphosphate (Ins1,4,5P3 ) and diacylglycerol
is located both in the plasma membrane and at internal (DAG). The Ins1,4,5P3 is one of the major inputs into the
sites. inositol phosphate metabolic pathway that produces the
inositol required for lipid synthesis.
This complex phosphoinositide metabolic network par-
ticipates in a number of highly versatile signalling cas-
Phosphoinositide signalling settes (Module 2: Figure phosphoinositide signalling sys-
Signalling through the phosphoinositide lipids is com- tems):
plex because there are a number of signalling cassettes
associated with both the synthesis and hydrolysis of the • Inositol 1,4,5-trisphosphate (InsP3 )/Ca2 + signalling
phosphoinositides. Phosphoinositide metabolism can be cassette
divided into two main parts. Firstly, there is inositol lipid • Diacylglycerol (DAG)/protein kinase C (PKC) sig-
metabolism, which describes the way in which the parent nalling cassette
molecule PtdIns is metabolized to form a number of lipid • PtdIns 3-kinase signalling
intermediates, some of which are key elements in differ- • PtdIns4,5P2 signalling cassette
ent signalling cassettes. Secondly, there is inositol phos- • Multipurpose inositol polyphosphate signalling path-
phate metabolism, which is a complex pathway respons- way
ible for metabolizing soluble inositol phosphates. Some
of the inositol phosphates generated by this metabolism Inositol lipid metabolism
have been implicated as messengers operating within the The different phosphoinositide signalling pathways are
multipurpose inositol polyphosphate signalling pathway. derived from the parent molecule phosphatidylinositol
PtdIns4,5P2 is of particular interest because it is (PtdIns) (Module 2: Figure PtdIns structure). Unlike the
the precursor used to generate the second messen- other phospholipids found in cellular membranes, PtdIns
gers inositol 1,4,5-triphosphate (InsP3 ) and diacylglycerol is unique in that the free hydroxy groups at the 3-, 4- and
(DAG) that function in the inositol 1,4,5-trisphosphate 5-positions on the inositol ring can be phosphorylated
(InsP3 )/Ca2 + signalling cassette and the diacylglycerol further to create a family of phosphoinositides (Module
(DAG)/protein kinase C (PKC) signalling cassette respect- 2: Figure phosphoinositide metabolism). One of the more
ively. PtdIns4,5P2 is also a precursor that is metabolized to important lipids involved in phosphoinositide signalling is
PtdIns3,4P2 and PtdIns3,4,5P3 , which function as second PtdIns4,5P2 , which is a nodal point for a number of sig-
messengers to activate protein kinases in the PtdIns 3-k- nalling systems (Module 2: Figure phosphoinositide sig-
inase signalling pathway. In addition to being a precursor nalling systems).
for these various signalling pathways, PtdIns4,5P2 can also The metabolism of PtdIns is carried out by a collection
function as a messenger for the PtdIns4,5P2 signalling cas- of inositol lipid kinases and inositol lipid phosphatases.
sette, where localized synthesis or hydrolysis of this lipid The numbers below refer to the different reactions shown
functions to regulate a number of cellular systems such as in Module 2: Figure phosphoinositide metabolism:
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r40
4 Inositol lipid
PtdIns3P PtdIns3,5P 2
13
1
metabolism
11
6
2 7
PtdIns PtdIns4P 5 PtdIns3,4P 2 PtdIns3,4,5P 3
8
3 12 8
9 10
PtdIns5P 6 PtdIns4,5P 2
11
PtdIns3,5P 2
Phospholipase C
Lipid resynthesis
DAG Ins1,4,5P 3
G-6-P
Inositol phosphate
Inositol synthase Inositol metabolism
Phosphatidylinositol (PtdIns)
C C
O O
C C C O P
H2 H H2
O OH
HO 1
OH
HO HO
3 5
4
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r41
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r42
1. The Class III PtdIns 3-kinase (PtdIns 3-K) adds the 5-position of PtdIns3,4P2 by the PtdIns4P 5-k-
a phosphate to the 3-position of PtdIns to form inase (PtdIns4P 5-K) (i.e. the same enzyme used for
PtdIns3P. Step 8).
2. PtdIns 4-kinase (PtdIns 4-K) adds a phosphate to 11. The myotubularins remove the 3-phosphate from
the 4-position of PtdIns to form PtdIns4P. It can PtdIns3P and also from PtdIns3,5P2 .
also be formed by removal of the 3-phosphate from 12. The 5-phosphate on PtdIns4,5P2 is removed by vari-
PtdIns3,4P2 by phosphatase and tensin homologue ous lipid phosphatases such as oculocerebrorenal syn-
deleted on chromosome 10 (PTEN). drome of Lowe (OCRL) and the synaptojanins.
3. The PIKfyve kinase is thought to be responsible for 13. The 5-phosphate on PtdIns3,5P2 is removed by the
adding a phosphate to the 5-position of PtdIns to form Sac domain phosphatase Sac3, which is an orthologue
PtdIns5P. of yeast Fig 4.
4. The PIKfyve also adds a phosphate to the 5-position
of PtdIns3P to form PtdIns3,5P2 . The formation of
Inositol lipid kinases
PtdIns3,5P2 , which changes in cells following osmotic
There are a number of inositol lipid kinases that function
stress, is a key component of the PtdIns3,5P2 sig-
to phosphorylate hydroxyls on the inositol headgroup of
nalling cassette (Module 2: Figure PIKfyve activation).
phosphatidylinositol.
5. Types I and II PtdIns 3-kinase (PtdIns 3-K) add
a phosphate to the 3-position of PtdIns4P to form
PtdIns3,4P2 . PtdIns3,4P2 has been suggested to func- PtdIns 3-kinase (PtdIns 3-K)
tion as a messenger operating within the plasma mem- The PtdIns 3-kinases (PtdIns 3-Ks) are a family of en-
brane, where it serves to recruit and activate protein zymes that have been classified into three classes (Module
kinases such as protein kinase B (PKB). PtdIns3,4P2 2: Figure PI 3-K family).
can also be formed by other enzymes (see Steps 6 and
7). Class I PtdIns 3-kinases
6. PtdInsP kinase II adds a phosphate to the 4-position The primary function of the Class I PtdIns 3-kinases is to
of PtdIns3P to form PtdIns3,4P2 . The same enzyme phosphorylate PtdIns4,5P2 to form the lipid second mes-
can add a phosphate to the 4-position of PtdIns5P to senger PtdIns3,4,5P3 (Module 2: Figure PtdIns 3-kinase
form PtdIns4,5P2 . signalling). These Class I enzymes are divided into two
7. Inositol polyphosphate 5-phosphatase such as Src ho- groups: five regulatory subunits and three catalytic sub-
mology 2 (SH2) domain-containing inositol phos- units (Module 2: Figure PI 3-K family).
phatase (SHIP) removes a phosphate from the 5- The Class IA enzymes are heterodimers that are formed
position of PtdIns 3,4,5P3 to form PtdIns3,4P2 . from a regulatory subunit combining with a catalytic sub-
8. A PtdIns4P 5-kinase (PtdIns4P 5-K) adds a phosphate unit. There are five regulatory subunits (p85α, p85β, p55α,
to the 5-position of PtdIns4P to form PtdIns4,5P2 . p50α and p55γ), which are typical adaptor proteins. The
The latter can also be formed by Steps 6 and 9. p85 regulatory subunit contains an Src homology 3 (SH3)
PtdIns4P5-K can also phosphorylate PtdIns3,4P2 to domain, a breakpoint-cluster-region homology (BH) do-
form PtdIns3,4,5P3 . main, two proline-rich regions (P) on either side of the
9. Phosphatase and tensin homologue deleted on chro- BH domain and two Src homology (SH2) domains that
mosome 10 (PTEN) removes a phosphate from the are separated by a p110-binding domain, enabling them to
3-position of PtdIns3,4,5P3 . interact with a p85-binding domain located on the three
10. A Class I PtdIns 3-kinase adds a phosphate to the catalytic subunits (p110α, p110β and p110δ). The differ-
3-position of PtdIns4,5P2 to form PtdIns3,4,5P3 . ent binding domains on the regulatory subunits enhance
PtdIns3,4,5P3 , which functions as one of the second the versatility of the Class IA enzyme by enabling the
messengers in the PtdIns 3-kinase signalling pathway, catalytic subunit to be activated by interacting with a vari-
can also be formed by the addition of a phosphate to ety of signalling molecules:
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r43
• The Src homology (SH2) domains of the regulatory sub- early endosome protein sorting and intraluminal vesicle
unit enable the enzyme to associate with phosphotyr- formation (Module 4: Figure intraluminal endosomal ves-
osine residues on the cytoplasmic domains of recept- icle formation) and endosome vesicle fusion to early en-
ors such as the platelet-derived growth factor receptor dosomes (Module 4: Figure endosome vesicle fusion). In
(PDGFR) (Module 1: Figure PDGFR activation) or the the case of autophagy, hVps34 plays a central role in driv-
CD19 B cell co-receptor (Module 9: Figure B cell activ- ing the early induction, nucleation and elongation steps
ation). responsible for forming the autophagic vacuole (Module
• The Src homology 3 (SH3) domain can bind to proline- 11: Figure autophagy signalling mechanisms).
rich regions of Shc, Cbl and dynamin.
• The proline-rich regions can bind to the SH3 domains
of Abl, Src, Lck, Lyn, Fyn and growth factor receptor PtdIns 4-kinase (PtdIns 4-K)
bound protein 2 (Grb2). PtdIns 4-kinase catalyses phosphorylation of PtdIns on the
• The p85β inhibitory subunit is a target for miR-126, 4-position of the inositol ring to produce PtdIns4P (Step
which plays an important role in the regulation of 2 in Module 2: Figure phosphoinositide metabolism). En-
angiogenesis. zyme activity is found in most cellular membranes (plasma
membrane, endoplasmic reticulum, Golgi, nuclear mem-
The Class IB enzyme has a different activation mechan- brane and secretory vesicles). Cells have two classes of
ism in that it is stimulated by heterotrimeric G proteins PtdIns 4-K: Type II and Type III.
(Module 2: Figure PtdIns 3-kinase signalling). It has a The Type II PtdIns 4-K, which contains wortmannin-
p110γ catalytic subunit and two regulatory subunits (p101 insensitive α- and β-isoforms, may be responsible for gen-
and p84) (Module 2: Figure PI 3-K family). These regulat- erating the lipid substrates in the membrane that are used
ory subunits may mediate the translocation of the p110γ for signalling. The enzymatic activity of PtdIns 4-kinase is
catalytic subunit to the membrane by binding to the Gβγ greatly enhanced in various cancer cells.
subunit. The Type III PtdIns 4-K, which has α- and β-isoforms,
The Class I enzymes interact strongly with the onco- is sensitive to the drug wortmannin. The PtdIns 4-KIIIα
gene Ras (Module 2: Figure PtdIns 3-kinase signalling) and found in the endoplasmic reticulum and the PtdIns 4-
this can have important consequences for both upstream KIIIβ found in the cytosol and Golgi are responsible
and downstream events, depending on the cellular context. for producing PtdIns4P, which is one of the localized
With regard to the former, the binding of Ras can enhance phosphoinositide lipid signalling molecules used for ves-
enzyme activation and the generation of lipid messengers. icle trafficking (Module 2: Figure localized inositol lipid
On the other hand, the association with Ras might mediate signalling). The PtdIns 4-KIIIβ at the Golgi is controlled
some of the downstream effects of the PtdIns 3-kinases. by the Arf signalling pathway (Module 2: Figure Arf sig-
Class I PtdIns 3-kinases are strongly inhibited by the nalling). It is the Type III PtdIns 4-K isoform that is ac-
fungal metabolite wortmannin (an irreversible inhibitor) tivated by the neuronal Ca2 + sensor-1 protein (NCS-1)
and by LY294002 (a reversible inhibitor). to enhance exocytosis. Originally, it was considered that
PtdIns4P functioned solely as a precursor for the forma-
Class II PtdIns 3-kinase tion of PtdIns4,5P2 , but there is increasing evidence for a
The Class II PtdIns 3-kinase has a more restricted substrate role as part of a PtdIns4P signalling cassette.
range in that it phosphorylates just PtdIns and PtdIns4P.
There are no regulatory subunits, and the three catalytic
subunits (PI3KC2α, PI3KC2β and PI3KC2γ) are char- PtdIns phosphate kinases
acterized by having a C-terminal phox homology (PX) There is a family of PtdIns phosphate kinases that are di-
domain and a C2 domain (Module 2: Figure PI 3-K fam- vided into three subfamilies (Types I--III) that are localized
ily). to different compartments and function to phosphorylate
different phosphoinositides.
Class III PtdIns 3-kinase
The Class III PtdIns 3-kinase has a restricted substrate
range in that it phosphorylates just PtdIns to form PtdIns4P 5-kinase (PtdIns4P 5-K)
PtdIns3P. The prototype of this class is vacuolar pro- This versatile family of Type I PtdIns phosphate kinases
tein sorting 34 (Vps34) protein found in Saccharomyces (also abbreviated as PIPKI) is composed of three isoforms
cerevisiae of which there is a human homologue (hVps34). (α, β and γ) that are located in different cellular regions
The activity of hVps34 is regulated by Ca2 + and this con- such as the plasma membrane, focal adhesions, Golgi and
tributes to the regulation of the target of rapamycin (TOR), nucleus. Their primary role is to phosphorylate PtdIns4P
which functions in cell growth control (see steps 4 and 5 in to PtdIns4,5P2 (Step 8 in Module 2: Figure phosphoinos-
Module 9: Figure target of rapamycin signalling). There is itide metabolism).
a Ca2 + -dependent CaM-binding domain located between
residues 318 and 334 in the accessory domain (Module 2: PtdIns4P 5-kinase Iα
Figure PI3-K family). This enzyme functions at multiple locations in the cell. It is
The hVps34 plays an important role in intracellular traf- the major enzyme responsible for forming PtdIns4,5P2 at
ficking such as the early endosome to plasma membrane the plasma membrane. It is also found within the nucleus
trafficking (Module 4: Figure early endosome budding), at nuclear speckles that are sites of mRNA processing.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r44
Class IA
p85 p85 SH3 P BCR P SH2 p110 binding SH2
Regulatory
subunits
p110 p110 p110 p85 Ras C2 Helical Kinase
Catalytic subunits
Class II
PI3KC2
PI3KC2 P P Ras C2 Helical Kinase PX C2
PI3KC2 Catalytic subunits
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r45
Inositol lipid phosphatases in the active site to form a disulphide bond with Cys-71.
There are a large number of inositol lipid phosphatases that This disulphide bond formation is specifically reversed by
contribute to inositol lipid metabolism (Module 2: Figure thioredoxin. A reversible inactivation of PTEN may thus
phosphoinositide metabolism). The situation is complic- contribute to the accumulation of PtdIns3,4,5P3 (Module
ated in that some of these phosphatases have a broad range 2: Figure plasma membrane ROS formation), which may
of substrates and can act on both inositol lipids and inos- thus help to promote proliferation by switching off the
itol phosphates. The following are the phosphatases that metabolism of the 3-phosphorylated lipid second mes-
act predominantly on inositol lipids: sengers. This reversible inactivation of PTEN contrib-
utes to the accumulation of PtdIns3,4,5P3 by setting
• Phosphatase and tensin homologue deleted on chromo- up a positive-feedback loop, since the formation of this
some 10 (PTEN) lipid messenger is responsible for stimulating the produc-
• 5-Phosphatase II tion of H2 O2 (Module 2: Figure plasma membrane ROS
• Inositol polyphosphate 5E-phosphatase (INPP5E) formation).
• Myotubularins There are additional enzymes that hydrolyse the 3-
• Oculocerebrorenal syndrome of Lowe (OCRL) phosphorylated position. Transmembrane phosphatase
• Proline-rich inositol polyphosphate 5-phosphatase with tensin homology (TPTE) is localized to the plasma
(PIPP) membrane, but appears not to have phosphatase activity.
• Skeletal muscle and kidney enriched inositol phos- TPTE and PTEN homologous inositol lipid phosphatase
phatase (SKIP) (TPIP) occurs as α and β isoforms. The TPIPα isoform
• Synaptojanins hydrolyses PtdIns3,4,5P3 , PtdIns3,5P2 , PtdIns3,4P2 and
PtdIns3P. It has N-terminal transmembrane domains that
5-Phosphatase II appear to localize the protein to the ER.
5-Phosphatase II, which is also known as inositol PTEN is a potent tumour suppressor that is frequently
polyphosphate 5B-phosphatase (INPP5B), is a 75 kDa inactivated in many different cancers, e.g. endometrial,
protein that preferentially hydrolyses PtdIns4,5P2 and prostate, mammary carcinomas, melanomas and thyroid
PtdIns3,4,5P3 , but can also act on the inositol phosphates tumours. When PTEN is inactivated in neurons, there is a
Ins1,4,5P3 and Ins1,3,4,5P4 . This 5-phosphatase II closely progressive increase in cell size and increased phosphoryla-
resembles oculocerebrorenal syndrome of Lowe (OCRL) tion of protein kinase B (PKB) that create cerebellar ab-
both in structure and function. Like OCRL, it has a cent- normalities resembling those seen in human Lhermitte--
ral 5-phosphatase catalytic domain followed by an ASH Duclos disease (LDD).
domain and a RhoGAP domain. The ASH domain enables Germline mutations in the PTEN gene have been im-
it to interact with Rab5. The C-terminal end has a CAAX plicated in the development of Cowden’s disease and
region that can be prenylated to facilitate its membrane Bannayan--Zonana syndrome, where there is an increased
localization. risk of breast and thyroid cancers. An increase in the ex-
5-Phosphatase II is located on the Golgi where it may pression of PTEN by the tumour suppressor p53 may
function in the trafficking of vesicles to both the ER and contribute to p53-induced apoptosis.
to the early endosome.
Myotubularins
Inositol polyphosphate 5E-phosphatase (INPP5E) There is a large family of myotubularins that function as
Inositol polyphosphate 5E-phosphatase (INPP5E), which lipid phosphatases that dephosphorylate PtdIns3P and also
is also known as Type IV 5-phosphatase, is widely ex- PtdIns3,5P2 (Module 2: Figure phosphoinositide meta-
pressed where it functions to remove the 5-phosphate from bolism). They may also act on PtdIns3,5P2 . Mammalian
PtdIns4,5P2 , PtdIns3,5P2 and PtdIns3,4,5P3 . cells express 15 myotubularins. The founding member is
MTM1 and the remainder are MTMR2--MTMR14. These
Phosphatase and tensin homologue deleted on enzymes have a phosphatase domain, and a GRAM do-
chromosome 10 (PTEN) main, which associates with membranes and a C-terminal
PTEN (phosphatase and tensin homologue deleted on coiled-coil domain that links these enzymes to other pro-
chromosome 10) is a lipid phosphatase that is mutated teins. One of the isoforms, MTMR6, appears to have a
in many human cancers. Its gene is a tumour suppressor, specific role in the PtdIns3P signalling cassette. Hydro-
which functions in cell migration, proliferation and sur- lysis of PtdIns3P may control the activity of the Ca2 + -
vival. PTEN inactivates the 3-phosphorylated lipid second activated intermediate-conductance (IK) channel (KCa 3.1),
messengers that operate within the PtdIns 3-kinase sig- and this may be of particular significance for the relation-
nalling cassette. It functions to remove the phosphate from ship between K + channels and cell proliferation.
the 3-position of PtdIns3,4P2 and PtdIns3,4,5P3 (Module These enzymes are of interest because mutations
2: Figure phosphoinositide metabolism). in MTM1 are responsible for X-linked recessive
PTEN is a redox-sensitive enzyme, which may contrib- myotubular myopathy and MTMR2 is mutated in
ute to a positive-feedback loop that enhances redox sig- Charcot-Marie-Tooth disease 4B. Missense mutations in
nalling (Module 2: Figure plasma membrane ROS form- MTMR14 have also been described in centronuclear my-
ation). It is inhibited by H2 O2 , which induces Cys-124 opathy (CNM).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r46
Oculocerebrorenal syndrome of Lowe (OCRL) Skeletal muscle and kidney enriched inositol
Oculocerebrorenal syndrome of Lowe (OCRL) is a phosphatase (SKIP)
Rho-GAP-domain-containing enzyme that can hydro- As its name implies, skeletal muscle- and kidney-enriched
lyse both inositol phosphates (Ins1,4,5P3 and Ins1,3,4,5P4 ) inositol phosphatase (SKIP) is strongly expressed in
and the phosphoinositides PtdIns4,5P2 and PtdIns3,4,5P3 . skeletal muscle and kidney, but is also found in heart
OCRL also contains an ASH [ASPM (abnormal spindle- and brain. It’s C-terminal SKICH domain attaches it to
like microcephaly-associated protein/SPD2 (spindle pole the plasma membrane and to membranes in the perinuc-
body2)/hydin] domain, which is thought to provide a lear region. It acts to hydrolyse both PtdIns4,5P2 and
binding site for microtubules. One of the functions of PtdIns3,4,5P3 and has been implicated in insulin signalling.
OCRL is to control membrane and protein trafficking
during endocytosis where it operates primarily at the in- Sac3/Fig4
terface between the trans-Golgi network (TGN) and the The suppressor of actin 3 (Sac3), which is the mammalian
endosomes. orthologue of Fig4 in yeast, is a SAC domain lipid phos-
A deficiency of this enzyme is responsible for Lowe’s phatase that removes the 5-phosphate from PtdIns3,5P2 to
oculocerebrorenal (OCRL) syndrome. Some patients with form PtdIns3P (see step 13 in Module 2: Figure phosphoin-
Dent’s disease also carry mutations in OCRL. ositide metabolism). Sac3/Fig4 is part of the PAS complex
and has an important structural role in that it also helps to
Synaptojanin facilitate the kinase activity of PIKfyve that operates in the
There are two synaptojanins: synaptojanin 1 (SJ1) and PtdIns3,5P2 signalling cassette (Module 2: Figure PIKfyve
synaptojanin 2 (SJ2). activation).
Mutations in Sac3/Fig3 have been linked to
Synaptojanin 1 (SJ1) Charcot-Marie-Tooth disease 4J.
Synaptojanin 1 (SJ1) is a multi-functional inositol poly-
phosphate 5-phosphatase that has an important role in the Inositol phosphate metabolism
process of endocytosis (Module 4: Figure endocytosis). The Ca2 + -mobilizing messenger function of inositol
There are two lipid phosphatase domains arranged in tan- 1,4,5-trisphosphate (InsP3 ) is terminated through its meta-
dem: an N-terminal Sac1 domain, which dephosphorylates bolism by a complex inositol phosphate metabolic path-
PtdIns3P and PtdIns4P, and an adjacent 5-phosphatase that way (Module 2: Figure inositol phosphate metabolism)
acts on PtdIns4,5P2 and PtdIns3,4,5P3 . The C-terminal re- that has two main functions. Firstly, it produces free inos-
gion has a proline-rich domain (PRD) that targets synpto- itol that is resynthesized to PtdIns, which can be reused
janins to the SH3 domains of dynamin, endophilin and for further signalling. Secondly, it generates an assortment
amphiphysin on clathrin-coated pits (Module 4: Figure of inositol phosphates, some of which contribute to the
scission of endocytic vesicles). Alternative splicing of this multipurpose inositol polyphosphate signalling pathway.
region gives rise to the SJ1-145 and SJ1-170 isoforms. The The Ins1,4,5P3 that enters the metabolic pathway is
former is strongly expressed in presynaptic terminals. SJ1 metabolized via two pathways. It is dephosphorylated by
has a primary role in coat removal in the final stages of en- Type I inositol polyphosphate 5-phosphatase (step 1) to
docytosis and is particularly important for synaptic vesicle form Ins1,4P2 or it can be phosphorylated by InsP3 3-
recycling. Since SJ1 is distributed throughout the neuron, kinase to form Ins1,3,4,5P4 (step 4). Both Ins1,4P2 and
it also plays a role in postsynaptic endocytosis. Ins1,3,4,5P4 are putative messengers in the multipurpose
The activity of SJ1 is regulated by a phosphorylation/ inositol polyphosphate signalling pathway. The Ins1,4P2
dephosphorylation cycle operated by the dual- is sequentially dephosphorylated to free inositol. The
specificity tyrosine-phosphorylation regulated kinase Ins1,3,4,5P4 is dephosphorylated to Ins1,3,4P3 , which oc-
1A (DYRK1A) and calcineurin (CaN) respectively. cupies an important position in the metabolic pathway
in that either it is dephosphorylated down to inositol,
Synaptojanin 2 (SJ2) as part of an inositol recycling pathway, or it can be
Synaptojanin 2 (SJ2) has a catalytic domain that closely phosphorylated further to form additional inositol poly-
resembles that of synaptojanin 1 (SJ1). Despite this close phosphates. The inositol phosphates in the pink boxes in
similarity, SJ2 does seem to have some distinct functions. Module 2: Figure inositol phosphate metabolism have been
Like SJ1, SJ2 has also been implicated in clathrin-mediated implicated as intracellular messengers. InsP3 mobilizes in-
endocytosis. ternal Ca2 + and the putative functions of the others are
described in the multipurpose inositol polyphosphate sig-
Proline-rich inositol polyphosphate 5-phosphatase nalling pathway.
(PIPP) Metabolism of the inositol phosphates is carried out by
The proline-rich inositol polyphosphate 5-phosphatase a large number of inositol phosphate kinases and phos-
(PIPP) has N- and C-terminal proline-rich domains. phatases (Module 2: Figure inositol phosphate metabol-
There also is a SKICH domain responsible for attaching ism):
PIPP to the plasma membrane where it acts to hydro-
lyse PtdIns4,5P2 and PtdIns3,4,5P3 . It can also hydrolyse Inositol polyphosphate 5-phosphatase (INPPs)
Ins1,4,5P3 and Ins1,3,4,5P4 . It is highly expressed in the This large family of enzymes, which are products of mul-
brain where it appears to function in neurite extension. tiple genes and splice variants, removes the 5-phosphate
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r47
The InsP3 / Ca 2+
signalling cassette
group from inositol lipids and, in some cases, can also act allowing the enzyme to disperse into the cytosol, InsP3
on inositol phosphates. All members of the family share a metabolism is severely curtailed. It seems that much of the
central conserved catalytic domain: InsP3 is metabolized close to its site of action at the plasma
membrane.
• 5-Phosphatase I Src homology 2 (SH2) domain-containing inositol
• 5-Phosphatase II phosphatases (SHIP)
• Oculocerebrorenal syndrome of Lowe (OCRL) The Src homology 2 (SH2) domain-containing inositol
• Src homology 2 (SH2) domain-containing inositol phosphatases (SHIP1 and SHIP2) hydrolyse Ins1,3,4,5P4
phosphatase (SHIP) and PtdIns3,4,5P3 . The SHIPs, which come in different
• Proline-rich inositol polyphosphate 5-phosphatase forms, are found in haematopoietic cells, where they play
(PIPP) a role in inhibiting signalling. In B cells, for example, the
• Skeletal muscle and kidney enriched inositol phos- FcγRIIB receptor has an immunoreceptor tyrosine-based
phatase (SKIP) inhibitory motif (ITIM) to which SHIPs attach causing a
• Synaptojanins reduction in Ca2 + signalling by hydrolysing PtdIns3,4,5P3
and thereby reducing the stimulatory effect of the Tec tyr-
5-Phosphatase I osine kinase family on phospholipase Cγ (Module 2: Fig-
The 5-phosphatase I functions to hydrolyse the inos- ure ROS effects on Ca2 + signalling). SHIPs perform a
itol phosphates Ins1,4,5P3 and Ins1,3,4,5P4 (Steps 1 in similar function in mast cells (Module 11: Figure mast cell
Figure 2 inositol phosphate metabolism). If this enzyme inhibitory signalling). SHIP1 functions to localize PIP3 at
is deleted, there is an increase in the level of InsP3 , the front of the cell during neutrophil chemotaxis (Module
and this was associated with a transformed phenotype. 11: Figure neutrophil chemotaxis).
This enzyme is inhibited following phosphorylation by
Ca2 + /calmodulin-dependent protein kinase II (CaMKII). Inositol polyphosphate 1-phosphatase
Type I, which hydrolyses the inositol phosphates, is direc- Steps 2 in Module 2: Figure inositol phosphate meta-
ted to the membrane by isoprenylation of the C-terminal bolism. This enzyme dephosphorylates both Ins1,3,4P3
region. If these membrane attachment sites are removed, and Ins1,4P2 . This enzyme has been implicated in the
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r48
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r49
PPInsP5 (InsP7 )
ADP + Pi
14 15
Ins1,3,4,5,6P
5
10 11 12
17 8 9
Inositol lipid signalling
4 1 7 +
Ins1,4,5P
-
3 Ins1,3,4P3
2
17
1 5
3 3 3
diacylglycerol (DAG) (Module 2: Figure InsP3 and DAG • Inositol 1,4,5-trisphosphate (InsP3 ) and Ca2 + release
formation). This is a bifurcating signalling pathway in that
InsP3 generates a Ca2 + signal, whereas DAG functions to
stimulate protein kinase C (PKC). The InsP3 released from PtdIns conversion into the precursor lipid PtdIns4,5P2
the membrane diffuses into the cytosol where it engages The precursor PtdIns4,5P2 , which is hydrolysed to give
the InsP3 receptors (InsP3 Rs) to release Ca2 + from the InsP3 , is part of the complex inositol lipid metabolic path-
endoplasmic reticulum. way (Module 2: Figure phosphoinositide metabolism). The
The operation of this InsP3 /Ca2 + signalling cassette can synthesis of the lipid precursor PtdIns4,5P2 from PtdIns is
be divided into separate components: controlled by two substrate cycles involving lipid kinases
and phosphatases (Module 2: Figure InsP3 and DAG form-
• PtdIns conversion into the precursor lipid PtdIns4,5P2 ation). In the first step, the hydroxy group at the 4-position
• Hydrolysis of PtdIns4,5P2 to generate InsP3 and DAG of the inositol ring is phosphorylated to form PtdIns4P.
• Metabolism of InsP3 and DAG and the resynthesis of In the next step, the PtdIns4P is phosphorylated further
PtdIns to yield the precursor PtdIns4,5P2 . The next step is the
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r50
Agonist
Receptor
PtdIns PtdIns4P PtdIns4,5P 2 Diacylglycerol
Plasma
membrane
Protein
PtdIns PtdIns4P phosphorylation
4-kinase 5-kinase P
InsP P P
3
Calcium signalling
Agonist-dependent formation of the second messengers inositol 1,4,5-trisphosphate (InsP3 ) and diacylglycerol (DAG).
The inositol lipids that function in signalling are embedded in the inner leaflet of the plasma membrane. The precursor lipid is phosphatidylinositol
(PtdIns), which is successively phosphorylated, first on the 4-position to form PtdIns4P and then on the 5-position to form PtdIns4,5P2 . Activated
cell-surface receptors are coupled through the G protein Gq/11 to phospholipase C (PLC) that hydrolyses PtdIns4,5P2 to generate inositol 1,4,5-
trisphosphate (InsP3 ). InsP3 activates Ca2 + signalling, and diacylglycerol (DAG) stimulates protein kinase C (PKC) to initiate protein phosphorylation
(Module 2: Figure PKC structure and activation). An animated version of this figure is available.
agonist-dependent hydrolysis of PtdIns4,5P2 to generate for diacylglycerol (DAG) metabolism. Similarly, there are
InsP3 and diacylglycerol (DAG). two separate mechanisms of inositol 1,4,5-trisphosphate
(InsP3 ) metabolism.
Hydrolysis of PtdIns4,5P2 to generate InsP3 and
diacylglycerol (DAG) Diacylglycerol (DAG) metabolism
External stimuli (e.g. hormones, neurotransmitters and The second messenger DAG is metabolized via two separ-
growth factors) gain access to this signalling pathway ate pathways. It can be phosphorylated by diacylglycerol
by activating cell-surface receptors. The latter fall into (DAG) kinase to form phosphatidic acid (PA) or it is hy-
two main classes, the G protein-coupled receptors (GP- drolysed by diacylglycerol (DAG) lipase. The PA is trans-
CRs) and the protein tyrosine kinase-linked receptors ferred to the endoplasmic reticulum, where it interacts
(PTKRs). During the transduction process, the precursor with CTP to form the CDP/DAG complex, which is a
lipid PtdIns4,5P2 is hydrolysed by phospholipase C (PLC) precursor in the resynthesis of PtdIns (Module 2: Figure
to produce both InsP3 and DAG. The family of PLCs InsP3 /DAG recycling).
can be distinguished by the way they are coupled to cell-
surface receptors. In general, the GPCRs use the PLCβ Diacylglycerol (DAG) kinase
isoforms, whereas the receptor tyrosine kinases (RTKs) Diacylglycerol (DAG) kinase α (DAGKα), which is one
are coupled to the PLCγ isoforms (Module 2: Figure PLC of a family of nine mammalian isotypes, has a number
structure and function). of domains, including Ca2 + -binding EF-hand motifs and
DAG functions to activate the diacylglycerol an N-terminal recoverin homology domain that is related
(DAG)/protein kinase C (PKC) signalling cassette, to the recoverin family of neuronal Ca2 + sensors. These
whereas the InsP3 diffuses into the cytosol to activate the two domains appear to function as a unit during Ca2 + -
InsP3 receptors to release Ca2 + stored in the endoplasmic induced activation of DAGKα. In response to an increase
reticulum. The signalling function of this bifurcating sig- in Ca2 + , DAGKα translocates to the membrane, where it
nalling pathway is curtailed by the metabolism of InsP3 phosphorylates DAG to phosphatidic acid (PA) (Module
and the resynthesis of PtdIns. 2: Figure InsP3 /DAG recycling). DAG kinase functions
in the scission of COPI-coated vesicles that bud off from
Metabolism of InsP3 and DAG and the resynthesis the Golgi (Module 4: Figure COPI-coated vesicles).
of PtdIns
The metabolism of InsP3 and DAG and the resynthesis Diacylglycerol (DAG) lipase
of PtdIns are the OFF reactions that terminate the ac- A diacylglycerol (DAG) lipase is responsible for removing
tions of these two messengers. There are two pathways one of the fatty acid tails from the sn-position of DAG
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r51
Proliferation
Metabolism T cell Fertilization
Exocytosis
Contraction Liver cells Mesangial cell
b-Cell
Smooth muscle Smooth muscle
L Cell
Mesangial cell Brown fat cell
Mast cell,
Modulation of Macrophage
ventricular and Parathyroid gland
atrial cell contraction Piuitary cells
Astrocytes
Fluid secretion Renin-producing
Intestinal cell granular cells
Parietal cell
Pancreas 2+ Chemotaxis
Salivary gland InsP3 /Ca Neutrophils
Sweat gland Osteoclast
precursors (?)
Aldosterone
secretion
Glomerulosa cell Differentiation
Osteoclasts
Brown fat cells
Aggregation
Blood platelets Neuronal synaptic Ion channel
Sensory systems plasticity opening
Taste cells Purkinje neurons Astrocytes
Hippocampal neurons T Cells
to form monoacylglycerol (Module 2: Figure InsP3 /DAG phorylated by InsP3 3-kinase to form Ins1,3,4,5P4 (Step 4).
recycling). This hydrolysis of DAG, which is a Ca2 + - These two products then enter a complex metabolic path-
sensitive process, may represent the primary mechanism way that plays an important role in recycling the inositol
for removing the DAG that is produced following the headgroup. Cells have access to three separate sources of
hydrolysis of inositol lipids. inositol: recycling the second messenger InsP3 , de novo
The 2-arachidonylglycerol (2-AG) formed by DAG synthesis from glucose 6-phosphate or uptake of diet-
lipase is one of the endocannabinoids that has multiple ary inositol circulating in the plasma (Module 2: Figure
messenger functions. InsP3 /DAG recycling). Drugs such as lithium and val-
proate may control manic-depressive illness by reducing
Inositol 1,4,5-trisphosphate (InsP3 ) and Ca2 + signalling the supply of inositol by inhibiting the inositol mono-
The primary function of inositol 1,4,5-trisphosphate phosphatase and inositol synthase respectively. The sup-
(InsP3 ) is to function as a second messenger to release ply of free inositol is one of the essential precursors for the
Ca2 + from the internal stores. The 1,4,5-trisphosphate re- synthesis of PtdIns.
ceptors (InsP3 Rs) located on the endoplasmic reticulum
respond to InsP3 by releasing puffs of Ca2 + (Module 3:
Synthesis of PtdIns
Figure InsP3 R activation). These InsP3 Rs are sensitive to
The two second messengers that are formed during phos-
both InsP3 and Ca2 + and can thus function as co-incident
phoinositide signalling can be recycled back to the pre-
detectors (Module 2: Figure Ca2 + -induced Ca2 + release).
cursor lipid PtdIns4,5P2 through a series of steps (Module
This InsP3 /Ca2 + signalling system controls many differ-
2: Figure InsP3 /DAG recycling):
ent cellular processes in a large number of different cell
types (Module 2: Figure InsP3 /Ca2 + signalling functions).
1. Conversion of PtdIns into the precursor lipid
PtdIns4,5P2 .
Inositol 1,4,5-trisphosphate (InsP3 ) metabolism 2. The agonist-dependent activation of phospholipase C
The inositol 1,4,5-trisphosphate (InsP3 ) that is formed dur- (PLC), which hydrolyses PtdIns4,5P2 to generate the
ing signalling enters the pathways of inositol phosphate second messengers inositol 1,4,5-trisphosphate (InsP3 )
metabolism from which it emerges as free inositol. It is and diacylglycerol (DAG).
dephosphorylated by Type I inositol polyphosphate 5- 3. The InsP3 is recycled back to free inositol by a com-
phosphatase (Steps 1 in Module 2: Figure inositol phos- plex metabolic pathway illustrated in Module 2: Figure
phate metabolism) to form Ins1,4P2 or it can be phos- inositol phosphate metabolism.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r52
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r53
SMIT1
PtdIns PtdIns4P PtdIns4,5P 2 PLC DAG DAG MAG (2-AG)
DAG lipase
1 kinase 4
2
MAG 7
InsP 3 + lipase
G-6-PO4
Valproate
Ca 2+
InsP 3 InsP 3
- Inositol
Pase kinase
Glycerol
synthase Arachidonic
PITP acid
de novo InsP 2 InsP4 PA
synthesis
Lithium InsP 1 3
Recycling
- -Inositol
monophosphatase
PITP
PtdIns Dietary
inositol
Inositol
CTP
6
PtdIns CDP.DAG PA
PtdIns 5 CDP.DAG
synthetase synthetase
Endoplasmic reticulum
EF hands
PLC 1 - 4) PH X Y C2
PLC (1 - 4) PH X Y C2
PLC RasGEF PH X Y C2 RA RA
EF hands
PLC X Y C2
G PH C2 G PH PH C2 RA PH C2
EF EF SH2 P P
BLNK
Gq EF XY + RA EF XY
XY P P
XY SH2 RasGEF
P Ras
G G Translocation +
IP IP IP IP
3 3 Ca 2+ 3 3
+
Ca 2+ PH Ca 2+ Ca 2+ Ca 2+
EF SH2
XY SH2
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r54
In general, Gβγ is less efficacious than Gα in stimulating lowing B-cell antigen receptor (BCR) activation (Module
PLC. 9: Figure B cell activation). This translocation to the cell
The two G protein subunits interact with PLCβ at dif- surface has two important consequences for the activation
ferent sites. The α subunit interacts with a region within of the enzyme. Firstly, it brings the enzyme close to its
the long C-terminal tail, whereas the βγ subunit interacts substrate in the membrane. Secondly, by interacting with
with a site within the Y region of the catalytic site (Module tyrosine kinases, PLCγ1 is itself phosphorylated on tyr-
2: Figure PLC structure and function). osine residues located at positions 771, 783 and 1254 (black
PLCβ also contains GAP (GTPase-activating protein) triangles in Module 2: Figure PLC structure and function).
activity that stimulates the intrinsic GTPase activity of the Phosphorylation at Tyr-783 is particularly important for
α subunit. When an agonist binds to the GPCRs, it induces switching on enzyme activity. The PLCγ2 isoform is ac-
a conformational change that is transmitted to the under- tivated by phosphorylation of tyrosine residues 753 and
lying G protein, causing it to dissociate. At this time the 759, mainly by the tyrosine kinase Btk (Module 2: Figure
GDP bound to the α subunit is exchanged for GTP. The ROS effects on Ca2 + signalling).
active GTP/α subunit complex can then activate PLCβ The enzymatic activity of PLCγ is also stimulated by
and this activation process is terminated when the intrinsic the PtdIns3,4,5P3 produced by the PtdIns 3-kinase sig-
GTPase activity of the α subunit hydrolyses GTP back nalling pathway and thus represents a major point of in-
to GDP allowing the GDP/α subunit to once again bind teraction between these two signalling pathways. This in-
to the βγ subunit to form the inactive complex. The in- teraction is particularly important during lymphocyte ac-
trinsic GTPase activity of the α subunit is rather low, but tivation, where the Tec tyrosine kinase family are activ-
is greatly enhanced by two mechanisms. There is a GAP ated by PtdIns3,4,5P3 to phosphorylate and activate both
activity associated with the long C-terminal tail of PLCβ. PLCγ1 and PLCγ2. Both isoforms bind strongly to this
Therefore PLCβ plays a direct role in terminating its own highly charged lipid through the N-terminal PH domain,
activity. In addition, there are regulators of G protein sig- and this interaction enhances enzymatic activity.
nalling (RGS) proteins. There are about 20 of these RGS The Src homology 3 (SH3) domain, which binds to
proteins, of which RGS2--RGS4 seem particularly effect- proline-rich sequences, may enable PLCγ to bind to other
ive in interacting with Gαq . The GTPase activity of Gαq components, such as the cytoskeleton and the protein dy-
is enhanced 25-fold by RGS4. There is considerable dis- namin.
crimination with regard to how individual RGS proteins
bind to specific receptor/Gαq complexes enabling them
to exert an agonist-specific inhibitory mechanism. This Phospholipase Cδ (PLCδ)
mechanism could explain the different types of Ca2 + sig- Less is known about the activation of PLCδ. Unlike PLCβ
nals observed in hepatocytes following stimulation with and PLCγ, PLCδ appears not to be regulated by receptors
different agonists. directly. Once PLCδ1 has associated with the membrane,
it appears to be activated by an elevation in cytosolic Ca2 + .
Modulation of PLCβ by other signalling pathways This sensitivity to changes in intracellular Ca2 + is thought
In general, the phosphorylation of PLCβ, particularly iso- to depend on the C2 domain (Module 2: Figure PLC struc-
forms 2 and 3, by protein kinase A (PKA) results in inhib- ture and function).
ition of the enzyme. Crystallographic studies of PLCδ1 have begun to reveal
how PLC enzymes function to cleave their lipid substrates
Phospholipase Cγ (PLCγ) that are embedded in the plasma membrane.
PLCγ functions predominantly in early development and
in the signalling pathways that control cell proliferation.
PLCγ1 knockout mice die at embryonic day 9, by which Phospholipase Cε (PLCε)
time the embryos appear normal, albeit somewhat smaller. Phospholipase Cε (PLCε) differs from the other isoforms
PLCγ is characterized by having a large insert between by having two Ras-association domains (RA) at its C-
the X and Y domains (Module 2: Figure PLC structure and terminus (Module 2: Figure PLC structure and function).
function). This insert contains an additional pleckstrin ho- It binds specifically to the GTP-bound forms of Ha-Ras
mology (PH) domain, which is itself split by another insert and Rap1A. The enzyme is targeted to the membrane
containing two Src homology 2 (SH2) domains and a single through its ability to bind to these G proteins. It also has
Src homology 3 (SH3) domain. The SH2 domains play a a Cdc25 homology domain that is a guanine nucleotide
critical role in the activation of PLCγ because they provide exchange factor (GEF) motif for Rap1, which enables it to
a docking module that enables the enzyme to translocate to translocate to the perinuclear region following epidermal
the membrane to dock to phosphorylated tyrosine residues growth factor (EGF) stimulation, where it can activate the
on activated receptors or associated scaffolding proteins. mitogen-activated protein kinase (MAPK) signalling path-
This tyrosine phosphorylation occurs during activation of way. There is evidence that cyclic AMP acting through the
protein tyrosine kinase-linked receptors (PTKRs) or the exchange protein activated by cAMP (EPAC) can stimu-
non-receptor protein tyrosine kinases (e.g. Src, Syk, Btk, late Rap1 to activate PLCε (Module 2: Figure cyclic AMP
Lck, Fyn). This sequence of events is well illustrated by signalling) and this mechanism has been implicated in the
the activation of PLCγ1 during activation of the T cell re- control of autophagy (Module 11: Figure autophagy sig-
ceptor (Module 9: Figure TCR signalling) or PLCγ2 fol- nalling mechanisms).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r55
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r56
Plasma membrane
R
PLC
DAG C1
PtdIns4,5P Translocation
2 CC4
2
InsP3 P P
P
C1 Substrate
P
C2
CC4
2
C4
2+ PS P P P
Ca
C1
P P P
Substrate Substrate
cPKC
Structure of PKC isoforms and activation mechanism of the conventional protein kinase C (cPKC) isoforms.
The nine genes that code for protein kinase C (PKC) fall into three families. Conventional PKCs (cPKCs) have a domain structure that has an N-terminal
pseudosubstrate (PS) domain followed by regulatory domains (C1 and C2), which are responsible for binding the diacylglycerol (DAG) and Ca2 +
responsible for membrane targeting, an ATP-binding C3 domain and the C4 catalytic domain. The C1 region is present as a tandem repeat (C1A
and C1B). The PS domain has an autoinhibitory function in that it associates with the catalytic site on C4, thus preventing it from phosphorylating its
substrates. Novel PKCs (nPKCs) have a similar domain structure, except that they have a C2-like domain that does not bind Ca2 + . Atypical (aPKCs)
also lack a C2 domain, and the C1 domain is small and fails to bind DAG. The illustration at the bottom indicates how cPKC is activated, as described
in the text.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r57
PtdIns4,5P2
Autophagic PtdIns3P
vesicle PtdIns3,5P2
PtdIns3,4,5P3 Lysosome
• PtdIns4,5P2 regulation of membrane trafficking and en- catalysing the exchange of GDP for GTP. The active G
docytosis proteins can then have a number of functions. For example,
• PtdIns4,5P2 regulation of exocytosis one function of Rac-GTP is to activate actin polymeriz-
• PtdIns4,5P2 activation of phospholipase D ation (Module 2: Figure Rac signalling). Similarly, Cdc42
• PtdIns4,5P2 regulation of ion channels and exchangers also stimulates actin remodelling (Module 2: Figure Cdc42
• PtdIns4,5P2 function in focal adhesions signalling). The consequence of this remodelling varies de-
• PtdIns4,5P2 regulation of phagocytosis pending on which G protein is operating. For example,
the Cdc42 and Rac polymerization of actin results in the
PtdIns4,5P2 regulation of actin remodelling formation of filopodia and ruffles respectively (Module 4:
There are a number of cellular processes, such as chemo- Figure actin remodelling).
taxis, locomotion, phagocytosis, shape change and cy- The formation of PtdIns4,5P2 contributes to actin
tokinesis, where there are rapid changes in the cytoskeleton remodelling by acting on a number of the mo-
in response to external stimuli such as growth factors and lecules that control actin polymerization such as the
cytokines. Inositol lipids play a significant role in transmit- Wiskott-Aldrich syndrome protein (WASP) and the re-
ting information from the plasma membrane to a variety of lated Wiskott-Aldrich syndrome protein (WASP) verpro-
cell signalling systems (Module 2: Figure localized inositol lin homologous (WAVE) proteins. WASP and WAVE relay
lipid signalling). The formation of PtdIns4,5P2 functions to information from the upstream signalling elements to the
control actin remodelling (Module 4: Figure actin remod- downstream cytoskeletal regulators. Perhaps the most im-
elling). Its main actions are to uncap the barbed end of actin portant example of the latter is the actin-related protein 2/3
filaments and to facilitate actin nucleation and polymeriz- (Arp2/3) complex (containing seven strongly associated
ation by controlling a variety of actin regulatory proteins. subunits of which two are the actin-related proteins Arp2
A critical component of the signalling network is the Rho and Arp3) that is responsible for catalysing the polymer-
family of monomeric G proteins (Arf, Rho, Cdc42 and ization of actin. PtdIns4,5P2 appears to have two actions.
Rac) that relay information from various signalling path- It binds to and activates WASP and to Scar and thus con-
ways such as the PtdIns 3-kinase signalling pathway to the tributes to the relay of information to Arp2/3. In addition,
effector molecules that are directly responsible for remod- it can alter the activity of various proteins that modify the
elling the actin network. One of the signalling molecules structure of actin. For example, it is an indirect activator
is PtdIns4,5P2 . of Cdc42 and it may loosen the gelsolin caps on the end of
The signalling cascade begins when external signals act- the barbed ends, opening up new sites for actin polymeriz-
ing through guanine nucleotide exchange factors (GEFs) ation. The PtdIns4,5P2 may also induce a conformational
stimulate members of the Rho family of G proteins by change in vinculin that enables it to bind to talin during
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r58
DAG + InsP 3 2+
Ca
PtdIns3,4,5P3
Rac Rho Arf PA
PLD PA SPHK S1P
Cytoskeleton
PtdIns PtdIns4P PtdIns4,5P2
Phagocytosis 2+
Ca
Exocytosis
(Primes vesicles)
Endocytosis
(Recruits AP-2 to
form clathrin-coated pits)
Ion channels
(Agonist-induced hydrolysis of
PtdIns4,5P2 activates TRPV1
but inhibits potassium channels)
the formation of the focal adhesion complex (Module 6: ing proteins) to endocytic vesicles to provide a scaffold to
Figure vinculin function). bind clathrin to form clathrin-coated pits (Module 4: Fig-
ure endocytosis). The PtdIns4P 5-kinase Iγ is recruited to
PtdIns4,5P2 function in focal adhesions the plasma membrane, where it phosphorylates PtdIns4P
The Iγ isoform of PtdIns4P 5-kinase (PtdIns4P 5-K) is to PtdIns4,5P2 , which recruits the adaptor protein AP-2
highly localized at the focal adhesion complex, where it to form the clathrin-coated pits.
is tightly bound to talin to regulate the local formation of
PtdIns4,5P2 (Module 6: Figure integrin signalling).
PtdIns4,5P2 regulation of phagocytosis
When macrophages engulf foreign particles, PtdIns4P 5-k-
PtdIns4,5P2 regulation of exocytosis inase (PtdIns4P 5-K) Iα is recruited to the plasma mem-
The synthesis of PtdIns4,5P2 has been implicated in the brane at the phagosome cup, where it induces a local pulse
ATP-dependent processes of priming vesicles as part of of PtdIns4,5P2 , which is then rapidly degraded by phos-
the exocytotic mechanism. The priming process seems to pholipase C (PLC) to leave behind diacylglycerol (DAG).
depend upon a number of steps that begin with the PtdIns This local formation of PtdIns4,5P2 seems essential for the
transfer protein carrying PtdIns to the vesicle membrane early process of phagocytosis.
where it is phosphorylated to PtdIns4P by PtdIns 4-kinase The localized transient increase in PtdIns4,5P2 may
(PtdIns 4-K) and then to PtdIns4,5P2 by the PtdIns4P function in the initial recruitment of actin to the phagocyte.
5-kinase (PtdIns4P 5-K). It is still not clear exactly how this
PtdIns4,5P2 functions to prime the vesicle for exocytosis.
The ability of the neuronal Ca2 + sensor-1 (NCS-1) to PtdIns4,5P2 activation of phospholipase D
facilitate exocytosis may depend on its ability to activate Phospholipase D (PLD), which catalyses the hydrolysis
the PtdIns 4-kinase (PtdIns 4-K). of phosphatidylcholine (PC) to generate phosphatidic acid
(PA), exists as two isoforms, PLD1 and PLD2. The PLD1
PtdIns4,5P2 regulation of membrane trafficking and is primarily located on vesicles associated with the en-
endocytosis dosomal/lysosomal pathway, whereas PLD2 is mainly
PtdIns4,5P2 plays a role in endocytosis by targeting found on the plasma membrane. An interaction between
adaptor protein 2 (AP2) and various clathrin-associated PtdIns4P 5-kinase α (PtdIns4P 5-Kα) and the PLDs en-
sortin proteins (CLASPs) (Module 4: Figure cargo sort- sures that there is a local generation of PtdIns4,5P2 that
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r59
plays an important role in regulating PLD activity (Module external signals can maintain information flowing through
2: Figure PLD signalling). the inositol 1,4,5-trisphosphate (InsP3 )/Ca2 + signalling
cassette.
PtdIns4,5P2 regulation of ion channels and exchangers Operation of the PtdIns 3-kinase signalling cassette can
A number of ion channels and exchangers appear to be be considered in two parts:
regulated by PtdIns4,5P2 . In some cases, the hydrolysis of
PtdIns4,5P2 results in channel opening as occurs for the • Generation and metabolism of the 3-phosphorylated
transient receptor potential (TRP) vanilloid 1 (TRPV1) lipid messengers
channel, whereas the TRPC6 channel, TRP melastatin 4 • Mode of action of the 3-phosphorylated lipid messen-
(TRPM4), TRP melastatin 7 (TRPM7) and TRP melast- gers
atin 8 (TRPM8) channels are closed (Module 2: Figure
One of the important functions of this pathway is to
PtdIns4,5P2 regulation of TRP channels). In the case of
regulate cell proliferation. Since a number of human can-
the inward rectifying K + channels, lipid hydrolysis res-
cers are found to have mutations in certain components
ults in channel opening (Module 2: Figure PtdIns4,5P2
of this pathway, there is considerable interest in the re-
regulation of K + channels). Modulation of the TRPV1
lationship between PtdIns 3-kinase signalling and cancer.
channel is particularly important in hyperalgesia (Module
A decline in the activity of this signalling pathway is the
10: Figure nociception).
cause of insulin resistance that leads to diabetes (Module
Much of the information on this regulatory function
12: Figure insulin resistance).
of PtdIns4,5P2 has emerged from studies on K + chan-
nels. Stimulation of phospholipase C (PLC) by G protein-
coupled receptors (GPCRs) causes a reduction in the level Generation and metabolism of the 3-phosphorylated
of PtdIns4,5P2 , which results in a reduction in the activity lipid messengers
of some of the voltage-dependent K + (Kv ) channels: Cells contain a number of phosphoinositides carrying a
phosphate on the 3-position (Module 2: Figure phosphoin-
• The human ether-a-go-go-related (HERG) K + channel ositide metabolism). One of these is PtdIns3,4,5P3 , which
(Kv 11.1 channel) is the main second messenger operating in the PtdIns
• The Kv 7.1 channel, which is coded for by the KCNQ1 3-kinase signalling pathway. This highly phosphorylated
gene, is regulated by PtdIns4,5P2 . This inositol lipid lipid is generated in cells following activation of either
keeps the channel open, but when PtdIns4,5P2 is hy- G protein-coupled or tyrosine kinase-coupled receptors
drolysed by angiotensin II, the channel closes. Such (Module 2: Figure PtdIns 3-kinase signalling).
lipid regulation is seen in adrenal zona glomerulosa cells These 3-phosphorylated lipid messengers are metabol-
(Module 7: Figure glomerulosa cell signalling) and also ized either by the type II inositol polyphosphate 5-phos-
in the heart. Mutation of KCNQ1 causes long QT) syn- phatases or by phosphatase and tensin homologue deleted
drome (LQT). on chromosome 10 (PTEN).
• The heteromultimer KCNQ2/3 is responsible for the
M channel in neurons and has been linked to a form of
Mode of action of the 3-phosphorylated lipid
epilepsy known as benign familial neonatal convulsions.
messengers
• KCNQ4, which codes for Kv 7.4 (Module 3: Table
The lipid messengers PtdIns3,4P2 and PtdIns3,4,5P3 act
voltage-dependent K + channels), is the delayed rectifier
within the plane of the plasma membrane by binding to a
that controls K + efflux from sensory hair cells of the in-
great variety of target proteins (Module 2: Figure PtdIns
ner ear. KCNQ4 mutations cause autosomal dominant
3-kinase signalling). Most of these downstream targets are
nonsyndromic deafness type 2 (DFNA2).
soluble proteins that translocate to the membrane by bind-
ing to the lipid messengers through various lipid-binding
PtdIns 3-kinase signalling domains [e.g. pleckstrin homology (PH), Phox homology
The PtdIns 3-kinase signalling cassette, which generates (PX), C2 domains and basic amino acid regions] (Module
the lipid second messenger phosphatidylinositol 3,4,5- 6: Figure modular lipid-binding domains). Once drawn on
tetrakis phosphate (PtdIns3,4,5P3 ), has multiple functions to the membrane, these target proteins are activated and
in regulating a wide range of cellular processes such as the function as effectors to control a large number of cellular
control of glycogen metabolism, lipid synthesis, protein processes:
synthesis, gene transcription and cell growth, inflamma-
tion, cytoskeletal rearrangement and apoptosis (Module • Contribution to liver cell signalling mechanisms to con-
2: Figure PtdIns 3-kinase signalling). With regard to the trol glycogen metabolism (Module 7: Figure liver cell
latter, the PtdIns 3-kinase signalling cassette has a special signalling).
function in cell survival through its contribution to the • Functions in the insulin control of skeletal muscle gly-
hormonal modulation of apoptosis and by enhancing the cogen synthesis (Module 7: Figure skeletal muscle E-C
activity of the target of rapamycin (TOR). PtdIns 3-kinase coupling).
signalling is one of the major pathways used by the insulin • Functions in white fat cells to control lipid metabolism
receptor to regulate energy uptake and storage. (Module 7: Figure lipolysis and lipogenesis).
This lipid signalling pathway has a special relationship • Functions in the control of cell proliferation (Module 9:
to Ca2 + signalling in that it can regulate the way in which Figure growth factor signalling).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r60
AGONIST
Channel open + Channel closed
membrane K membrane
hyperpolarized depolarized
R
PtdIns PLC
PtdIns4P
4-Kinase 5-Kinase PtdIns4,5P
PtdIns PtdIns4P 2
InsP3
DAG
DAG
Inositol Kinase
phosphate
metabolism
PtdIns
Inositol
Phosphatidic
PtdIns acid
synthase
AGONIST Cations
TRPC6
TRPM4 TRPM4
TRPM7 TRPM7
TRPV1 TRPM8
TRPM8
opens closes
TRPV1
R
PLC
PtdIns PtdIns4P
4-Kinase 5-Kinase PtdIns4,5P
PtdIns PtdIns4P 2
InsP3
DAG
Inositol
phosphate
metabolism DAG
Kinase
PtdIns
Inositol
PtdIns Phosphatidic
synthase acid
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r61
Growth factor
PtdIns3,4,5P3 GPCR
PTKRs
Ras
P P Ras p101/
p85 p110 p110 p84
P P
PtdIns- Class IB PtdIns-
P P
4,5P2 Class IA PI 3-K 4,5P2
PI 3-K
PDK1/2 Rac
Rho Superoxide
formation
Cdc42
Btk PKB
Itk
Cytoskeletal
rearrangement
PLC
PKCs
S6K TOR BAD GSK3 FOXO
IP DAG
3
Protein Cell Glycogen Gene
transcription
Ca 2+ PKCs synthesis survival metabolism
• PtdIns 3-kinase signalling in cardiac hypertrophy is an (PKB), which translocates to the membrane, where it binds
example where this signalling system carries out mul- to PtdIns3,4,5P3 (Module 2: Figure PtdIns 3-kinase sig-
tiple roles in the same cell (i.e. inhibits apoptosis, ac- nalling). This binding alters the conformation of PKB so
tivates protein synthesis and facilitates a programme that critical sites become available to PDK1. Like PKB,
of foetal gene transcription (Module 12: Figure hyper- PDK1 has pleckstrin homology (PH) domains that also
trophy signalling mechanisms). bind to the 3-phosphorylated lipid messengers that serve
• Modulation of InsP3 -induced Ca2 + release by phos- to activate their kinase activity. PDK1 is also responsible
phorylation of the InsP3 receptor, and this could provide for phosphorylating and activating other signalling mo-
a possible mechanism for the action of insulin in liver lecules such as ribosomal S6 protein kinase 1 (S6K1) and
cells (Module 7: Figure liver cell signalling). atypical protein kinase Cζ (PKCζ).
• PtdIns3,4,5P3 activates the monomeric G proteins Rac
(Module 2: Figure Rac signalling), Rho (Module 2: Fig- Protein kinase B (PKB)
ure Rho signalling) and Cdc42 (Module 2: Figure Cdc42 Protein kinase B (PKB), which is also known as Akt,
signalling). is a serine/threonine protein kinase that functions in
• Formation of osteoclast podosomes (Module 7: Figure the PtdIns 3-kinase signalling pathway (Module 2: Fig-
osteoclast podosomes). ure PtdIns 3-kinase signalling). PKB has three members
• Contributes to the amplification of the early polarity (PKBα, PKBβ and PKBγ) that are activated through a
signalling during neutrophil chemotaxis (Module 11: two-stage process. Firstly, it translocates to the mem-
Figure neutrophil chemotactic signalling). brane by binding to either PtdIns3,4P2 or PtdIns3,4,5P3
• Functions as a regulator of autophagy (Module 11: Fig- through pleckstrin homology (PH) domains. The latter
ure autophagy). appears to be particularly important when cells are stud-
ied in vivo. The next stage depends upon its interaction
Phosphoinositide-dependent kinase 1 (PDK1) with phosphoinositide-dependent kinase 1 (PDK1), which
One of the main functions of phosphoinositide-dependent then completes the activation process by phosphorylating
kinase 1 (PDK1) is to phosphorylate protein kinase B PKB on Thr-308. In addition, a DNA-dependent protein
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r62
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r63
1
Cysteine-rich domain
L1
SS SS SS SS
SS SS
PtdIns4,5P PtdIns3,4,5P
2 3
972 P 5
P IRS
P p85
1158 P P P P
1162 PI 3-K
P P
1163 P 2 P
PDK1/2
3
1328
P P
6
1334 P P 4
PKB
which is a classical scaffolding protein (Module 6: Figure • It stimulates glucose uptake and glycogen synthesis
IRS domain structure). in skeletal muscle cells (Module 7: Figure skeletal
The function of the insulin receptor depends upon the muscle E-C coupling).
activation of the PtdIns 3-kinase signalling pathway that • It stimulates glycogen synthesis in liver cells (Module
occurs through the sequence of events shown in Module 7: Figure liver cell signalling).
2: Figure insulin receptor:
The onset of diabetes (i.e. Type 2 diabetes) begins when
cells become resistant to the action of insulin in energy
uptake and storage.
1. Insulin binds to the extracellular domain to induce a
conformational change in the receptor resulting in the
activation of the intracellular tyrosine kinase domains. PtdIns3,5P2 signalling cassette
2. Once activated, the tyrosine kinase domains undergo The PtdIns3,5P2 signalling cassette functions in membrane
autophosphorylation whereby they phosphorylate up and protein trafficking and particularly in the events that
to six tyrosine residues on the opposite β chain. occur during the early endosome maturation to lysosome
3. The insulin receptor substrate (IRS), which is a scaf- (see step 10 in Module 4: Figure membrane and pro-
folding domain (Module 6: Figure IRS domain struc- tein trafficking). The early endosome is rich in PtdIns3P
ture), attaches itself to juxtamembrane phosphotyr- that is converted into PtdIns3,5P2 (Module 2: Figure loc-
osine residue 972. Once it is drawn into the vicinity alized inositol lipid signalling), which then orchestrates
of the receptor, the tyrosine kinase domain also phos- the trafficking events responsible for the transformation
phorylates IRS on multiple residues. of the early endosome into the multivesicular endosome
4. The phosphotyrosine residues on IRS then function as (MVE) that end up as lysosomes. The PtdIns3,5P2 seems
docking sites for Class IA PtdIns 3-kinase (PI 3-K). to act by stimulating TRPML1 channels to create the
5. The PI 3-K then phosphorylates PtdIns4,5P2 to form local domains of Ca2 + necessary to activate the endo-
the lipid second messenger PtdIns3,4,5P3 . some fusion to form the lysosomes. The formation of
6. The PtdIns3,4,5P3 then activates the PtdIns 3-kinase PtdIns3,5P2 is carried out by PhosphoInositide Kinase
signalling pathway (Module 2: Figure PtdIns 3-kinase for five position containing a Fyve finger (PIKfyve),
signalling) that controls a number of cellular processes: which has a number of protein interaction domains
• It stimulates lipogenesis in white fat cells (Module 7: that enables it to interact with a number of other pro-
Figure lipolysis and lipogenesis). teins to form a functional PIKfyve--ArPIKfyve--Sac3
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r64
ArPIKfyve
PIKfyve
Ph Sac3/Fig4
os
C Kinase ph
ata
E se
N FYV
PtdIns3,5P
3P 2
PtdIns PtdIn
s3P
(PAS) complex (Module 2: Figure PIKfyve activation). The • Early endosome sorting and intraluminal vesicle form-
N-terminal FYVE domain binds to the substrate PtdIns3P. ation (Module 4: Figure intraluminal endosomal vesicle
The Cpn160_TCP1 domain interacts with the associated formation)
regulator of PIKfyve (ArPIKfyve), which forms a dimer • Early endosome to plasma membrane trafficking
and functions as a scaffolding protein to assemble the PAS (Module 4: Figure early endosome budding)
complex. The C-terminal kinase domain is then positioned • Early endosome to trans-Golgi network (TGN) traf-
to catalyse the conversion of PtdIns3P into PtdIns3,5P2 . ficking (Module 4: Figure endosome budding to TGN)
The suppressor of actin 3 (Sac3), which is the mammalian • Phagosome maturation (Module 4: Figure phagosome
orthologue of Fig4 in yeast, is a SAC domain lipid phos- maturation).
phatase that removes the 5-phosphate from PtdIns3,5P2 to • Formation of PtdIns3P has a role to play in activating
form PtdIns3P. Sac3 is part of the PAS complex and has an the isolation membrane responsible for initiating the
important structural role in that it also helps to facilitate events of autophagy (Module 11: Figure autophagy).
the kinase activity of PIKfyve. • PtdIns3P plays a role in regulating the activity of the
Mutations in Sac3/Fig3 have been linked to intermediate conductance (IK) channel, particularly as
Charcot-Marie-Tooth disease 4J. part of the relationship between K + channels and cell
proliferation.
PtdIns3P signalling cassette PtdIns3P levels can be reduced through the action of
PtdIns3P, which is formed by the phosphorylation of the myotubularin family of 3-phosphatases (MTM1 and
PtdIns by the Class III PtdIns 3-kinase, has a specific role MTMR1--MTMR14). These enzymes are of interest be-
to play in controlling a number of cellular processes. cause MTM1 mutations are responsible for X-linked re-
One of the main functions of PtdIns3P is to regulate cessive myotubular myopathy, MTMR2 mutations occur
intracellular vesicle trafficking especially at the level of in Charcot-Marie-Tooth disease 4B and MTMR14 muta-
the early endosome (Module 2: Figure localized inositol tions have been linked to centronuclear myopathy (CNM).
lipid signalling). Most of the PtdIns3P is found on internal
membranes and particularly those that function in vesicle PtdIns4P signalling cassette
trafficking: For a long time, PtdIns4P was considered to be only a
precursor of PtdIns4,5P2 , but now there are indications
• This function is particularly evident in the endosome that it might have a signalling role to regulate membrane
vesicle fusion to the early endosome (Module 4: Figure and protein trafficking. One role is to control coat re-
endosome vesicle fusion) moval following the formation of clathrin-coated vesicles
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r65
(Module 4: Figure scission of endocytic vesicles). Another this GAP to come off the membrane. A closely related
role is to control trafficking through the endoplasmic retic- GAP1m is located on the ER.
ulum/Golgi transport system (Module 2: Figure localized
inositol lipid signalling), where it is formed by at least two Ins3,4,5,6P4
PtdIns 4-kinases (PtdIns 4-Ks). The small GTPase ADP- Ins3,4,5,6P4 functions as an inhibitor of the Ca2 + -sensitive
ribosylation factor Arf-1 recruits the PtdIns 4-KIIIβ to Cl − channels (CLCAs) in epithelial cells, which regulate
the Golgi. At resting levels of Ca2 + , this PtdIns 4-KIIIβ salt and fluid secretion, cell volume homoeostasis and elec-
is kept inactive when bound to the Ca2 + -sensing proteins trical excitability in neurons and smooth muscle cells. It
calneuron-1 or calneuron-2. In response to a local pulse of appears to act by preventing Ca2 + /calmodulin-dependent
Ca2 + , the inhibitory calneurons are replaced by neuronal protein kinase II (CaMKII) from activating the channel.
Ca2 + sensor 1 (NCS-1) that stimulates PtdIns 4-KIIIα to Ins3,4,5,6P4 is formed by an Ins1,3,4,5,6P5 1-phos-
begin to produce the PtdIns4P necessary for vesicle form- phatase, which is activated by Ins1,3,4P3 (Module 2: Fig-
ation. ure inositol phosphate metabolism).
In addition, the Golgi also has a PtdIns 4-kinase α that
produces the PtdIns4P that associates with activating pro-
tein 1 (AP-1) to regulate the trafficking of clathrin-coated InsP6
vesicles through the trans-Golgi network. There are a number of suggestions concerning the possible
messenger role of InsP6 . Cells contain high levels of InsP6
(approximately 15--100 μM), and much of this is prob-
PtdIns5P signalling cassette ably not in solution, but is probably attached to the phos-
PtdIns5P has been implicated in several signalling events. pholipids in membranes through electrostatic interactions
It may modulate the PtdIns 3-kinase signalling pathway with bivalent cations. The level of InsP6 does not change
by interfering with the metabolism of the lipid messenger much during acute stimulation, but its level can vary over
PtdIns3,4,5P3 . It may also have a signalling role within the the long term, as occurs during the cell cycle and during
nucleus to control the response to DNA damage. PtdIns5P cellular differentiation. The various proposed messenger
located on chromatin may provide an anchor to bind in- functions outlined below may thus depend upon highly
hibitor of growth family, member 2 (ING2), which then localized fluctuations in specific cellular compartments.
results in acetylation of the p53 tumour suppressor.
Trafficking of vesicles
Multipurpose inositol polyphosphate InsP6 may inhibit clathrin cage assembly by binding to ad-
signalling pathway aptor protein (AP)-2 and -3. Such a role in membrane traf-
The process of inositol phosphate metabolism generates ficking is also consistent with the observation that InsP6
a large number of inositol phosphates (Module 2: Figure binds to synaptotagmin by competing with the inositol
inositol phosphate metabolism). Many of these are meta- lipid-binding site. It therefore seems that InsP6 may func-
bolic intermediates, but some have been implicated in a tion as a negative regulator of endocytic vesicle traffic.
variety of control functions: Such a possibility may explain the observation that
GRAB, which is a guanine nucleotide exchange factor that
Ins1,4P2 acts on Rab3A, interacts with InsP6 kinase which converts
There is some evidence to suggest that Ins1,4P2 may func- InsP6 into InsP7 .
tion within the nucleus to activate DNA polymerase. This
inositol phosphate has also been implicated in Ca2 + sig- Endocytosis
nalling and cardiac hypertrophy. In insulin-secreting β-cells, InsP6 appears to promote dy-
namin I-mediated endocytosis through a mechanism that
depends upon protein kinase C (PKC), which may act
Ins1,3,4P3
to inhibit the phosphoinositide phosphatase synaptojanin,
This inositol phosphate has an important signalling func-
thereby raising the level of PtdIns4,5P2 that has been im-
tion as a negative regulator of the Ins1,3,4,5,6P5 1-phos-
plicated in vesicle dynamics.
phatase (Module 2: Figure inositol phosphate metabol-
ism) that controls the level of Ins3,4,5,6P4 , which is an Regulation of Ca2 + channels
inhibitor of Ca2 + -sensitive Cl- channels. InsP6 is present in many brain regions and appears to be
elevated following neural activity. It may act by stimulat-
Ins1,3,4,5P4 ing adenylyl cyclase to produce cyclic AMP, which then
This inositol phosphate, which is formed by phosphorylat- increases the activity of L-type Ca2 + channels. Alternat-
ing Ins1,4,5P3 , has been implicated in the control of Ca2 + ively, it may activate L-type Ca2 + channels through an
entry into cells. However, its mode of action is unknown. inhibition of protein phosphatases. In vascular smooth
Some clues concerning its action may come from the iden- muscle cells, InsP6 appears to act through a protein kinase
tification of GAP1IP4BP , which is one of the GTPase- C (PKC)-dependent pathway.
activating protein (GAP) family (Module 2: Table mono-
meric G protein toolkit). GAP1IP4BP normally associates Regulation of gene transcription
with the plasma membrane. When Ins1,3,4,5P4 binds to Studies on yeast have revealed that ARG82, which is an
the membrane-anchoring domain of GAP1IP4BP , it causes Ins1,4,5P3 6-kinase that phosphorylates Ins1,4,5P3 within
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r66
Cellular responses
2+ eNOS cGK I Protein
Ca iNOS GCKGC targets
nNOS cGK II
sGC
NO GC
cGMP GMP
PDE5
O2-
2+
GSH Mn NADPH
RNS +
NADP
signalling TRXR
2+ S S HNO
ONOO- GS-NO
SH SH
Mn - NO
TRX TRX
GSH GSNO
Protein NADH
target Cellular responses GSNOR GSNHOH
NAD+
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r67
Reductase domain
O
2
Oxidase domain CAM
Arginine
Oxidase domain
Haem BH4
CAM FMN FAD NADPH
Reductase domain
Ca 2+ S1177
Citrulline NO
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r68
Myristic
eNOS acid
Inactive
Caveolin Palmitic
CAM FAD BH4
acid
FMN Heme
Calcium-induced
NOS activation
eNOSActive
Arginine Citrulline
NADPH NADP
2+ O2
Ca NO
calmodulin (CaM) to stimulate the enzyme to release NO rophages, where its expression is up-regulated by inflam-
(Module 2: Figure eNOS activation). matory mediators. Although macrophages are the main
The NO released from endothelial cells diffuses out to cells that express iNOS, it is also found in other cell types
regulate smooth muscle cell contraction and hence controls (cardiac cells, vascular smooth muscle cells and glial cells).
blood pressure, smooth muscle cell proliferation, aggrega- Unlike the other isoforms, the activation of iNOS does
tion of blood platelets and leucocyte adhesion. Studies on not require an elevation of Ca2 + . However, iNOS does
NO/cyclic GMP and cardiac hypertrophy have revealed bind calmodulin (CaM), which is essential for its activa-
that expression of eNOS in endothelial cells can inhibit tion. Since the enzyme is constitutively active, its primary
hypertrophy in neighbouring cardiac cells. Given its cent- regulation depends upon its induction by inflammatory re-
ral role in regulating so many cellular processes, alterations ceptors such as those that respond to interferon-γ (IFN-γ)
in the endothelial production of NO have been implicated or lipopolysaccharide (LPS). As large amounts of enzyme
in many disease states, such as hypertension, diabetes and are produced, this is a high-output pathway capable of de-
hypercholesterolaemia. livering NO for prolonged periods as part of the cells de-
fence against invading micro-organisms. As such, it does
Inducible nitric oxide synthase (iNOS) not strictly function as a messenger. However, the large
Inducible nitric oxide synthase (iNOS), which is also production of NO at the sites of inflammation will spill
known as immunocyte NOS, was first described in mac- over to affect neighbouring cells. The large up-regulation
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r69
of iNOS may account for the fall in blood pressure during a group of single membrane-spanning receptors that use
endotoxic shock. an enzyme to transduce information. In this case, it is the
guanylyl cyclase region of the cytoplasmic domain that
Neuronal nitric oxide synthase (nNOS) functions both as a transducer and an amplifier to generate
Neuronal nitric oxide synthase (nNOS) was first described the second messenger cyclic GMP.
in neurons, but has since been found in other cell types such
as skeletal muscle, which has an alternatively spliced vari- Cyclic GMP hydrolysis
ant that has a 34-amino-acid insert between exons 16 and The enzyme that reverses the second messenger action of
17. In both neurons and muscle, nNOS is closely associated cyclic GMP by hydrolysing it to GMP is the cyclic GMP-
with the plasma membrane where it binds to various pro- specific phosphodiesterase (PDE5), which can be activated
teins through its PDZ domains. In neurons, nNOS binds by cGKI, thus setting up a negative-feedback loop. Excess-
to the postsynaptic density (PSD) proteins such as PSD- ive signalling through the cyclic GMP signalling pathway
93 and PSD-95 (Module 10: Figure postsynaptic density), will thus be curtailed through this ability of cyclic GMP
whereas in skeletal muscle it interacts with α1-syntrophin to enhance its own hydrolysis. PDE5 is of considerable
(a binding partner of dystrophin). interest as it is the target of Viagra.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r70
proteins, but is first of all converted into reactive nitro- active site. This oxidized Trx is then reduced by NADPH
gen species (RNS) that are then responsible for carrying through the activity of the seleno-flavoprotein TrxR.
out the nitrosylation reaction. These nitrosylation reac- The other mechanism depends on S-nitrosoglutathione
tions are reversed by denitrosylation reactions. Many of reductase (GSNOR), which is also known as GSH-
the functions of NO are carried out by this nitrosylation- dependent formaldehyde dehydrogenase and Class III al-
sensitive signalling pathway and there is growing evidence cohol dehydrogenase (ADH3). The GSNOR metabolizes
for nitrosylation dysfunction in disease. the GSNO, which is one of the reactive nitrogen spe-
cies (RNS), which is produced through two mechanisms.
Reactive nitrogen species (RNS) It is formed when NO interacts with GSH and is also
The reactive nitrogen species (RNS) that carry out the released following the denitrosylation of target proteins
nitrosylation reaction are formed when NO interacts (Module 2: Figure NO and cGMP signalling). The GS-
with various acceptors such as superoxide radical (O2 − • ), NOR uses NADH as an electron donor to irreversibly
cysteine (Cys), glutathione (GSH) or transition metal ions convert GSNO into GSNHOH. In the absence of GS-
(Mn + , e.g. Fe3 + or Cu2 + ) (Module 2: Figure NO and NOR, the level of GSNO increases as does the amount
cGMP signalling): of S-nitrosylated proteins, which suggest that these SNO
proteins might be in equilibrium with GSNO and this
1. NO + O2 − → ONOO- (peroxynitrite)
might account for the fact that certain cellular proteins
2. NO + Mn + → Mnn + -NO
seem to by constitutively nitrosylated.
3. NO + GSH → GS-NO
4. NO + Cys → Cys-NO
Redox signalling
The interaction between NO and O2 − • forms the Cells have evolved a sophisticated mechanism of intracel-
strong oxidant peroxynitrite (ONOO − ), which is very lular signalling based on localized changes in the oxidation
much more reactive than the two parent molecules. It can state of specific proteins. The internal environment of cells
react with electron-rich groups such as protein sulfhy- is normally highly reduced. Certain forms of stress are as-
dryls as part of the nitrosylation reaction to form the S- sociated with an increase in the oxidative state, and this
nitrosothiols (SNOs). Although peroxynitrite has a brief can induce apoptosis. It is also well known that certain
half-life (approx. 15 ms), it exists for long enough to dif- phagocytic cells, such as neutrophils, can rapidly generate
fuse through a cell and perhaps also to neighbouring cells superoxide radical (O2 − • ) and hydrogen peroxide (H2 O2 )
enabling it to function as an intra- and inter-cellular mes- that are used to kill other cells during inflammatory re-
senger. sponses. In addition to these pathological effects, there is
Low molecular mass thiols, such as glutathione (GSH), increasing evidence that the redox system has been adapted
can also be nitrosylated by NO to form GS-NO. to perform a variety of signalling functions and can mod-
ulate the activity of other signalling pathways. As such,
Nitrosylation reaction they can control many cellular processes, including cell
The S-nitrosylation reaction depends upon the transfer of proliferation, apoptosis and cellular senescence. Some of
NO from one of the reactive nitrogen species (RNS) to these effects are exerted through a two-way interaction
a peptidyl cysteine thiol group of target proteins (R-SH) with Ca2 + signalling. For example, redox signalling can
(Module 2: Figure NO and cGMP signalling): help to promote the tyrosine phosphorylation events that
generate many signalling cascades and it can modulate the
1. R-SH + ONOO- → R-SNO
activity of the ryanodine receptors (RYRs) and inositol
2. R-SH + Mn + -NO → R-SNO
1,4,5-trisphosphate receptors (InsP3 Rs) that release Ca2 + .
3. R-SH + GS-NO → R-SNO
Conversely, Ca2 + can stimulate redox signalling, particu-
4. R-SH + Cys-NO → R-SNO
larly within the mitochondrion, indicating that there are
Specificity is determined by the fact that the target pro- dynamic interactions operating between these signalling
teins (R-SH) have hyperreactive cysteine groups where the pathways.
thiol moiety exists as a thiolate anion due to the presence There are two main types of redox signalling. The first
of positively charged amino acids in the immediate vicinity type is reactive oxygen species (ROS) signalling, which
of the protein chain. depends on the formation of ROS. The second type is
reactive nitrogen species (RNS) signalling, which is carried
Denitrosylation reactions out by RNS and is linked to the nitric oxide (NO)/cyclic
Denitrosylation is carried out by two main denitrosylases GMP signalling pathway.
(Module 2: Figure NO and cGMP signalling). One mech-
anism depends on the oxidoreductase thioredoxin (Trx) Reactive oxygen species (ROS) signalling
operating in concert with Trx reductase (TrxR). In its re- ROS signalling has all the hallmarks of a classical signalling
duced state, the two cysteine residues in the highly con- mechanism. The second messengers are the reactive oxy-
served -Cys-Gly-Pro-Cys- active site are reduced and the gen species (ROS) formed in response to many agonists.
hydrogens are used to release the NO as HNO and to Reactive oxygen species (ROS) formation depends on the
convert the SNO group on the target protein into an SH stimulation of a NADPH oxidase that removes an electron
group. During this denitrosylation reaction, a disulphide from NADPH and adds it to oxygen to create superoxide
bond is formed between the vicinal cysteine residues at the radical (O2 − • ), which is one of the ROS found in cells.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r71
REDOX
SIGNAL SIGNALLING
PATHWAY
R Messenger
formation
O2
_ SOD
H O2
2
Catalase
H O
2
Messenger
metabolism
Messenger
OH OH action
Oxidation
SH
S
SH
S Recovery
Reduction
Oxidation-sensitive
processes
Cellular
response
Superoxide dismutase (SOD) rapidly converts the O2 − • pathways [mitogen-activated protein kinase (MAPK) cas-
into hydrogen peroxide (H2 O2 ), which is one of the main cade and Ca2 + signalling]. It is therefore not surprising to
messenger molecules used by the redox signalling pathway find a role for redox signalling in proliferation and cancer.
(Module 2: Figure summary of redox signalling). There is also a strong relationship between redox signalling
Rapid reactive oxygen species (ROS) metabolism en- and schizophrenia (Module 12: Figure schizophrenia).
sures that H2 O2 , like other intracellular messengers, has a
short half-life. This metabolism of H2 O2 is carried out by Reactive oxygen species (ROS)
a range of enzymes, including catalase, glutathione peroxi- Reactive oxygen species (ROS) is a collective term
dase (GPx) and peroxiredoxin (Prx). Since the inside of the that refers to those oxygen species [superoxide (O2 − • ),
cell is a highly reducing environment, the last two enzymes hydrogen peroxide (H2 O2 ) and the hydroxyl radical
can draw upon a large reservoir of reducing equivalents in (OH• )] that are more reactive than ground-state oxygen
order to metabolize the ROS. The cell has a large redox [Module 2: Figure reactive oxygen species (ROS)]. These
buffer capacity in the form of glutathione, which func- are sometimes considered synonymous with free radicals,
tions to maintain the redox balance in the cell. The fact but not all ROS are free radicals. The latter are defined
that H2 O2 is metabolized so rapidly means that its site of as atoms or molecules that contain one or more unpaired
action is highly localized close to its site of production. electrons. With regard to signalling, it is the O2 − • and
The reactive oxygen species (ROS) messenger action of H2 O2 that appear to be the most important messengers.
H2 O2 depends upon its ability to react with the cysteine Also, there are indications that these two messengers may
residues of a certain group of target proteins. The latter are perform different functions.
marked out by virtue of having hyperreactive thiol groups There are two important sources of reactive oxygen spe-
that are rapidly oxidized to form a disulphide bond. The cies (ROS): one is at the plasma membrane and the other
recovery from this oxidized state back to a fully reduced is within the mitochondria (Module 2: Figure sites of ROS
thiol group is carried out by the glutaredoxin and/or the formation).
thioredoxin systems.
Finally, the oxidized target proteins activate a num- Superoxide (O2 − • )
ber of oxidation-sensitive processes that bring about a The superoxide radical (O2 − • ) that is formed by the one-
number of cellular responses such as gene activation, mod- electron reduction of O2 is short-lived (half-life of 10 − 6
ulation of ion channels and the activity of other signalling s) in that it rapidly dismutates into hydrogen peroxide
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r72
(H2 O2 ). This conversion can occur spontaneously, but the Superoxide dismutase (SOD)
reaction is greatly accelerated by the enzyme superoxide A family of metalloproteinases that converts superoxide
dismutase (SOD). radical (O2 − • ) into hydrogen peroxide (H2 O2 ) (Module
2: Figure plasma membrane ROS formation):
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r73
OO O2 Oxygen
e- REACTIVE OXYGEN
SPECIES (ROS)
OO O2
-. Superoxide
e-
H OO H H2 O2 Hydrogen
peroxide
e-
O H OH . Hydroxyl
radical
Paired electrons
Unpaired electrons
Formation and metabolism of the reactive oxygen species (ROS).
To understand the properties of reactive oxygen species (ROS) and how they are formed, it is best to begin with oxygen. Oxygen is a strong oxidizing
agent in that it has two unpaired electrons (e − ; red dots), which have parallel spins (i.e. they spin in the same direction as indicated by the two black
arrows) and occupy separate π-antibonding orbitals. Given that they have these unpaired electrons, oxygen qualifies as a free radical. However,
oxygen is relatively inert because, in order to react with another molecule, it has to accept a pair of electrons with antiparallel spins to fit into the empty
spaces in the π orbitals. Because of this restriction, oxygen accepts electrons (e − ) one at a time and this leads to the formation of the different ROS.
Plasma membrane reactive oxygen species (ROS) to carry out the first step of ROS formation i.e. the re-
formation duction of oxygen to superoxide radical (O2 − • ) (Module
A large number of receptors responding to external sig- 2: Figure plasma membrane ROS formation). In addition
nals stimulate the formation of reactive oxygen species to this activation through Rac, it seems that the enzyme
(ROS), including cytokine receptors (tumour necrosis can also be regulated through diacylglycerol (DAG) and
factor α, interleukin-1 and interferon-γ), growth factor Ca2 + acting through protein kinase C (PKC), which phos-
receptors [platelet-derived growth factor (PDGF), epi- phorylates p47phox , one of the cytoplasmic components of
dermal growth factor (EGF) and basic fibroblast growth NADPH oxidase, to bring about the assembly of the mul-
factor (bFGF) receptors] and G protein-coupled receptors ticomponent complex. Non-phagocytic cells that generate
(GPCRs) (5-hydroxytryptamine, bradykinin, angiotensin ROS for signalling use a similar, but genetically distinct,
II, thrombin and endothelin receptors). Just how all these NADPH oxidase called Nox1, which plays a significant
receptors are coupled to the formation of ROS is still role in redox signalling in proliferation and cancer.
somewhat uncertain, but there is increasing evidence that In phagocytes, the O2 − • is released to the outside of the
the mechanism might resemble that found in phagocytic cell, where it is able to attack invading micro-organisms,
cells. whereas, in non-phagocytic cells, it functions as a mes-
In phagocytes, external signals acting through cell- senger to activate a signalling cascade on the inside of the
surface receptors stimulate the PtdIns 3-kinase signalling cell (Module 2: Figure plasma membrane ROS formation).
pathway to form the lipid messenger PtdIns3,4,5P3 Superoxide dismutase (SOD) rapidly converts the O2 − •
(Module 2: Figure PtdIns 3-kinase signalling), which then into hydrogen peroxide (H2 O2 ), which appears to be the
acts through Rac to stimulate NADPH oxidase. This mul- primary messenger molecule of this redox signalling path-
ticomponent enzyme uses NADPH as an electron donor way.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r74
Agonist
NADPH oxidase
complex on the
plasma membrane
NADH
ROS
NAD+
HO
2
Growth
Cytokines factors Hormones
NADPH
oxidase
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r75
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r76
GSSG
Reduction
GSH Glu Cys Gly
Oxidation
S
H2O GSSG Grx-(SH) S
2
Glutathione (GSH) peroxide (H2 O2 ) to water, thus curtailing its messenger ac-
Glutathione (GSH) is a redox buffer that regulates the tion. PrxI and PrxII are cytosolic, whereas Prx III is found
cellular redox balance (Module 2: Figure GSH/GSSG on mitochondria and PrxIV is on the endoplasmic retic-
couple). GSH is a tripeptide consisting of glutamic acid, ulum. The operation of the catalytic cycle goes through the
cysteine and glycine. It is synthesized by two enzymes. following steps (Module 2: Figure peroxiredoxin catalytic
First, there is glutamate cysteine ligase (GCL), which is cycles):
made up of two subunits: a GCL catalytic subunit (GCLC)
and a GCL modifier subunit (GCLM). The GCLC car-
1. H2 O2 is generated near the plasma membrane when
ries out an ATP-dependent condensation reaction between
the PtdIns3,4,5P3 (PIP3 ) formed by receptor activation
cysteine and glutamate to form gamma-glutamylcysteine.
stimulates NADPH oxidase.
Secondly, a GSH synthetase (GSS), which is also known as
2. H2 O2 interacts with the reduced cysteine residues
GSH S-transferase (GST), adds a glycine to the dipeptide
(Cys-SH) in the N-terminal regions of the thioredoxin
gamma-glutamylcysteine to form GSH.
(Trx) dimers to form two oxidized sulphenic residues
A dysregulation of GSH metabolism has been implic-
(Cys-SOH).
ated in schizophrenia (Module 12: Figure schizophrenia).
3. The Cys-SOH can then interact with the conserved
Cys-SH on the C-terminal regions of the neighbouring
Glutathione peroxidase (GPx) dimer to form two intermolecular disulphides.
The glutathione peroxidase (GPx) family uses the reducing 4. The Prx disulphide is converted back into the reduced
power of glutathione to convert H2 O2 into water (Module form by Trx, which is regenerated by thioredoxin re-
2: Figure H2 O2 metabolism). ductase (Module 2: Figure recovery of protein oxida-
tion).
Peroxiredoxin (Prx) 5. The sulphenic residues formed by Reaction 2 can un-
The peroxiredoxins (PrxI to PrxIV) are a family of small dergo hyperperoxidation by interacting with further
antioxidant proteins that function to metabolize hydrogen molecules of H2 O2 to form the sulphinic acid residues.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r77
Catalase
2 H 2O2 2 H 2O + O2
GSH
peroxidase
H 2O2 + 2GSH 2 H 2O + GSSG
Peroxiredoxin
H 2O2 + Prx(SH) 2 H2 O + PrxS 2
2
6. This hyperperoxidation reaction can be reversed by a 1. The primary action of H2 O2 is to oxidize the hyperre-
reaction that requires ATP catalysed by the enzyme active cysteine to form a sulphenic acid group (-SOH),
sulphiredoxin (Srx). which can be metabolized further along a number of
7. The phosphorylated intermediate is reduced back to pathways.
the reduced form of Prx by the Trx system. 2. The sulphenic acid residue can interact with nitrogen on
8. The Prx system is very efficient at limiting the size of a neighbouring serine residue to form an intramolecular
reactive oxygen species (ROS) microdomains. How- cyclic sulphenyl amide as occurs during the oxidation of
ever, cell-surface receptors are capable of enlarging this protein tyrosine phosphatases (Module 2: Figure ROS
microdomain by inducing a local inactivation of Prx. formation and action).
The activated receptor, perhaps acting through the non- 3. The sulphenic acid residue can be converted into an
receptor protein kinase Src, brings about an inactiva- intramolecular disulphide bond with the elimination of
tion of the Prx molecules in the local vicinity by phos- water.
phorylating Prx on Tyr-194 thus enabling the plume of 4. The sulphenic acid residue can interact with glutathione
H2 O2 to spread away from the receptor. (GSH) to form an intermolecular disulphide bond.
5. The sulphenic acid residue can undergo hyperperoxid-
The reducing equivalents derived from thioredoxin ation by interacting with another molecule of H2 O2 to
(Trx) are used to regenerate Prx-(SH)2 : form a sulphinic acid intermediate (Cys-SO2 H).
6. The sulphinic acid intermediate undergoes further hy-
Prx-S2 + Trx-(SH)2 → Prx-(SH)2 + Trx-S2 perperoxidation to form the sulphonic acid intermedi-
ate (Cys-SO3 H).
When Prx1 in mice is knocked out, animals develop 7. The sulphinic acid group (Cys-SO2 H) can be reduced
haemolytic anaemia and malignant cancers. by a reaction that requires ATP and is catalysed by the
enzyme sulphiredoxin (Srx).
Reactive oxygen species (ROS) messenger action
The primary action of hydrogen peroxide (H2 O2 ) is to The various oxidated intermediates can be converted
reversibly oxidize a variety of target proteins with a high back into the initial reduced state by either the thioredoxin
degree of specificity (Steps 1--7 in Module 2: Figure revers- (Trx) or the glutaredoxin (Grx) system (Module 2: Figure
ible and irreversible ROS oxidations): recovery of protein oxidation).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r78
Growth
Cytokines factors Hormones
PI 3-K PIP3
P NOX/DUOX
Prx
-SH -SH 1
-SH Src
-SH
8
P H2 O2
PTP
O
H O H O
Prx
-SH -SH O S -SH
Prx
-SH 2 2 -SH O 6 ATP
-SH S
O
S Srx
Trx 2
S 5
Prx
-SOH -SH O
4
Prx
P S -SH
-SH -SOH
SH
-SH
Trx --S 3 SH S
Trx --S O
P
Prx
H S S H
S S
7
H O
2
Prx
S -SH -SH
Trx
S
-SH
-SH
Metabolism of H2 O2 by peroxiredoxin.
Peroxiredoxin (Prx) plays a major role in restricting the microdomain of hydrogen peroxide (H2 O2 ) that forms beneath the plasma membrane by rapidly
removing this messenger through a series of catalytic reactions as described in the text. Information adapted from Curr. Opin. Cell Biol., Vol. 17, Rhee,
S.G., Kang, S.W., Jeong, W., Chang, T.-S., Yang, K.-S. and Woo, H.A., Intracellular messenger function of hydrogen peroxide and its regulation by
peroxyredoxins, pp. 183--189. Copyright (2005), with permission from Elsevier; see Rhee et al. 2005.
These oxidation processes can occur through a num- reversible change may accumulate with time and the pro-
ber of mechanisms. What is remarkable about this process gressive damage may result in ageing.
is its specificity. Only a subset of proteins are modified, There is a suggestion that the hyperperoxidation reac-
and within these there is a high degree of specificity in tions that lead to the irreversible oxidation may be avoided
that only certain thiols are modified. How is it that an by an internal reaction whereby the sulphenic acid is rap-
oxidizing agent such as H2 O2 is able to seek out and se- idly converted into a sulphenylamide species by interacting
lectively modify specific target proteins?The answer lies with the main-chain nitrogen atom of an adjacent serine
in the fact that proteins vary considerably in their sens- residue (Step 2 in Module 2: Figure reversible and irrevers-
itivity to mild oxidizing agents, such as H2 O2 . Most of ible ROS oxidations). The formation of this sulphenyl-
the cysteine residues in proteins have a high acidic con- amide intermediate protects against further oxidation, and
stant (i.e. pK a values of approximately 8.5), which means the enzyme can be reactivated by converting the intermedi-
that they are resistant to attack by H2 O2 . However, some ate back into a thiol group via a mixed disulphide reaction
of the cysteine residues, particularly those located next to involving GSH.
positively charged amino acids, have pK a values between Two of the main signalling molecules whose activities
4 and 5 and thus exist as a thiolate anion (Cys-S − ), which are reduced by oxidation are the protein tyrosine phos-
is very vulnerable to oxidation, and these have been re- phatases and phosphatase and tensin homologue deleted
ferred to as hyperreactive cysteine residues (the S − group on chromosome 10 (PTEN) (Module 2: Figure ROS form-
marked with an asterisk in Module 2: Figure reversible and ation and action). An analysis of tyrosine phosphatase
irreversible ROS oxidations). structure and function reveals the presence of a hyperre-
The sulphenic acid intermediate is somewhat unstable active cysteine residue in the catalytic domain that is sens-
and can be converted into a number of intermediates by itive to oxidants resulting in inactivation of the enzyme.
either eliminating water or causing it to interact with GSH Other examples of proteins that have such hypersensitive
(Reactions 2, 3 and 4 in Module 2: Figure reversible and ir- residues include the cell cycle regulatory enzyme Cdc25C,
reversible ROS oxidations). In addition, sulphenic acid can the Ca2 + -release channels ryanodine receptors (RYRs)
be oxidized further by H2 O2 to sulphinic acid and sulph- and inositol 1,4,5-trisphosphate receptors (InsP3 Rs). The
onic acid. The formation of sulphinic acid is reversible specificity with which this redox signalling system exerts
through a reaction that requires ATP and sulphiredoxin its effects therefore depends on the fact that H2 O2 will
(Srx). However, the final step to form sulphonic acid is only modify hyperreactive cysteine residues that exist in
irreversible and can result in serious damage and has been these target proteins of the different oxidation-sensitive
implicated in the ageing process. One idea is that this ir- processes.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r79
Protein
substrate
NH
*
S
N
Grx and Trx
systems
SH S 8
H O
H2 O 2 2
1 SH
H 2O 2
NH NH
Sulphenic H O
acid SOH 2
3
S
SH S
H2 O 2
5 GSH 4 NH
H 2O
SSG
NH H O
Sulphinic 2
acid SO H SH
2
7
SH
Srx NH O
H2 O 2
S
6 ATP PO4
H 2O
NH SH
Sulphonic
acid SO H
3
SH
Reactive oxygen species (ROS) messenger action through the reversible oxidation of target proteins.
The target protein (blue) undergoes a variety of oxidative covalent modifications, some of which induce the conformational changes responsible for
mediating a variety of oxidation-sensitive processes. The target proteins that are modified by reactive oxygen species (ROS) have a hyperreactive
cysteine thiolate anion (asterisk) that is highly sensitive to oxidation by H2 O2 to initiate a cascade of reactions as described in the text.
Growth
factors
Cytokines Hormones
NOX/DUOX
Formation of H2 O2 and its action to regulate phosphotyrosine phosphatase (PTP) and phosphatase and tensin homologue deleted on chromo-
some 10 (PTEN).
The hydrogen peroxide (H2 O2 ) formed by the NADPH oxidase (NOX)/DUOX (dual oxidase) complex creates a microdomain in which it can inactivate
enzymes involved in various signalling pathways: 1. The phosphotyrosine phosphatase (PTP) that dephosphorylates various signalling proteins is
inactivated following its oxidation by H2 O2 ; 2. The inositol lipid phosphatase and tensin homologue deleted on chromosome 10 (PTEN), which
dephosphorylates the lipid second messenger PtdIns3,4,5P3 , is inactivated following its oxidation by H2 O2 . These two enzymes can be reactivated
following their reduction by the thioredoxin (Trx) system (Module 2: Figure recovery of protein oxidation).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r80
THIOREDOXIN SYSTEM
Glucose 100 M 1 M 1-20 M
NADPH TrxR-(SH) Trx-(SH)2 S
2
S
Pentose
cycle SH
GLUTAREDOXIN SYSTEM
100 M 1 M 1-10mM 1 - 20 M
NADPH GrxR-(SH) GSH Grx-(SH) S
2 2
S
SH
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r81
mitochondrial membrane potential and contributes to the the mitochondrial permeability transition pore (MTP) to
inhibition of apoptosis by regulating the nitrosylation induce apoptosis. As so many key signalling functions are
levels of the mitochondrial caspases. Activation of the being influenced, it is not surprising to find that there is a
FAS signalling system can increase the activity of Trx2, role for redox signalling in many cellular processes:
which switches the balance towards the more active de-
nitrosylated form of the caspases. • redox signalling in proliferation and cancer
Expression of the thioredoxin-interacting protein • redox signalling in apoptosis
(Txnip), which binds to Trx and inhibits its participation • redox signalling and DNA damage
in the denitrosylation reaction, is reduced in schizophrenia • redox signalling in vascular homoeostasis
and thus contributes to the increase in redox signalling in • redox signalling and gene transcription
schizophrenia (Module 12: Figure schizophrenia). • redox signalling and modulation of Ca2 + signalling
• redox signalling in schizophrenia
Thioredoxin reductase (TrxR)
Thioredoxin reductase (TrxR) together with thioredoxin Redox signalling in proliferation and cancer
(Trx) is an important oxidoreductase system that has a One of the main actions of redox signalling is to con-
significant role in regulating the redox state (Module 2: trol growth. During the action of many growth factors
Figure recovery of protein oxidation). there is an increase in the production of hydrogen peroxide
Trx reductase is unusual in that it contains seleno- (H2 O2 ) (Module 2: Figure plasma membrane ROS form-
cysteine (SeCys) located in the C-terminal active site, ation), which facilitates growth factor signalling by in-
which has a highly conserved -Gly-Cys-SeCys-Gly- se- hibiting tyrosine phosphatases and the tumour suppressor
quence. The N-terminal region contains flavin--adenine phosphatase and tensin homologue deleted on chromo-
dinucleotide (FAD). The enzyme operates by transferring some 10 (PTEN). The latter inhibits the hydrolysis of
electrons from NADPH to FAD and then on to the active PtdIns3,4,5P3 (PIP3 ), which functions in cell migration,
site in the C-terminus. proliferation and survival. H2 O2 inactivates PTEN by in-
The level of Trx reductase is greatly increased in vari- ducing a disulphide bond to form between Cys-124 in the
ous tumour cells, where it may play an important role active site and Cys-71. This disulphide is specifically re-
in inhibiting apoptosis by regulating the activity of Trx versed by thioredoxin. A reversible inactivation of PTEN
that inhibits apoptosis signal-regulating kinase 1 (ASK1). may thus contribute to the accumulation of PIP3 , which
An enhanced level of TrxR may prevent apoptosis by en- will thus set up a positive-feedback loop, since the forma-
suring that the Trx remains reduced to ensure that ASK1 tion of PIP3 is responsible for stimulating the production
remains inactive. of H2 O2 .
The ability of this thioredoxin system to reverse redox Many cancer cells are known to use ROS to control
signalling is inhibited by Ca2 + , which acts to convert a their proliferation. There are five human homologues of
large proportion of the reduced Trx-(SH)2 into its ox- Nox1. When Nox1 is overexpressed in fibroblasts, there
idized form. Such an action would enhance the growth- is an increase in proliferation and tumour formation. The
promoting activity of the redox signalling system. addition of antioxidants can reduce the growth of cancer
Thioredoxin-2 (Trx-2) is a mitochondria-specific mem- cells.
ber of the Trx family. It functions to regulate the mitochon- Many cancer cells, like a number of stem cells, have en-
drial membrane potential and contributes to the inhibition hanced ROS defences in the form of elevated levels of GSH
of apoptosis. and thioredoxin, which make them particularly resistant to
apoptosis. Thioredoxin may also play a role in increasing
Glutathione reductase the expression of the hypoxia-inducible factor 1α (HIF-
Glutathione reductase is responsible for converting oxid- 1α), resulting in an increase in vascular endothelial growth
ized GSSG back into the reduced GSH (Module 2: Figure factor (VEGF) and tumour angiogenesis.
recovery of protein oxidation):
Redox signalling in apoptosis
GSSG + NADPH + H + → 2GSH + NADP + In addition to playing a role in cell proliferation, there is a
darker side to reactive oxygen species (ROS) in that they
Oxidation-sensitive processes can also activate apoptosis. One of the actions of redox
The redox signalling pathway acts to regulate a vari- signalling is that it contributes to Ca2 + -induced apop-
ety of oxidation-sensitive processes (Module 2: Figure tosis at the level of the mitochondria. The uptake of Ca2 +
plasma membrane ROS formation). The cellular pro- and the resulting increase in ROS formation act syner-
teins that are sensitive to oxidation are those that contain gistically to open the mitochondrial permeability trans-
hyperreactive cysteine residues. One of the main func- ition pore (MTP) (Module 5: Figure mitochondrial Ca2 +
tions of redox signalling is to modulate the activity of signalling). ROS can also increase apoptosis by stimulat-
other signalling systems that contain protein compon- ing the acidic sphingomyelinases (SMases) that produce
ents with such hyperreactive cysteine residues, e.g. Ca2 + - ceramide (Module 2: Figure sphingomyelin signalling).
releasing channels [inositol 1,4,5-trisphosphate receptors Cells have different ways of suppressing this ROS-
(InsP3 Rs) and ryanodine receptors (RYRs)], transcription induced apoptosis. One mechanism is carried out by
factors, protein tyrosine phosphatases and by activating PtdIns 3-kinase signalling during which protein kinase
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r82
B (PKB) plays a prominent role through the Forkhead nalling effects on redox signalling and there are redox sig-
box O 3a (FOXO3a) transcription factor, which acts nalling effects on Ca2 + signalling.
by increasing the amount of manganese superoxide dis-
mutase (MnSOD) to provide greater protection against
ROS (Module 4: Figure FOXO control mechanisms). Ca2 + signalling effects on redox signalling
An overactive redox signalling system may contribute One of the actions of Ca2 + is to enhance redox signalling
to the increase in neuronal cell death that characterizes by interfering with the recovery of the oxidation-sensitive
Alzheimer’s disease (Module 12: Figure astrocyte-induced processes. Ca2 + acts by turning down the thioredoxin sys-
neuronal death) and Down’s syndrome. tem by inhibiting the thioredoxin reductase that normally
switches off redox signalling.
Redox signalling and DNA damage
One of the major pathological consequences of excess ROS
Redox signalling effects on Ca2 + signalling
formation is DNA damage. When this damage occurs dur-
There are numerous examples of redox signalling acting
ing the G1 phase of the cell cycle, specific repair mechan-
to enhance Ca2 + signalling. For example, the two Ca2 +
isms function to repair the damage and they also induce
release channels ryanodine receptors (RYRs) and the InsP3
the process of G1 checkpoint signalling to DNA double-
receptors (InsP3 Rs) can be activated by oxidation of key
strand breaks (DSBs) (Module 9: Figure G1 checkpoint
cysteine residues. In the case of the latter, the oxidizing
signalling).
agent thimerosal faithfully reproduces the Ca2 + transi-
ents normally induced by sperm fusion during fertilization
Redox signalling in vascular homoeostasis (Module 2: Figure thimerosal-induced Ca2 + signalling).
Hydrogen peroxide (H2 O2 ) may function as an Another example is that hydrogen peroxide (H2 O2 ) can
endothelium-derived hyperpolarizing factor (EDHF) that markedly enhance Ca2 + signalling by inhibiting the Src
diffuses across to relax neighbouring smooth muscle cells. homology 2 (SH2) domain-containing protein tyrosine
This action may be particularly important in regulating the phosphatase-1 (SHP-1), which normally acts to keep in
tone of cerebral arteries. check the protein tyrosine phosphorylation cascade that
occurs during B cell receptor (BCR) activation (Module 2:
Redox signalling and gene transcription Figure ROS effects on Ca2 + signalling). This is a reciprocal
The redox signalling pathway has been implicated in the interaction because it is the increase in Ca2 + that activates
control of gene transcription, particularly with regard to the formation of H2 O2 through a Ca2 + -dependent activ-
the activation of nuclear factor κB (NF-κB). Whether this ation of dual oxidase (DUOX). This is a good example of
activation is due to a direct modulation of the transcription the cross-talk that can exist between signalling pathways.
factor by messengers such as H2 O2 or indirectly through
activation of other signalling pathways remains to be de-
termined. Mitogen-activated protein kinase
A large number of other transcription factors [activat- (MAPK) signalling
ing protein 1 (AP-1), specificity protein 1 (SP1), c-Myb,
Overview
p53 and Egr-1] are redox-sensitive. Many of these have
The multifunctional mitogen-activated protein kinase
a highly conserved cysteine residue located within their
(MAPK) signalling system consists of separate pathways
DNA-binding domains that has to be reduced in order
that function to control a number of different cellular pro-
for the factor to bind DNA (Module 4: Figure SRF and
cesses such as gene transcription, metabolism, motility, cell
AP-1). In theory, therefore, such factors would be inhib-
proliferation, apoptosis, synaptic plasticity and long-term
ited by oxidation. There is a nuclear redox factor 1 (Ref-1)
memory. These different downstream effectors are activ-
that functions to control transcription by reducing this
ated by the final MAPK components associated with the
cysteine.
three main signalling pathways:
HDAC oxidation is an important mechanism used to
control chromatin remodelling and gene transcription. • Extracellular-signal-regulated kinase (ERK) pathway
• c-Jun N-terminal kinase (JNK) pathway
Redox factor 1 (Ref-1) • p38 pathway
Ref-1 plays a role in the nucleus to promote gene tran-
scription (Module 4: Figure SRF and AP-1) and to protect These different pathways are assembled by combining
cells against oxidative stress. There is a possibility that it components from an extensive mitogen-activated protein
might also have a function within the cytoplasm to reduce kinase (MAPK) signalling toolkit.
the Rac-1-regulated production of reactive oxygen species The mitogen-activated protein kinase (MAPK) sig-
(ROS). nalling properties such as their spatio-temporal control
mechanisms help to explain how they operate to regulate
Redox signalling and modulation of Ca2 + so many cellular processes.
signalling The activity of the MAPK signalling pathway is reversed
There are reciprocal interactions operating between the by the mitogen-activated protein kinase (MAPK) phos-
redox and Ca2 + signalling pathways. There are Ca2 + sig- phatases.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r83
Mitogen-activated protein kinase (MAPK) Raf-1, A-Raf and B-Raf that phosphorylate two serine
signalling toolkit residues on the MAPK/ERK kinase (MEK) components
There is an extensive mitogen-activated protein kinase MEK1/2. The latter are dual-specificity protein kinases
(MAPK) signalling toolkit, which can be divided into that phosphorylate the tyrosine and threonine residues of
different functional components such as the transducers, the characteristic MAPK components ERK1/2 that are re-
the MAPK kinase kinases (MAPKKKs), MAPK kinases sponsible for stimulating the downstream effectors, many
(MAPKKs), MAPKs, MAPK scaffolding proteins and of which are transcription factors (Module 2: Figure ERK
MAPK target proteins (Module 2: Table MAPK signalling signalling). There is thus a linear transfer of information
toolkit). Specific components from this toolkit are then through a phospho-relay system based on a sequential
assembled into the different signalling pathways (Module series of phosphorylation events.
2: Figure MAPK signalling). An important feature of this ERK pathway, which can be
activated by both protein tyrosine kinase-linked receptors
Extracellular-signal-regulated kinase (ERK) (PTKRs) and by G protein-coupled receptors (GPCRs), is
pathway its spatial organization (Module 2: Figure ERK signalling).
The extracellular-signal-regulated kinase (ERK) pathway In the case of the PTKRs, growth factors such as
is one of the major signalling cassettes of the mitogen- platelet-derived growth factor (PDGF) usually cause
activated protein kinase (MAPK) signalling pathway receptor dimerization, which allows the cytosolic tyrosine
(Module 2: Figure MAPK signalling). It performs a num- kinase domains to come together and to phosphorylate
ber of important signalling functions, including the control each other (Module 1: Figure PDGFR activation).
of cell proliferation and the synaptic plasticity responsible These phosphorylated residues then function as docking
for learning and memory. The main MAPK/ERK kinase motifs to pull in signalling components such as Shc,
kinase (MEKK) components are the Raf family members growth factor receptor-bound protein 2 (Grb2) and
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r84
Antigen
BCR
PtdIns4,5P
2 DUOX O2
P PLC 2
P P
BLNK
P P
P P P
P IP3
Lyn
P H2O2
Syk
P 2+ +
P Btk Ca
SHP1
SHP1
SHP1
_ _
_
Reciprocal interaction between the ROS and Ca2 + signalling pathways during B cell receptor (BCR) activation.
Cross-linking the B cell receptor (BCR) with antigen sets up a protein phosphorylation cascade that begins with Lyn phosphorylating both the receptor
and Syk. The latter then binds to the phosphorylated receptor, where it phosphorylates the adaptor protein B cell linker (BLNK) and the tyrosine kinase
Bruton’s tyrosine kinase (Btk). The latter phosphorylates BLNK and phospholipase Cγ2 (PLCγ2), which associates with BLNK and begins to hydrolyse
PtdIns4,5P2 to form inositol 1,4,5-trisphosphate (IP3 ). This phosphorylation cascade is kept in check by the tyrosine phosphatase Src homology 2
(SH2) domain-containing protein tyrosine phosphatase-1 (SHP-1). One of the functions of the Ca2 + released by IP3 is to set up a positive-feedback
loop based on the activation of the Ca2 + -sensitive enzyme dual oxidase (DUOX) that generates hydrogen peroxide (H2 O2 ). The latter feeds back to
inhibit SHP-1, which enables the signalling cascade to work more effectively in generating Ca2 + signals. This formation of H2 O2 is highly localized
as a microdomain in the immediate vicinity of the BCR (Module 2: Figure ROS microdomains). This figure is based on information taken from Singh
et al. 2005.
Son-of-sevenless (SoS) that then activate the small GTP- There are a number of putative mechanisms for linking
binding protein Ras. Activated Ras then interacts with the the activation of G protein-coupled receptors (GPCRs) to
protein kinase Raf, which initiates the phosphorylation the ERK pathway. The release of βγ subunits may activ-
cascade of the ERK pathway. The three components of ate Src, which can then feed into the processes that ac-
this pathway (Raf-1, MEK1/2 and ERK1/2) are held in tivate Ras. The arrestins can also function as scaffolds to
place at the cell surface by the scaffolding protein kinase assemble components of the ERK pathway such as Raf1
suppressor of Ras 1 (KSR1). Up to this point, all the signal and ERK1/2. Alternatively, activation of phosphoinositide
transduction processes have occurred at the cell surface, hydrolysis by Gq to produce inositol 1,4,5-trisphosphate
and the next information transfer step depends upon the (InsP3 ) and diacylglycerol (DAG) can access the ERK
diffusion of the activated enzyme from the cell surface pathway via two mechanisms. The InsP3 /Ca2 + can act
to the nucleus. Once it is phosphorylated, the activated through proline-rich tyrosine kinase 2 (Pyk2), whereas
phospho-ERK1/2 leaves the plasma membrane to diffuse DAG and Ca2 + act through protein kinase C (PKC).
into the cytoplasm and then into the nucleus, where it One of the major functions of the ERK pathway is
phosphorylates and activates a number of transcription to activate a range of different transcription factors such
factors (Module 2: Figure ERK signalling). Some of as cyclic AMP response element-binding protein (CREB)
these genes code for MAPK signalling components, (Module 4: Figure CREB activation) and Elk-1 (Module
such as MAPK phosphatase 1 (MKP-1), which sets up 4: Figure ETS activation).
a negative-feedback loop. In addition, phospho-ERK1/2 This ERK pathway contributes to the control of a large
can also act together with Ca2 + to stimulate cytoplas- number of cellular processes:
mic phospholipase A2 (cPLA2 ). The Ca2 + induces the
cPLA2 to associate with cytosolic membranes, whereas • Regulation of cell proliferation such as T cell activation
the ERK1/2 phosphorylates Ser-505 and Ser-727 to (Module 9: Figure TCR signalling)
stimulate the enzymatic release of arachidonic acid from • Cardiac hypertrophy (Module 12: Figure hypertrophy
phospholipid precursors. signalling mechanisms)
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r85
BCR
Resting
SHP1 DUOX SHP1
Lyn
SHP1
BLNK
SHP1 SHP1 SHP1 SHP1
SHP1 PLC IP3
Syk
Btk
SHP1 SHP1
SHP1 2+ SHP1
SHP1 Ca
SHP1
SHP1 SHP1 SHP1
SHP1 SHP1
SHP1 SHP1 SHP1
SHP1
Antigen
Stimulated
DUOX
SHP1 SHP1
Lyn
SHP1
BLNK
SHP1 SHP1 SHP1 SHP1
SHP1 PLC IP3
Syk
SHP1 SHP1
Btk
SHP1 SHP1
SHP1
SHP1 2+
H O microdomain
SHP1
SHP1
2 2 Ca
SHP1
SHP1 SHP1 SHP1 SHP1
SHP1 SHP1
SHP1 SHP1
PROLIFERATION
• Synaptic plasticity such as long-term potentiation (LTP) ible for feeding information into the JNK pathway. The
in hippocampal neurons apoptosis signal-regulating kinase 1 (ASK1) is an example
• Proliferation of endothelial cells during angiogenesis of such a kinase that initiates the signalling cascade that
(Module 9: Figure VEGF-induced proliferation) leads to JNK activation. One way of trying to cope with
• Phosphorylation of the transcription factor p53 this complexity is to examine specific examples such as the
(Module 4: Figure p53 domains) activation of JNK by the interleukin-1 receptor (Module
• Remodelling the ERK signalling pathway may contrib- 2: Figure JNK signalling).
ute to the development of polycystic kidney disease The JNK pathway can also be activated through G pro-
(Module 12: Figure polycystins and polycystic kidney tein-coupled receptors (GPCRs) using G proteins such as
disease) G12/13 . Just how G proteins feed into the cascade is unclear,
• Activation of phospholipase A2 (PLA2 ) in mast cells but it seems that they activate the GTP-binding proteins
(Module 11: Figure mast cell signalling) such as Rac and Cdc42. Alternatively, the arrestins that
associate with GPCRs during the process of receptor de-
sensitization may function as a scaffold to bring together
c-Jun N-terminal kinase (JNK) pathway components of the JNK pathway such as MKP7 and JNK3.
The c-Jun N-terminal kinase (JNK) pathway is one of the The MAPK signalling system operates a negative-
major signalling cassettes of the mitogen-activated pro- feedback loop in that some of the genes activated by the
tein kinase (MAPK) signalling pathway. It functions in the JNK pathway code for signalling components such as the
control of a number of cellular processes, including prolif- scaffold protein JNK-interacting protein 1 (JIP1), which
eration, embryonic development and apoptosis. The path- will bind JNK and thus limits its action.
way takes its name from the c-Jun N-terminal kinases 1--3 This JNK pathway contributes to the control of a large
(JNK1--JNK3), which are the MAPKs that interact with number of cellular processes:
the final effectors (Module 2: Figure MAPK signalling).
They contain the dual phosphorylation motif Thr-Pro- • Phosphorylation of the transcription factor p53
Tyr, which is phosphorylated following activation of the (Module 4: Figure p53 domains).
upstream phosphorylation cascade. • The JNK pathway has been implicated in the
The JNK pathway is activated by a bewildering number mitogen-activated protein kinase (MAPK) signalling in
of mechanisms. This complexity is evident by the fact that cardiac hypertrophy (Module 12: Figure hypertrophy
there are 13 MAPK kinase kinases (MAPKKKs) respons- signalling mechanisms).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r86
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r87
Transducers
Grb2 SOS Rac Cdc42 Rac Cdc42
Ras Rho
Effectors Ets, Elk1, SAP1 c-Jun, Jun-B, Jun-D, ATF2, Ets, MEF2,
cPLA2 ATF2, Elk1 SAP1, MAPKAP2
Growth factors
GPCR PTKR
P
cPLA2 +
ERK1/2
PL
Arachidonic
acid P
ERK1/2
P MKP-1
Negative
ETS SAP1 ELK1 feedback
MKP1 loop
Proliferation
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r88
Interleukin-1
GPCR
RAC/
TRAF6 TAK1 Cdc42 G
12/13
P MEKK1
JIP1
P MKK7 PI3K-
P
JNK
P
Cytochrome c
JNK
Caspases
Negative feedback
loop
APOPTOSIS P ?
JNK
P
Proliferation,
embryonic development
The organization and topology of the c-Jun N-terminal kinase (JNK) pathway.
The c-Jun N-terminal kinase (JNK) pathway can be activated in many ways, including via different receptor mechanisms and by various environmental
stresses such as osmotic, redox and radiation stress. These different inputs are transduced by separate mechanisms that all feed into the JNK
signalling cascade. With regard to receptor activation, the JNK pathway can be activated by various cytokines such as interleukin-1 as illustrated
here. The interleukin-1 receptor (IL-1R) is composed of two receptor-binding domains that interact with interleukin-1 and a non-binding accessory
protein. Once activated by interleukin-1, the IL-1R recruits the adaptor protein tumour-necrosis-factor-receptor-associated factor 6 (TRAF6), which then
recruits the mitogen-activated protein kinase kinase kinase (MAPKKK) called transforming growth factor β-activated kinase 1 (TAK1) responsible for
initiating the phosphorylation cascade by phosphorylating MAPK/extracellular-signal-regulated kinase (ERK) kinase kinase 1 (MEKK1). The MEKK1
then phosphorylates the dual-specificity protein kinase MAPK kinase 7 (MKK7) responsible for phosphorylating the tyrosine and threonine residues on
JNK. This activation cascade occurs in the vicinity of the plasma membrane, where it is organized by the scaffolding protein JNK-interacting protein 1
(JIP1). Once JNK is phosphorylated, it leaves the multimolecular activation complex and then diffuses into the nucleus, where it activates transcription
factors responsible for controlling processes such as proliferation, apoptosis and embryonic development.
pathway, causes neurofibromatosis type 1-like syndrome ceptor for lipopolysaccharide (LPS) (Module 2: Figure Toll
(NFLS). receptor signalling).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r89
cellular processes. A question therefore arises as to how There are two remarkable aspects of the NF-κB sig-
the fidelity of these signalling pathways is achieved in or- nalling pathway. Firstly, it can control a very large number
der to reduce cross-talk and to ensure that they carry out of genes that are often activated as large cohorts in spe-
their particular functions. It seems that much of this fi- cific cells by different stimuli. Secondly, it is used by a
delity is achieved by using molecular scaffolds to hold number of different signalling systems with subtle vari-
together all the components of each signalling pathway in ations in the mechanism and the components that are used
a multimolecular complex. In this way, information can to convey information into the nucleus. The tumour nec-
be passed from one component to the next without inter- rosis factor α (TNFα) signalling pathway and the Toll
ference from other signalling pathways (Module 6: Figure receptor signalling pathway will be described to illustrate
signalling hierarchies). Examples of such scaffolds are the the main features of the NF-κB signalling pathway. The
scaffolding proteins kinase suppressor of Ras 1 (KSR1) receptor activator of nuclear factor κB (NF-κB) ligand
(Module 2: Figure ERK signalling) and JNK-interacting (RANKL), which is a transmembrane protein that belongs
protein 1 (JIP1) (Module 2: Figure JNK signalling). to the TNF family of cytokines, activates the RANKL re-
Other determinants of fidelity are the docking sites ceptor (RANK) that uses the NF-κB signalling pathway
that enable the different mitogen-activated protein kinases to control osteoclastogenesis (Module 8: Figure osteoclast
(MAPKs) to bind to their specific downstream effectors. differentiation).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r90
Module 2: Table NF-κB signalling toolkit ‘classical’ mechanisms as illustrated by the following se-
The nuclear factor κB (NF-κB) signalling toolkit quence of events (Module 2: Figure NF-κB activation):
Nuclear factor κB (NF-κB)
transcription system Comments
NF-κB/Rel family of 1. Occupation of the TNF receptor (TNF-R) by TNF
transcription factors induces receptor oligomerization to form a complex
p50 (NF-κB1) p50 has a p105 precursor protein that attracts the adaptors TRADD and the TNFR-
p52 (NF-κB2) p52 has a p100 precursor protein
p65 (NF-κB3, also known as associated factor 2 (TRAF2), which is an adaptor that
RelA) belongs to the TNF-receptor-associated factor (TRAF)
RelB family.
c-Rel
Inhibitor of NF-κB (IκB) family 2. TRAF2 is a RING domain E3 ubiquitin ligase that as-
IκBα Bind to p65 and c-Rel sociates with the heterotrimeric ubiquitin-conjugating
IκBβ (E2) complex that contains Ubc13 and Uev1A. This
IκBγ
IκBε is a K63 ubiquitinating complex that adds ubiquitin
IκBζ Binds preferentially to p50 chains to TRAF2 and this then helps to recruit the
Bcl3 B cell lymphoma 3 binds to receptor-interacting protein 1 (RIP1), which is also
p50/p50 and p53/p53
homodimers. ubiquitinated. These ubiquitin chains provide an im-
Inhibitor of NF-κB (IκB) portant scaffolding role in the assembly of additional
kinases (IKKs) elements of the signal transduction pathway. For ex-
IKKα
IKKβ ample TRAF2 interacts with apoptosis signal-regulat-
NEMO (IKKγ) A regulatory subunit responsible ing kinase 1 (ASK1) that then relays information to
for the interaction with both the JNK signalling and p38 signalling pathways
upstream kinases on the
receptor complex (Module 2: 3. The developing receptor complex attracts additional
Figure NF-κB activation) components such as the transforming growth factor
Associated proteins β activated kinase-1 (TAK1), the TAK1-binding (TAB)
Cdc37
Hsp90 proteins 1 to 3 (TAB1-3) and the multisubunit cytoplas-
mic complex containing the inhibitor of NF-κB (IκB)
kinase (IKK) α/IKKβ dimer and the regulatory NF-κB
essential modifier (NEMO) subunit, which is a central
and helix--loop--helix domains (Module 2: Figure NF-κB,
player in this translocation sequence.
IκB and IKK structure). These two protein-association
4. Once this complex is complete, the TAK1 phos-
domains enable the enzyme to associate with a large multi-
phorylates and activates IKKβ.
subunit complex in the cytoplasm. Another important
5. The IKKβ then phosphorylates IκBα on two sites (Ser-
component of this complex is nuclear factor κB (NF-
32 and Ser-36).
κB) essential modulator (NEMO) (IKKγ), which is a
6. The phosphorylated IκBα is then susceptible to ubi-
regulatory/structural subunit responsible for the inter-
quitination by the Skp1/cullin/F-box (SCF) ubiquitin
action with upstream kinases on the receptor as part of
ligase.
the tumour necrosis factor α (TNFα) signalling pathway
7. The polyubiquitinated IκBα is then sent to the protea-
(Module 2: Figure NF-κB activation). In the case of NF-κB
some, where it is degraded, resulting in the liberation
activation in T-cells, the IKK is stimulated by protein
of the NF-κB heterodimer p50/p65.
kinase θ (PKCθ) using the scaffolding proteins CARMA1,
8. The NF-κB is imported into the nucleus, where it
Bcl10 and MALT1 (Module 9: Figure TCR signalling).
binds to the κB promoter elements to activate ex-
The tumour suppressor CYLD binds to NEMO and
pression of many different genes (Module 4: Figure
inhibits the subsequent phosphorylation of IκB as part of
NF-κB activation and function). One of these genes
the TNFα signalling pathway.
is hypoxia-inducible factor 1α (HIF-1α), which thus
serves to link the innate immune response to the hyp-
Tumour necrosis factor α (TNFα) oxic response.
signalling pathway 9. Transcription ceases when NF-κB is exported from the
The basic operation of the nuclear factor κB (NF-κB)/Rel nucleus. One of the genes activated by NF-κB is IκBα,
family of transcription factors is that they are activated which thus sets up a negative-feedback loop, because it
in the cytoplasm and then translocate into the nucleus to binds to the NF-κB that is exported from the nucleus
activate transcription (mechanism 2 in Module 4: Figure to reconstitute the inactive cytoplasmic complex.
transcription factor activation). There are a number of vari- 10. The ubiquitin signalling pathway contributes to the re-
ations in the way that this translocation process is initiated, covery of this signalling cascade after TNFα is with-
depending on the nature of the incoming signals and the drawn by removing the ubiquitin scaffolds that hold to-
receptors that are being activated. In addition to the activ- gether the transducing complex. The deubiquitinating
ation of NF-κB, these non-enzyme-containing receptors enzymes A20 and CYLD are particularly active in re-
can activate other signalling pathways (Module 1: Figure moving the ubiquitin chains. The reversible ubiquit-
cytokines). In this section, attention will focus on the NF- ination of signal transducing components is thus an
κB signalling pathway, which is used by the tumour nec- essential part of the processing of information by this
rosis factor α (TNFα). It is considered to be one of the TNF signalling pathway.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r91
NF-κB/Rel family
p65 RHD
c-Rel RHD
RelB RHD
p50 RHD
p52 RHD
Ankyrin repeat
IκB family domain
IκBα
IκBβ
IκBγ
IκBε
Bcl3
IKK family
IKKα Ser kinase ZIP HLH
Zn finger
Tumour necrosis factor (TNF)-receptor-associated and stimuli derived from pathogens that are known
factor (TRAF) family as pathogen-associated molecular patterns (PAMPs)
The tumour necrosis factor (TNF)-receptor-associated (Module 11: Figure formation and action of PAMPs).
factor (TRAF) family has seven members, which func- These PAMPs act on Toll-like receptors (TLRs) and the
tion in the signalling pathways of various TNF receptor IL-1 receptor (IL-1R) and these form a TLR/IL-1R family
superfamily and Toll/interleukin-1 receptor mechanisms. that act through a similar Toll receptor signalling path-
TRAF2 functions as an adaptor for the tumour necrosis way (Module 1: Figure cytokines). The primary func-
factor receptor (Module 2: Figure NF-κB activation). In tion of this signalling pathway is to stimulate the tran-
the case of osteoclasts, it is TRAF6 that couples the scriptional processes that result in the expression of a
receptor activator of nuclear factor κB (NF-κB) ligand wide range of inflammatory cytokines and immunoreg-
(RANKL) receptor (RANK) to downstream signalling ulators (Module 2: Figure Toll receptor signalling). As
pathways (Module 8: Figure osteoclast differentiation). such, the Toll receptor signalling pathway has to trans-
mit information from the TLRs and the IL-1R on the
cell surface to the transcriptional factors such as nuclear
Toll receptor signalling pathway factor κB (NF-κB) and activating protein 1 (AP-1) (c-
The Toll receptor signalling pathway plays a central Jun/Fos) that act within the nucleus. This information
role in inflammatory responses (Module 11: Figure in- transfer system will be illustrated by reference to the
flammation). This pathway is activated by two types of response of the receptor TLR4 to lipopolysaccharide (LPS)
stimuli: cytokines, represented by interleukin-1 (IL-1), (Module 11: Figure formation and action of PAMPs). As
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r92
TNFR
DD
DD
DD
DD
DD
DD
DD
10
Ubc13/ Ubc13/
Uev1a Ubiquitin Uev1a A20 Ubiquitin
TRAF2
TRAF2
TRAF2
TRADD 2 CYLD
ASK1
RIP1 RIP1
TAB1-3
JNK IKK NEMO TAB1-3
p38 IKK P TAK1
TAK1
5 4 3
P P P P NEMO
6
Proteasome I B I B I B IKK IKK
p50 p65 p50 p65 p50 p65
7
I B
8 IL-6
p50 p65 CYLD
A20
B HIF-1
The ‘classical’nuclear factor κB (NF-κB) signalling pathway activated by the tumour necrosis factor receptor (TNFR).
The p50 and p65 isoforms of the nuclear factor κB (NF-κB)/Rel family form the NF-κB dimer that is activated in the tumour necrosis factor α (TNFα)
signalling pathway. The activated TNF receptor (TNFR) recruits a signalling complex to the membrane (Steps 2--4), which contains the inhibitor of
NF-κB (IκB) kinase (IKK) α/IKKβ dimer that is responsible for phosphorylating the IκBα subunit that retains p50/p65 in the cytoplasm (Step 5). When
the IκBα is phosphorylated, it is ubiquitinated and degraded by the proteasome (Steps 6 and 7). The p50/p65 homodimer is imported into the nucleus
(Step 8), where it activates a large number of genes. One of these genes codes for IκBα, which sets up a negative-feedback loop by exporting
p50/p65 from the nucleus (Step 9). Adapted from Trends Biochem. Sci., Vol. 30, Viatour, P., Merville, M.-P., Bours, V. and Chariot, A., Phosphorylation of
NF-κB and IκB proteins: implications in cancer and inflammation, pp. 43--52. Copyright (2004), with permission from Elsevier; see Viatour et al. 2005.
for many other signalling pathways, information is trans- factor (TNF)-receptor-associated factor (TRAF) fam-
ferred through both protein--protein interactions and pro- ily that has a critical role to play in the next series of
tein phosphorylation reactions. The ubiquitin signalling reactions.
system also has an important role in orchestrating this Toll 3. The IRAK-1 and TRAF6 dissociate from the receptor
receptor signalling pathway as shown in the following se- and move in to the cytoplasm.
quence (Module 2: Figure Toll receptor signalling): 4. The TRAF 6 is a RING domain E3 ubiquitin lig-
ase that associates with the heterotrimeric ubiquitin-
conjugating (E2) complex that contains Ubc13 and
1. The TLR4 is a transmembrane protein that has
Uev1A. This is a K63 ubiquitinating complex that
leucine-rich repeats in its ectodomain, while the
results in the autoubiquitination of TRAF6. The
cytoplasmic domain has a Toll/interleukin 1 (IL-
ubiquitinated TRAF6 then binds the transforming
1) receptor (TIR) domain. The lipopolysaccharide
growth factor β activated kinase-1 (TAK1) and the
(LPS) that initiates this signalling pathway binds first
TAK1-binding (TAB) proteins 1 to 3 (TAB1-3). The
to an extracellular LPS-binding protein (LBP) and
multisubunit cytoplasmic complex containing the in-
to CD14, which is a glycosylphosphatidylinositol-
hibitor of NF-κB (IκB) kinase (IKK) α/IKKβ dimer
anchored membrane glycoprotein, and this complex
and the regulatory NF-κB essential modifier (NEMO)
carries the LPS to the Toll-like receptor 4 (TLR4).
subunit are also drawn into the complex. The result-
2. The TIR domain on the TLR4 receptor forms ho-
ing activation of TAK1 is then responsible for relaying
mophilic interaction with the TIR domain of the
information out to other components of the signalling
adaptor proteins TIR adaptor protein (TIRAP) and
pathways.
MyD88. The latter is specific for certain TLRs, such
5. The TAK1 activates both the c-Jun N-terminal kinase
as TLR4, but not others. The other end of these ad-
(JNK) pathway and the p38 pathway (Module 2: Fig-
aptors have a death domain that draws in the IL-
ure MAPK signalling). The JNK and p38 function
1 receptor-associated kinases 1 and 4 (IRAK-1 and
to phosphorylate transcription factors such as AP-
IRAK-4), which undergoes an autophosporylation re-
1, which binds to the cyclic AMP response element
action that enables them to bind to another adaptor
(CRE) site.
called TRAF6, which belongs to the tumour necrosis
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r93
LBP TLR4
1
CD14
LPS
6. The other action of TAK1 is to phosphorylate the such as interleukin-2 and various pro-apoptotic genes
IKKβ component of the inhibitor of NF-κB (IκB) (nur77, Gadd45g, Ddit3 and Tia1) (Module 2: Figure
kinase (IKK) α/IKKβ dimer. Toll receptor signalling). This Ca2 + pathway has been
7. The phosphorylated IKKβ then acts to phosphorylate described in dendritic cells, but appears to be absent
IκBα to liberate the NF-κB. in macrophages.
8. The phosphorylated IκBα is then susceptible to ubi-
quitination by the Skp1/cullin/F-box (SCF) ubiquitin This signalling pathway is particularly evident on res-
ligase. The polyubiquitinated IκBα is then sent to the ident macrophages (Module 11: Figure macrophage sig-
proteasome, where it is degraded, nalling) and mast cells (Module 11: Figure mast cell sig-
9. The NF-κB enters the nucleus, binds to the κB site nalling) that respond to invading pathogens. Mutations in
and activates the genes that code for the inflammatory MyD88 have been linked to diffuse large B cell lymphoma
cytokines and immunoregulators that contribute to (DLBCL).
inflammatory responses (Module 11: Figure inflam-
mation).
10. An important aspect of the recovery of this signalling Virus recognition and antiviral responses
cascade after LPS is withdrawn, is the removal of The recognition and initiation of antiviral responses, which
the ubiquitin scaffolds that hold together the trans- is a part of the innate immune system, depend upon the ac-
ducing complex. The deubiquitinating enzymes A20 tivation of a number of signalling pathways such as the Toll
and CYLD are particularly active in removing the ubi- receptor signalling pathway. When viruses enter cells they
quitin chains. This ubiquitin signalling system thus are broken down into fragments such as double-stranded
plays an essential role in the processing of informa- RNA (dsRNA), single-stranded RNA (ssRNA), 5’ tri-
tion by this Toll receptor signalling pathway. phosphate ssRNA or CpG DNA, which are located either
11. In addition to functioning as a coreceptor to transfer in the cytoplasm or within the endosomal compartment
LPS to TLR4, CD14 may also be capable of activat- (Module 2: Figure virus recognition). These fragments are
ing a Ca2 + signalling pathway. The CD14 activates examples of the pathogen-associated molecular patterns
Src that is coupled to phospholipase Cγ1 (PLCγ1), (PAMPs) that are responsible for triggering a variety of in-
which is then capable of triggering an influx of ex- flammatory responses (Module 11: Figure formation and
ternal Ca2 + through an unknown mechanism. The action of PAMPs). The following sequence of reactions
increase in Ca2 + stimulates calcineurin (CaN) to de- describes how three main groups of receptors detect these
phosphorylate the transcription factor NFAT that viral PAMPs to initiate a number of antiviral signalling
enters the nucleus to activate expression of genes pathways (Module 2: Figure virus recognition):
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r94
Viruses
1 6
Endosome
TLRs NLRs
RLRs 7
5’Triphosphate ssRNA
dsRNA NALP3
CpG
ssRNA dsRNA dsRNA
DNA MDA5 P
TLR9 TLR3 P 9
LGP2 P
TLR7/8
ASC
RIG-I
MyD88 2 TRIF IPS1
Caspase-1
MyD88 4 8
Mitochondrion 10
TRAF6
I B
p50 p65 TBK1
NF- B IKK
IKK IKK p50 p65 Pro-IL-1
P P P P IL-1
I B 3 IRF3 5 IRF7
Import
Toll-like receptors (TLRs) leus where they contribute to the transcription of the
type I interferons (IFN-α and IFN-β).
1. Those viral PAMPs, which are directed into the endo-
Retinoic acid-inducible gene I (RIG-I)-like receptors
some, interact with Toll-like receptors (TLR3, TLR7/8
(RLRs)
and TLR9) that are located in the endosomal membrane
(see green box on the left of Module 2: Figure virus re- 6. Those viral PAMPs that are directed into the cytoplasm
cognition). interact with cytoplasmic receptors such as the RIG-I-
2. The TLR9, which responds to CpG DNA, and the like receptors (RLRs) (see yellow box in the middle of
TLR7/8 that bind ssRNA both recruit the adaptor Module 2: Figure virus recognition).
protein MyD88. The latter then acts through TRAF6, 7. The two main RLRs are retinoic acid-inducible gene
which is one of the tumour necrosis factor (TNF)- I (RIG-I) itself and melanoma-associated gene 5
receptor-associated factor (TRAF) family, to stimulate (MDA5). These two receptors have a characteristic
the IKKαβ. The latter then activates the transcription DExD/H box helicase domain that is responsible
factor NF-κB through the Toll receptor signalling path- for binding double-stranded RNA (dsRNA). RIG-I
way described in more detail earlier (Module 2: Figure can also respond to 5’ triphosphate ssRNA. These
Toll receptor signalling). two receptors also have a pair of N-terminal caspase
3. The NF-κB is imported into the nucleus where it func- recruitment domains (CARD), which are the func-
tions to induce the transcription of both the inflam- tional transducing components that signal to down-
matory cytokines and the genes for type I interferon stream elements. The LGP2 (laboratory of genetics and
(IFN). physiology-2), which also has a helicase domain, can
4. When activated by dsRNA, the TLR3 receptor interacts also bind dsRNA, but it lacks the CARD domains and
with the TIR-domain-containing adaptor protein indu- thus fails to transduce cellular signals but may act as a
cing IFN-β (TRIF). The latter then activates the two negative regulator of MDA5 and RIG-I.
IKK-related proteins TBK1 [TRAF-family member- 8. The CARD domains on MDA5 and RIG-I inter-
associated NF-κB activator (TANK)-binding protein] act with the IFN-β promoter stimulator-1 (IPS-1),
and IKKε, which is also known as inducible IKK which also contains an N-terminal CARD domain
(iIKK). and is attached to the outer mitochondrial membrane.
5. The activated TBK1/IKKε complex then phos- IPS1 is also known as MAVS (mitochondrial anti-
phorylates the interferon-regulatory factors (IFRs) viral signalling), VISA (virus-inducing signalling ad-
IRF3 and IRF7. When phosphorylated, these two IRFs aptor) or CARDIF (CARD adaptor inducing IFN-
form homodimers that are then imported into the nuc- β). The IPS1 protein then stimulates the TBK1/IKKε
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r95
complex that then phosphorylates the interferon- The fact that the activation of PLD1 seems to depend on
regulatory factors (IFRs) IRF3 and IRF7 as described the prior activation of other signalling pathways such as
above (see step 5). the diacylglycerol (DAG)/protein kinase C (PKC) sig-
nalling cassette or the PtdIns 3-kinase signalling cassette
Nucleotide oligomerization domain (NOD) protein-like
(Module 2: Figure PLD signalling) suggests that the PLD
receptors (NLRs)
signalling pathway is not an autonomous signalling system,
9. The double-stranded RNA (dsRNA) in the cytoplasm but should be considered more as a downstream effector
can also interact with the nucleotide oligomerization of these other signalling pathways.
domain (NOD) protein-like receptors (NLRs) (see A specific N-arachidonylphosphatidylethanolamine
pink box on the right of Module 2: Figure viral re- (NAPE) phospholipase D (PLD) (NAPE PLD) functions
cognition). One of the NLRs is the Nacht domain-, to generate anandamide, which is one of the endocannabin-
Leucine-rich repeat-, and PYD-containing protein 3 oids (Module 1: Figure anandamide).
(NALP3), which is also known as cryopyrin that re- The Arf signalling pathway plays an important role in
sponds to dsRNA to activate caspase-1. The interac- the activation of PLD (Module 2: Figure Arf signalling).
tion between NALP3 and caspase-1 is facilitated by an
adaptor called apoptosis-associated speck-like protein Phosphatidic acid (PA) action
containing a CARD (ASC). The interaction between The primary messenger of the phospholipase D (PLD) sig-
these three proteins takes place in a macromolecular nalling pathway is the lipid phosphatidic acid (PA), which
complex known as the inflammasome. has a number of actions within the cell (Module 2: Figure
10. The activated caspase-1 contributes to the develop- PLD signalling). The signalling function of PA is mainly
ment of an inflammatory response by cleaving pro- directed towards the regulation of various enzymes such as
IL-1β to form the inflammatory cytokine interleukin stimulation of the target of rapamycin (TOR) and sphin-
1β (IL-1β). gosine kinase or inhibition of protein phosphatase 1. It
also plays an important role in regulating phagocytosis
(Module 4: Figure phagosome maturation).
Phospholipase D (PLD) signalling In addition to such signalling functions, a local accu-
pathway mulation of PA may also alter the physical properties
The phospholipase D (PLD) signalling pathway functions of the membrane by creating curvatures to facilitate the
by generating phosphatidic acid (PA), which acts to reg- formation of vesicles for intracellular trafficking as oc-
ulate a wide range of cellular processes. Phospholipase D curs during the COPII-mediated transport from the ER
(PLD) activation depends upon a number of mechanisms, to the Golgi (Module 4: Figure COPII-coated vesicles)
and these may vary depending on where the signalling and the COPI-mediated transport from the Golgi to the
mechanism is located within the cell. The primary mes- ER (Module 4: Figure COPI-coated vesicles).
senger produced by this signalling pathway is PA, and
phosphatidic acid (PA) action is carried out through a Phosphatidic acid (PA) metabolism
number of downstream effectors. Phosphatidic acid (PA) Two separate enzymes carry out the metabolism of phos-
metabolism occurs through different pathways that gen- phatidic acid (PA). It can be dephosphorylated to diacyl-
erate further signalling molecules such as diacylglycerol glycerol (DAG) by a PA phosphohydrolase or it can be
(DAG) and lysophosphatidic acid (LPA). partially deacylated by a phospholipase A2 (PLA2 ) to form
lysophosphatidic acid (LPA) (Module 2: Figure PLD sig-
Phospholipase D (PLD) activation nalling). The LPA released from the cell is a potent agonist
Mammals have two phospholipase D (PLD) genes (PLD1 on receptors of the endothelial differentiation gene (EDG)
and PLD2), both of which have splice variants. Most atten- family (Module 2: Figure sphingomyelin signalling).
tion has focused on PLD1 as a signal transducer because it
has a low basal activity that increases markedly in response
to external stimuli. On the other hand, PLD2 has a high Sphingomyelin signalling pathway
basal activity and its role in signalling is uncertain. While The sphingomyelin signalling pathway that has been im-
most of the PLD2 is located on the plasma membrane, plicated in the control of a whole host of cellular pro-
PLD1 is found predominantly on intracellular membranes cesses through the generation and function of ceramide
(e.g. Golgi, endoplasmic reticulum and endosomes), but and sphingosine 1-phosphate (S1P), which are the main
has also been located at the plasma membrane, particu- messengers operating in this signalling pathway. The ac-
larly at caveolae. The structure of the enzyme contains tion of sphingosine 1-phosphate (S1P) is complicated be-
motifs responsible for its membrane location and catalytic cause, in addition to acting internally, S1P is released from
activity (Module 2: Figure PLD isoforms). The activity cells to function as an external ligand acting on cell-surface
of PLD1 increases following stimulation of both protein receptors. This sphingomyelinase signalling pathway also
tyrosine kinase-linked receptors (PTKRs) and G protein- produces ceramide, another messenger that plays a signi-
coupled receptors (GPCRs) (Module 2: Figure PLD sig- ficant part in processes such as cell proliferation, apoptosis
nalling). One of the problems with trying to understand and the response of the cell to stress and injury. One of the
the signalling function of this pathway is to determine difficulties in understanding this pathway is its pleiotropic
just how these different receptors act to stimulate PLD1. effect on cells with responses that are often diametrically
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r96
Palmitate Palmitate
(Cys 240) (Cys 241)
HKD HKD
PLD1 PX PH I II III IV 1072
Palmitate Palmitate
(Cys 240) (Cys 241)
HKD HKD
PLD2 PX PH I II III IV 1034
Growth Chemotactic
factors Antigen Chemokines factors
LPA
Protein phosphatase 1
Arf Rho RalA
Sphingosine kinase
PA +
mTOR
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r97
O C HO C O C HO C C OH C OH
H H
N C N C N C N C
H H
C C C C
SMase CDase SPHK O
O OH OH
O P O O P OH
O O
C
C
CH 3 N CH 3
CH 3
Sphingolipid metabolism.
The sphingomyelin signalling pathway depends on the conversion of sphingomyelin (SM) into a series of bioactive lipids capable of activating
various signalling mechanisms as described in Module 2: Figure sphingomyelin signalling. The numbers represent the relative cellular levels of these
sphingolipids. SMase, sphingomyelinase; CDase, ceramidase; SPHK, sphingosine kinase. Information for this Figure was taken from Hannun and
Obeid (2008).
opposed, such as proliferation and apoptosis. A clue to by dihydroceramide synthase (CerS). Finally, a desat-
this complexity lies in the fact that the pathway can spawn urase converts dhCer into ceramide (Cer). Mutations
a number of messengers, and the action of these is very in serine palmitoyl transferase (SPT) are responsible for
dependent on the current state of the cell, especially with type I hereditary sensory and autonomic neuropathies
regard to what other signalling pathways are active. (HSAN).
2. The ceramide formed at the ER is then transported
Generation and function of ceramide and to the Golgi by a ceramide transfer protein (CERT).
sphingosine 1-phosphate (S1P) A sphingomyelin synthase (SMS) located in the Golgi
The generation of ceramide and sphingosine 1-phosphate converts ceramide into sphingomyelin (SM), which is
(S1P), which are the two main bioactive ’messenger’ lip- transferred to the membrane through a vesicle transport
ids of the shingomyelin signalling pathway, begins with mechanism.
the hydrolysis of sphingomyelin (SM) by various sphin- 3. The hydrolysis of SM in the plasma membrane is activ-
gomyelinases (SMases) to form ceramide (Module 2: Fig- ated by receptors sensitive to stimuli such as tumour
ure sphingolipid metabolism). A ceramidase (CDase) then necrosis factor α (TNFα), interleukin 1, CD28 and
cleaves off one of the fatty acid chains to form sphingosine Fas. The coupling between receptors and the neutral
(Sph), which is then phosphorylated by sphingosine kinase sphingomyelinases (SMases) has been worked out in
(SPHK). As illustrated by the figures in Module 2: Fig- some detail for the TNFα receptor. A factor associated
ure sphingolipid metabolism, the relative cellular levels of with neutral SMase (FAN) functions to couple the en-
these sphingolipids vary enormously. The precursor SM is zyme to the neutral SMase activation domain (NSD)
present at the highest level and this then declines during of the TNFα receptor. These components of the sphin-
the different metabolic transformations. gomyelinase signalling pathway are often highly con-
An important aspect of this sphingomyelin signalling centrated in lipid rafts and caveolae, which represent
pathway is the cellular location and function of these dif- the site where some of the sphingomyelinases function
ferent metabolic steps (Module 2: Figure sphingomyelin to hydrolyse sphingomyelin.
signalling): 4. The activation of neutral SMase at the plasma mem-
brane provides one of the major sources of ceramide
1. Sphingomyelin synthesis is carried out first in the endo- (Cer), which can then be metabolized to other sig-
plasmic reticulum (ER), where ceramide is formed, and nalling sphingolipids (Module 2: Figure sphingolipid
is completed by the Golgi. The first step is carried out metabolism). A ceramidase (CDase) hydrolyses Cer to
by serine palmitoyl transferase (SPT) that combines ser- sphingosine (Sph), which can then be phosphorylated
ine and palmitate to form dihydrosphingosine (dhSph), by sphingosine kinase (SPHK) to form sphingosine
which is then converted into dihydroceramide (dhCer) 1-phosphate (S1P). Since the latter is soluble, it leaves
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r98
Neutral CDase Gq
N SMase N N SPHK Ca 2+ PI 3-K
P FAN OH OH DAG 8 Ras
SM Cer
N Sph ERK1/2
3
Golgi 4 N S1P
P DAG InsP3
2 Phospho-
SPPs ethanolamine
6 S1P lyase
OH
Ca 2+
N
Cer
Ionizing PKC
CAPPs PKB
Desaturase radiation ROS
CAPK
JNK ERK1/2 CaMKII
5
ER 7 PKC
N
dhCer
Acidic Cathepsin D 9
SMase
CerS 1
N
P
Survival
N
Apoptosis
N
dhSph
OH
the membrane and is free to diffuse both into and out of growth factor and hormone receptors that elevate second
the cell (see later). The SPHK is activated by a number messengers such as Ca2 + , DAG, ERK1/2 or cyclic AMP
of signalling pathways using messengers such as Ca2 + , that act by stimulating SPHK. In the absence of these sig-
DAG, cyclic AMP and ERK1/2 that are produced by nals, the main messenger will be ceramide, but this will
signalling pathways activated by growth factors and switch over to S1P if the SPHK is activated. This inter-
hormones. Ceramide can also be phosphorylated by relationship between ceramide and S1P has led to a cer-
a ceramide kinase to form ceramide 1-phosphate, for amide/S1P rheostat model, where a balance between these
which there is no apparent function. two messengers is thought to determine cell fate. In gen-
5. A variety of stress stimuli, such as ionizing radiation, eral, ceramide seems to tip the balance in favour of cell
UV irradiation and reactive oxygen species (ROS) act cycle arrest, senescence and apoptosis, whereas S1P pro-
by stimulating the acidic sphingomyelinases (SMases) motes survival and proliferation (Module 2: Figure sphin-
localized in lysosomes to hydrolyse sphingomyelin gomyelin signalling). The different outcomes controlled
(SM) to form ceramide (Cer) (Module 2: Figure sphin- by these two messengers may depend on their ability to
gomyelin signalling). activate separate signalling cascades.
6. S1P is metabolized via two separate pathways: it can
be converted back into sphingosine by a sphingosine 7. The ceramide formed at the plasma membrane or
1-phosphate (S1P) phosphatase (SPP) or it can be in the lysosomes acts on a number of targets such
cleaved by an S1P lyase to give palmitaldehyde and as ceramide-activated protein kinase (CAPK), protein
phosphoethanolamine. The lyase has a 20-amino-acid kinase Cζ (PKCζ), cathepsin D and ceramide-activated
transmembrane domain that positions the enzymes in protein phosphatases (CAPP), such as PP1 and PP2A.
cellular membranes. Most of these ceramide-sensitive targets act to promote
cell cycle arrest and apoptosis either directly or indir-
The sphingomyelinase signalling pathway is thus sens- ectly. For example, the cathepsin D converts Bid into
itive to external signals at a number of discrete steps. The tBid to promote apoptosis (see Step 3 in Module 11:
production of ceramide is accelerated by receptors sens- Figure apoptosis). On the other hand, the CAPPs such
itive to cytokines such as TNFα or to various stress sig- as PP2A can dephosphorylate various components that
nals such as ionizing radiation and reactive oxygen species are used by the EDG receptors to drive cell survival
(ROS). The formation of S1P can also be enhanced by and proliferation. For example the dephosphorylation
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r99
of protein kinase B (PKB) not only prevents it from The intracellular action of S1P is not as well defined,
inhibiting apoptosis but it will also reduce its ability to mainly because it is often difficult to separate an intra-
enhance proliferation. cellular action from that induced by its extracellular ac-
8. One of the actions of the soluble sphingosine 1-phos- tion. An intracellular action of S1P has been proposed for
phate (S1P) is to diffuse out of the cell passing through phagosome maturation, where it releases the Ca2 + neces-
the ABCC1 transporter, which is a family member of sary to activate the formation of PtdIns3P on endosomes
the ATP-binding cassette (ABC) transporters (Module (Module 4: Figure phagosome maturation). One of the
3: Table ABC transporters). The extracellular S1P then problems with trying to establish such an intracellular ac-
activates EDG receptors, which belong to the family tion for S1P is that it could also mobilize internal Ca2 +
of G protein-coupled receptors (GPCRs) (Module 1: by acting through the EDG receptors to generate InsP3 .
Table G protein-coupled receptors) that are capable of However, there are indications that S1P can act directly to
relaying information down a number of signalling path- release Ca2 + from an internal store. Unlike InsP3 , how-
ways. ever, release occurs without the appearance of elementary
9. These signalling pathways control cellular pro- events. One of the difficulties with this hypothesis is that
cesses, such as cell survival, proliferation and anti- the channel on the endoplasmic reticulum (ER) that is
inflammatory responses, which are opposite to those opened by S1P remains to be identified. An earlier pro-
controlled by ceramide. posal that S1P might act through Scamper has not been
substantiated. Another suggestion is that S1P functions as
This sphingomyelin signalling pathway has been implic- the Ca2 + influx factor (CIF) that is proposed to link store
ated in a number of cellular processes: depletion to Ca2 + entry. Another proposed action of S1P is
to activate the extracellular-signal-regulated kinase (ERK)
• S1P has been proposed to release the Ca2 + necessary to cascade to promote proliferation. Overexpression of the
activate the formation of PtdIns3P on endosomes during SPHK can induce tumour formation. Therefore the pre-
phagosome maturation (Module 4: Figure phagosome cise role of S1P and its relationship to ER signalling require
maturation). further clarification.
• S1P appears to contribute to the CD28 co-stimulatory
pathway during T cell activation (Module 9: Figure T Ceramide
cell signalling map). This is an enigmatic messenger in that it has been linked
• S1P contributes to the communication between en- to both proliferation and apoptosis, depending very much
dothelial cells and pericytes during angiogenesis (see on the background activity of other messenger systems.
Step 6 in Module 9: Figure angiogenesis signalling). In keeping with its different functions, ceramide can ac-
tivate a number of signalling components such as the
ceramide-activated protein kinase (CAPK), protein kinase
Sphingosine 1-phosphate (S1P) Cζ (PKCζ) and ceramide-activated protein phosphatases
The key enzyme in the formation of sphingosine 1- (CAPP), such as PP1 and PP2A. Some of these ceramide
phosphate (S1P) is sphingosine kinase (SPHK). The mes- targets enable it to interact with other signalling systems
senger function of S1P is complicated by the fact that it such as the c-Jun N-terminal kinase (JNK) and mitochon-
may have both intra- and extra-cellular actions. drial systems. With regard to the latter, ceramide may ac-
S1P can exert its extracellular action either in an tivate mitochondrial reactive oxygen species (ROS) form-
autocrine mode (activate the same cell from which it is ation through ceramide-activated protein kinase (CAPK).
released) (see Step 8 in Module 2: Figure sphingomyelin It is important to stress that apoptosis can occur without
signalling) or a paracrine mode (diffuse away to activate the need for ceramide. However, there is overwhelming
neighbouring cells). This extracellular action is mediated evidence that the formation of ceramide can strongly tip
by endothelial differentiation gene (EDG) receptors, so- the balance in favour of apoptosis. It contributes to this
called because they were first described in human um- activation of the cell death programme by activating the
bilical vein endothelial cells induced to differentiate by intrinsic pathway at the level of the mitochondria (Module
phorbol esters. There is a family of these EDG receptors 11: Figure apoptosis). One way of interacting with the mi-
that are all G protein-coupled receptors (GPCRs) capable tochondria depends on its activation of the JNK pathway,
of activating most of the conventional signalling pathways which is known to induce apoptosis (Module 2: Figure
(Module 1: Table G protein-coupled receptors). The EDG JNK signalling). Ceramide can also activate cathepsin D,
1, 3, 5, 6 and 8 receptors mediate the action of S1P, whereas which converts Bid into tBid, which is one of the pro-
the EDG 2, 4 and 7 receptors appear to respond to lyso- apoptotic members of the Bcl-2 superfamily.
phosphatidic acid (LPA), a related lysolipid. The EDG re-
ceptors that function to induce a mobilization of internal Sphingomyelinases (SMases)
Ca2 + act by stimulating the formation of inositol 1,4,5- Sphingomyelinases (SMases) exist in different isoforms
trisphosphate (InsP3 ). One function of the EDG receptors that can be distinguished by their pH optima: acidic, neut-
is to regulate cell motility and directional migration. An ral or alkaline. The last is found in bile and plays a role in di-
example of the latter is preosteoclast chemotaxis where S1P gestion. Sphingomyelin signalling seems to depend on the
directs preosteoclasts form the bone marrow back into the acidic and neutral isoforms (Module 2: Figure sphingomy-
blood (Module 8: Figure preosteoclast chemotaxis). elin signalling). The neutral SMase functions to generate
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r100
ceramide in response to the activation of receptors sensit- subunit. In the case of CAPP, ceramide acts to stimulate
ive to stimuli such as tumour necrosis factor α (TNFα) and phosphatase activity by binding to one of the regulatory
interleukin 1 (see Step 3 in Module 2: Figure sphingomy- B subunits. The ability of ceramide to inhibit growth is
elin signalling). The acidic form was originally identified probably mediated through PP2A.
in lysosomes where it generates ceramide in response to
stress stimuli (see Step 5). There also are indications that Scamper
the acidic SMase may act on sphingomyelin located in the A sphingolipid Ca2 + -release-mediating protein of the en-
outer leaflet. The acidic SMase is a component of lipid rafts doplasmic reticulum (ER) (Scamper) was originally pro-
and caveolae, which are microdomains of the plasma mem- posed to be the Ca2 + channel on the ER that responds
brane containing high levels of the precursor sphingomy- to signals from the sphingomyelin signalling pathway,
elin. It is this acidic isoform that is defective in patients but more recent studies have shown that it has a single
with Niemann-Pick disease. membrane-spanning segment that seems to remodel the
actin cytoskeleton.
Ceramide-activated protein kinase (CAPK)
Ceramide-activated protein kinase (CAPK) is a
Janus kinase (JAK)/signal transducer
membrane-bound proline-directed protein kinase
and activator of transcription (STAT)
that acts by phosphorylating Raf-1, thereby enabling
signalling pathway
ceramide to plug into the mitogen-activated protein kinase
The Janus kinase (JAK) and the signal transducer and ac-
(MAPK) cascade and could account for those cases where
tivator of transcription (STAT) function in the JAK/STAT
ceramide promotes both inflammation and proliferation.
signalling pathway provides a mechanism for rapidly ac-
tivating gene transcription in response to a large num-
Sphingosine kinase (SPHK)
ber (>35) of external ligands. This signalling pathway is
Sphingosine kinase (SPHK) appears as two isoforms
mainly activated by cytokines such as interferon, but is
(SPHK1 and SPHK2), which have different tissue dis-
also used by receptor tyrosine kinases [epidermal growth
tributions. SPHK1 is found at high levels in the lung
factor receptor (EGFR), platelet-derived growth factor
and spleen, whereas SPHK2 is expressed mainly in liver
receptor (PDGFR)], non-receptor tyrosine kinases and
and heart. Both have five highly conserved domains, with
G protein-coupled receptors (GPCRs). The Janus kinase
the ATP-binding site and catalytic site located in the C2
(JAK)/signal transducer and activator of transcription
domain.
(STAT) structure reveals the major features of these two
The enzyme is both membrane-bound and free in the
components and how they are linked during the signal
cytosol, and there is some uncertainty as to how it is
transducer and activator of transcription (STAT) activa-
activated by cell-surface receptors. It seems likely that
tion cascade. Cell-surface receptors act by phosphorylat-
it responds to various downstream signals emanating
ing the STATs, which are latent transcription factors. Once
from these receptors such as Ca2 + /calmodulin, diacylgly-
phosphorylated, these STATs leave the membrane and
cerol (DAG)/protein kinase C (PKC), cyclic AMP/protein
then dimerize before migrating into the nucleus where
kinase A (PKA) or extracellular-signal-regulated kinase
they bind to specific DNA-binding elements to activate
1/2 (ERK1/2) (see Step 4 in Module 2: Figure sphingomy-
transcription. There is considerable evidence for a Janus
elin signalling). Another activator is oxidized low-density
kinase (JAK)/signal transducer and activator of transcrip-
lipoprotein (LDL), which may play a role in cell prolifera-
tion (STAT) function in growth and development.
tion. Consistent with the activation by various messenger
Mutations in STAT3 have been linked to hyper-IgE syn-
pathways is the fact that SPHK contains consensus se-
drome (HIES).
quences for Ca2 + /calmodulin binding and phosphoryla-
tion sites for PKA, casein kinase II and PKC. Janus kinase (JAK)/signal transducer and
activator of transcription (STAT) structure
Sphingosine 1-phosphate (S1P) phosphatase (SPP) The two major components of the signalling pathway
Mammals have two sphingosine 1-phosphate (S1P) phos- are the Janus kinases (JAKs) and their substrates the sig-
phatases (SPPs). Both SPP1 and SPP2 have eight to ten nal transducers and activators of transcription (STATs)
transmembrane domains that locate the enzymes within (Module 2: Figure JAK and STAT structure). Of the four
the endoplasmic reticulum (ER). SPP-1 is located mainly mammalian JAKs, three are expressed fairly ubiquitously,
in the placenta and kidneys, whereas SPP2 is found in the whereas JAK3 is restricted to natural killer (NK) cells
brain, heart, colon, kidney, small intestine and lung. These and thymocytes, with some expression in vascular smooth
enzymes convert S1P back into ceramide and can diminish muscle cells and endothelium. The main structural com-
survival and promote apoptosis (see Step 6 in Module 2: ponent of the JAKs is the kinase domain that functions to
Figure sphingomyelin signalling). phosphorylate the STATs at a key tyrosine in the region of
residue 700 during the signal transducer and activator of
Ceramide-activated protein phosphatase (CAPP) transcription (STAT) activation cascade. The STATs have
Ceramide-activated protein phosphatase (CAPP) is a a number of functional domains whose three-dimensional
member of the protein phosphatase 2A (PP2A) family of structure reveals how the STAT dimers are formed and
serine/threonine phosphatases that consist of three sub- how they bind to DNA (Module 2: Figure STAT1/DNA
units: A and B are regulatory, whereas C is the catalytic complex).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r101
STATs
2&6 SH3 SH2
Signal transducer and activator of transcription 4. Once the STATs have docked, they are then phos-
(STAT) activation cascade phorylated by the JAKs on the tyrosine residue located
The signal transducers and activators of transcription in the C-terminal region (Module 2: Figure JAK and
(STATs) are a family of latent cytoplasmic receptors that STAT structure).
are activated by a phosphorylation cascade that can be 5. The phosphorylated STATs, which are dimerized
induced by many different receptors (e.g. cytokine recept- through an intermolecular SH2--phosphotyrosine in-
ors, tyrosine kinase-linked receptors, non-receptor tyr- teraction, leave the receptor.
osine kinases and G protein-linked receptors). The versat- 6. These dimers are imported into the nucleus using
ility of this signalling mechanism is greatly enhanced by importin-α (Imp-α) and attach to promoter regions
the way the Janus kinases (JAKs) and STATs can be mixed through their DNA-binding domains (Module 2: Fig-
and matched to generate an enormous number of com- ure STAT1/DNA complex).
binations as illustrated by the different cytokine receptors 7. STATs activate the transcription of a number of target
(Module 2: Figure JAK/STAT heterogeneity). genes. One group of these genes code for the suppressor
A typical activation cascade for cytokine receptors, of cytokine signalling proteins (SOCS), which thus
which illustrates the essential role of the JAKs in a se- function as part of a negative-feedback loop to limit
quence of tyrosine phosphorylations that culminates in the the action of the signalling pathway (Module 2: Figure
phosphorylation and activation of the STATs, is outlined JAK/STAT function).
in the following sequence (Module 2: Figure JAK/STAT 8. STAT activity is terminated by a nuclear protein tyr-
function): osine phosphatase (N-PTP) that removes the tyrosyl
phosphate groups. The inactive STAT is then exported
1. Agonists induce dimerization by binding to the extra-
from the nucleus by chromosome region maintenance
cellular domains of the receptor subunits.
1 (CRM1), thus completing the cycle.
2. The JAKs, which are associated with the cytoplasmic
domain of these receptors, phosphorylate each other.
3. The activated JAKs then phosphorylate tyrosine For some of the other receptors, these tyrosine phos-
residues on the receptors to provide docking sites for phorylations are carried out by kinases other than the
the Src homology 2 (SH2) domains on the STATs. JAKs. After the STATs are phosphorylated, they leave
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r102
the receptor and then dimerize before translocating into There is a marked increase in expression of the SOCS-3
the nucleus. This activation cascade can occur quickly, isoform in hypothalamic neurons following the action of
with the activated STATs appearing in the nucleus within leptin during the control of food intake and body weight
minutes. Transcriptional activity can be modulated by (Module 7: control of food intake).
phosphorylation of the serine residue in the transcrip-
tional activation domain (TAD) of STAT 1, 3, 4, 5A and 5B Janus kinase (JAK)/signal transducer and
(Module 2: Figure JAK and STAT structure). In the case of activator of transcription (STAT) function in
STAT 1 and STAT4, phosphorylation enhances transcrip- growth and development
tional activity, whereas the binding of STAT5a to DNA is The Janus kinase (JAK)/signal transducer and activator of
greatly prolonged. transcription (STAT) signalling pathway has a primary role
in the regulation of growth and development, particularly
Suppressor of cytokine signalling proteins of haematopoietic cells. For example, it functions in the
(SOCS) interleukin-2 signalling pathway responsible for driving
The suppressor of cytokine signalling proteins (SOCSs) the final signalling steps in lymphocyte activation (Module
are induced during the activation of the Janus kinase 9: Figure T cell signalling map).
(JAK)/signal transducer and activator of transcription A mutation in the γc component of cytokine recept-
(STAT) signalling pathway (Module 2: Figure JAK/STAT ors results in X-linked severe combined immune defi-
function). The SOCS act by inhibiting the Janus kinases ciency (X-SCID). Since JAK3 associates with γc , it seemed
(JAKs) and thus operate a negative-feedback loop to limit likely that X-SCID may result from an alteration in the
the action of cytokines. JAK/STAT signalling pathway. This was confirmed when
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r103
TYPE I CYTOKINES
JAK1 STAT5a, STAT5b
IL-2, IL-7,IL-9, IL-15 STAT3
JAK3
JAK1
IL-4 STAT6
JAK3
JAK1,JAK2
IL-13 STAT6
Tyk2
TYPE II CYTOKINES
IFN IFN JAK1, Tyk2 STAT1, STAT2
Heterogeneity of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) combinations used by different cytokine receptors.
The cytokines acting on cell-surface receptors (blue and mauve boxes) activate different combinations of Janus kinases (JAKs) and signal transducers
and activators of transcription (STATs). CNTF, ciliary neurotrophic factor; GCSF, granulocyte colony-stimulating factor; IFN, interferon; IL, interleukin;
LIF, leukaemia inhibitory factor; OSM, oncostatin M. The organization of some of the type I cytokine receptors is shown in Module 1: Figure type I
cytokine receptors.
SCID was found in patients carrying mutations in JAK3. growth factor β (TGF-β) superfamily, which are cytokines
SCID resulted from a dramatic reduction in the number of that regulate many cellular functions such as proliferation,
T cells, highlighting the important role for this signalling apoptosis, extracellular matrix formation and angiogen-
pathway in lymphocyte development. esis. In addition, they play a critical role in controlling
One of the functions of STAT3 is to stimulate the tran- events during early development and cell differentiation.
scription of genes that code for anti-apoptotic factors such There is an extensive Smad signalling toolkit, and the many
as Bcl-2 and the inhibitor of apoptosis (IAP) family of components can be mixed and matched to assemble a large
proteins. variety of Smad signalling pathways. The domain struc-
JAKs have also been implicated in certain forms of ma- ture of the Smad family illustrates their multifunctional
lignant transformation such as Sezary’s syndrome, v-Abl- roles in the Smad signalling mechanism that functions to
transformed cells and in some leukaemias. transfer information from activated receptors on the cell
surface to gene targets in the nucleus. This signalling mech-
anism has two main components. Firstly, there is a process
Smad signalling pathway of transforming growth factor β (TGF-β) receptor ac-
This signalling pathway takes its name from the Smads, tivation, which is responsible for activating the Smads.
which are a collection of intracellular signalling molecules Secondly, there is the Smad activation of transcription.
that act collectively to transfer information from cell- There are a number of mechanisms for the modulation of
surface receptors into the nucleus. As such, some of the Smad signalling. Transforming growth factor β (TGF-β)
Smads function as transcription factors, whereas oth- inhibition of cell proliferation is one of the major functions
ers either facilitate or inhibit this transcriptional activ- of the Smad signalling pathway. It plays an important role
ity. These Smads mediate the action of the transforming in the differentiation of intestinal cells. Alterations in the
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r104
Agonist
P P P P P P P P
JAK
P P P P P P
1 2
4 _
3
SH2 domain
DNA-binding STAT 5 PP
domain
SOCS
CRM1 Export Import Importin
8 6
Importin
CRM1
N-PTP Target genes
SOCS
P P 7
The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) activation cascade.
A schematic summary of the main sequence of events responsible for the activation of signal transducers and activators of transcription (STATs).
Agonist activation of cell-surface receptors induces dimerization of receptor subunits, resulting in the stimulation of resident Janus kinases (JAKs). The
JAKs then carry out a sequential series of three phosphorylation reactions to activate the STATs, which then enter the nucleus to induce transcription.
The binding between STATs and DNA is shown in Module 2: Figure STAT1/DNA complex .
Accessory receptors
Smad signalling toolkit
These are cell-surface receptors that function as co-
The Smad signalling pathway is made up from a large
receptors in that they promote the binding of the lig-
number of components (Module 2: Table Smad signalling
ands to their signalling receptors. For example, the access-
toolkit). Specific cell types express different combinations
ory receptor endoglin is essential for the action of activin
of these components so that there is considerable variab-
receptor-like kinase 1 (ALK1) during the activation of an-
ility in the nature of Smad signalling pathways. However,
giogenesis.
the overall organization is fairly similar and is best ex-
emplified by the action of transforming growth factor β
(TGF-β) itself. The different components of the toolkit
TGF-β signalling receptors
have been grouped together on the basis of their function
There are two groups of signalling receptors (Type I and II)
in the signalling pathway (Module 2: Table Smad signalling
(Module 2: Table Smad signalling toolkit). These receptors
toolkit):
contain a single membrane-spanning region that separates
the extracellular ligand-binding domain from the cytoso-
Ligand traps lic region that contains a serine/threonine kinase domain.
These are a large group of proteins that control access The Type I receptor also contains a glycine/serine-rich
of the ligands to their cell-surface receptors. These ligand (GS) domain, which is phosphorylated by the Type II re-
traps can have an important inhibitory action since they ceptor during the signal transduction process (as occurs
can prevent the ligands from reaching their cell-surface during the response to TGF-β Module 2: Figure TGF-βR
receptors. For example, follistatin inhibits the action of activation). Ligands act to complex these receptors so that
activin on gonadotrophs (Module 10: Figure gonadotroph the Type II can then activate the Type I, which in turn
regulation). activates the Smads (Module 2: Figure Smad signalling).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r105
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r106
PY P P
MH1 MH2 --SSXS- R-Smads
NLS (Smad1,2,3,5,8)
PY
MH2 I-Smads
(Smad6,7)
of the Smads. The single co-mediator Smad (Co-Smad, i.e. the following steps shown in Module 2: Figure TGF-βR
Smad4) resembles the R-Smads in some aspects. It also has activation.
MH1 and MH2 domains, but here the latter is split. In ad-
dition to the NLS, it also has a nuclear export signal (NES).
Smad4 lacks the C-terminal phosphorylation motif, but it 1. The ligand, in this case TGF-β, is often held in a latent
does contain a number of phosphorylation sites. The two ligand complex by being bound to one of the ligand trap
inhibitory Smads (I-Smads) lack an MH1 domain, but they proteins such as latency-associated polypeptide (LAP)
have the Smurf1/2-binding PY motif. or decorin. When it dissociates from the ligand trap, it
can be taken up by one of the accessory receptors such
as betaglycan.
Smad signalling mechanism 2. The TGF-β then associates with the two TGF-β re-
The Smad signalling mechanism can be divided into two ceptor components to assemble an agonist/receptor
parts. Firstly, there is the process of transforming growth complex. In the absence of ligand, the Type I and II
factor β (TGF-β) receptor activation, which concerns the receptor components exist as homodimers which are
way in which ligands such as TGF-β interact with the then brought together by TGF-β.
signalling receptors to trigger Smad activation (Module 3. When the two receptor types have been complexed
2: Figure TGF-βR activation). The critical aspects of this by TGF-β, the serine/threonine kinase domain on the
activation process are the phosphorylation reactions that Type II receptors phosphorylates the serine residues
occur within the receptor complex. The Type II recept- on the glycine/serine-rich (GS) region of the Type I
ors are constitutively active and phosphorylate the Type receptors.
I receptors. These activated Type I receptors then act to 4. These phosphorylated GS regions on the Type I re-
phosphorylate the Smads. ceptors provide a docking site for the MAD homology
The second part is the Smad activation of transcrip- domain 1 (MH1) domain of Smad2 or Smad3. This re-
tion, during which the phosphorylated receptor-regulated cruitment of the Smads to the membrane is facilitated
Smads (R-Smads), together with their partner Smad4, by Smad anchor for receptor activation (SARA). Once
translocate into the nucleus to induce gene transcription attached to the receptor, the SSXS motif is brought into
(Module 2: Figure Smad signalling). contact with the serine/threonine kinase domain, and
two of the serine residues are phosphorylated.
Transforming growth factor β (TGF-β) receptor 5. Once Smad2/3 have been phosphorylated, their affinity
activation for both the receptor complex and for SARA is reduced,
Activation of the transforming growth factor β (TGF-β) and the two proteins pass into the cytoplasm. The ac-
receptor depends upon a series of reactions as illustrated by tivated Smads then translocate into the nucleus where
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r107
TGF-
1
2 TGF-
P P P P MH1
SARA
Betaglycan 3
-SXSS-- MH2
Type II
receptors Type I
receptors
SARA 4
Glycine-serine-rich
SARA
P P MH1
domain (GS) MH1 MH2
-SXSS--
-SXSS-- MH2
Smad2
GENE TRANSCRIPTION
Smad3
(See Module 2: Figure Smad signalling)
Smad4 P
P
Smad2 Smad1
Smad3 Smad5
Smad8
P P
Coactivator/ Coactivator/
repressor P repressor P
TGF /activin BMP
TF target genes TF target genes
SBE SBE
The Smad signalling pathway links cell-surface transforming growth factor β (TGF-β) receptors to gene transcription.
There are two main types of Smad signalling. In the one shown on the left, receptors activated by ligands such as transforming growth factor β (TGF-β),
activin and Nodal phosphorylate either Smad2 or Smad3. The phosphorylated Smads then heterodimerize with the co-mediator Smad (Co-Smad)
Smad4 to form a dimer that then translocates into the nucleus. Once in the nucleus, the Smad dimer then binds to a specific Smad-binding element
(SBE), which has a GTCT motif that is recognized by the MAD homology domain 1 (MH1).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r108
they activate transcription (Module 2: Figure Smad sig- nalling pathway. One of its actions is to increase the tran-
nalling). scription of the p15INK4B gene that codes for p15, which is
one of the cyclin-dependent kinase (CDK) inhibitors that
Smad activation of transcription inhibits cyclin D/cyclin-dependent kinase 4 (CDK4) com-
The receptor-regulated Smads (R-Smads) function as tran- plex that is one of the early events of the cell cycle signalling
scription factors responsible for activating a large num- cascade (Module 9: Figure cell cycle signalling mechan-
ber of target genes. Once they have been activated by the isms). Another important action is to repress c-Myc, which
cell-surface receptors, the activated Smads translocate into is one of the major transcriptional activators of genes that
the nucleus (Module 2: Figure Smad signalling). Some of function in cell proliferation. Such an inhibition of Myc
the ligands, such as transforming growth factor β (TGF- occurs during skin development when Smad2/3 induces
β), activin and Nodal activate receptors that are coupled the transcription of the Myc repressors Mad1 and Ovol1
to Smad2 and Smad3, whereas bone morphogenetic pro- to inhibit keratinocyte proliferation.
tein (BMP) acts through Smad1, Smad5 or Smad8. Once TGF-β plays an important role in regulating the pro-
these Smads have been phosphorylated on their C-terminal liferation of mesangial cells (Module 7: Figure mesangial
SSXS motif (Module 2: Figure TGF-βR activation) they cells). It also regulates the proliferation of stem cells such
leave the receptor, where they combine with Smad4 to form as the skeletal muscle satellite cells (Module 8: Figure Satel-
a dimer that then translocates into the nucleus (Module 2: lite cell activation) and the epidermal stem cells (Module
Figure Smad signalling). Once the dimer enters the nuc- 8: Figure epidermal stem cell).
leus, it recognizes and binds to a specific DNA motif. Smad2 and 4 are tumour suppressors. A germline muta-
The transcriptional activity of the Smads is facilitated tion in Smad4 has been linked to juvenile polyposis syn-
by associating with other site-specific transcription factors dromes (JPSs).
(TFs). Their activity is also modulated by coactivators and
repressors. For example, Smad4 binds directly to the co-
activator p300, which has an important role in activat- Wnt signalling pathways
ing transcription. The pathway on the right, which car- The Wnt signalling pathways play a critical role in the
ries out the action of receptors that bind ligands such as control of cell proliferation, cell fate specification and dif-
bone morphogenetic protein (BMP), use Smad1, 5 or 8 to ferentiation. These different pathways are activated by ex-
transmit information into the nucleus. As for the pathway tracellular lipoprotein signalling molecules called Wnts re-
described above, Smad4 is again used as a partner for the sponsible for transmitting information between cells over
translocation process, and the transcriptional processes are relatively short distances. There are three main pathways:
also similar. the canonical and two non-canonical pathways (Module 2:
The Smads stimulate transcription of the collagen type I Figure Wnt signalling pathways).
during the fibrogenesis induced in activated hepatic stellate The primary function of the canonical Wnt/β-catenin
cells in the liver (Module 7: Figure hepatic stellate cell). pathway is to activate gene transcription to control pro-
cesses during both development and in the adult organism.
Modulation of Smad signalling The functions of the non-canonical Wnt pathways are still
There are a number of ways that the Smad signalling path- somewhat of an enigma, since their precise functions have
way can be modulated. One mechanism is by an increase not been clearly identified, but there are clear indications
in the expression of inhibitory Smads (I-Smads), which that they may function in planar cell polarity (PCP). The
target the cell-surface receptors for degradation. This pro- Wnt/planar cell polarity (PCP) pathway, which has been
cess is mediated by the Smad ubiquitin-regulatory factors characterized in Drosophila, appears to act through various
(Smurfs), which are a family of ubiquitin E3 ligases that GTP-binding proteins. A closely related Wnt/Ca2 + sig-
bind to the PY motif on the linker region of I-Smads nalling pathway, which has been described in vertebrates,
(Module 2: Figure Smad domain structure). The E3 ligase has a number of similar signalling components but also has
functions in the ubiquitin-proteasome system (Module 1: additional features such as the hydrolysis of PtdIns4,5P2 to
Figure ubiquitin-proteasome system). activate signalling through InsP3 /Ca2 + and diacylglycerol
The mitogen-activated protein kinase (MAPK) sig- (DAG)/protein kinase C (PKC).
nalling pathway can also modulate Smad signalling by
phosphorylating sites located in the linker regions of Wnts
Smad1 and 2 (Module 2: Figure Smad domain structure). The term Wnt results from the fusion of the names of
This is an example of signalling cross-talk in that it provides two orthologous genes, the Drosophila segment polarity
a mechanism for the tyrosine kinase-linked receptors to gene Wingless (Wg) and a mouse proto-oncogene Int-1.
antagonize the action of the transforming growth factor β The human genome has 19 Wnt genes, many of which
(TGF-β) superfamily. appear to have distinct functions. They contain numer-
ous cysteine residues, one of which is palmitoylated, thus
Transforming growth factor β (TGF-β) inhibition making the Wnts somewhat insoluble, which may help to
of cell proliferation explain why they are short-range ligands. A large number
One of the major functions of transforming growth factor of Wnt-binding proteins, such as secreted frizzled-related
β (TGF-β) is to inhibit cell proliferation by altering ex- protein (SFRP) and Wnt inhibitory factor (WIF) also re-
pression of some of the key regulators of the cell cycle sig- strict their sphere of influence by acting as Wnt buffers.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r109
Canonical Wnt/catenin pathway Wnt/planar cell polarity pathway Wnt/Ca 2+ signalling pathway
Wnt
? Wnt5A,11
CRD
CRD
CRD
Wnt Wnt
Fz Fz Fz2, Fz6
PtdIns4,5P2
PLC
Dsh Dsh Dsh
LRP5/6
DAAM1
InsP3 DAG
-catenin Rac Rho
? Ca 2+ PKC
JNK ROK
CaMKII
NFAT
p300 Wnt
-catenin genes
P
Myosin II
LEF-1 TCF
Summary of the signalling mechanisms used by the canonical and non-canonical Wnt signalling pathways.
All three signalling pathways are activated by frizzled (Fz) receptors that depend upon the dishevelled protein (Dsh) as part of the transduction
mechanism to transfer information into the cell. Most is known about the canonical Wnt/β-catenin pathway (Module 2: Figure Wnt canonical pathway)
with less information on the two non-canonical pathways. In the Wnt/planar cell polarity (PCP) pathway, Dsh transfers information to the small GTP-
binding proteins Rho and Rac. The Wnt/Ca2 + signalling pathway is connected to the dishevelled-associated activator of morphogenesis 1 (DAAM1),
which relays information to the Rho pathway. In addition, Dsh also relays information to phospholipase C (PLC) to produce InsP3 and diacylglycerol
(DAG).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r110
CRD
SOST Dkk1 Wnt SFRP
CRD SFRP Wnt
Fz LRP5/6 Fz
Kremen
CKI CKI P
P Dsh P
P P
Dsh
Axin
GSK3
6
CKI
Proteasome
P P P APC
P -catenin B P
APC PP
3 A 2A
B
Axin Amino
A
-catenin
acids
PP2A
Amino -catenin protein GSK3
acids synthesis and 2 7 -catenin
degradation cycle CKI -catenin accumulates and
Protein
-catenin translocates into
-catenin synthesis
-catenin the nucleus
Protein 1 degradation -catenin
synthesis -catenin complex
8 9
HDAC Wnt
4 p300
-catenin genes
LEF-1 TCF
Ac Ac Ac Ac Ac TCF
LEF-1
Deacetylation Acetylation
6. The LRP5/6 co-receptor is then phosphorylated by ative effects that characterize the operation of the Wnt
membrane-bound casein kinase Iγ (CKIγ) isoform, signalling pathway.
which adds phosphates to multiple sites that have
PPPSP motifs. Some of these motifs are also phos- In summary, the Wnt signalling pathway acts by switch-
phorylated by a membrane-associated GSK-3β. These ing off the GSK-3β-dependent degradation pathway, thus
phosphorylated motifs then provide binding sites for enabling β-catenin to accumulate in the cytosol and to
the attachment of the scaffolding protein axin. Another enter the nucleus to activate transcription of the Wnt tar-
key event is the binding of Dishevelled (Dsh), which get genes.
is another scaffolding protein containing various signal
transduction domains (e.g. DIX, PDZ and DEP). Dsh
becomes hyperphosphorylated by an unknown mech- Low density lipoprotein (LDL) receptor-related
anism and this contributes to its role in inhibiting the protein family (LRP)
degradation complex. Axin and Dsh also bind to each Members of the low-density lipoprotein (LDL) receptor
other through their DIX domains. As the multiprotein superfamily are cell-surface proteins with multiple func-
complex associates with the membrane, the organiza- tions. The LDL receptor-related protein (LRP) family has
tion of the subunits is altered so that the activity of multiple members (LRP1--6, LRP8, LRP10--12) with mul-
GSK-3β is inhibited, thus reducing the degradation of tiple functions:
β-catenin. Loss-of-function mutations of LRP5 have
been linked to osteoporosis pseudoglioma (OPPG). • LRP11 is an endocytic receptor for apolipoprotein E
7. When GSK-3β is inhibited, the newly synthesized β- (ApoE), which plays an important role in the onset of
catenin is stabilized and accumulates within the cyto- Alzheimer’s disease (AD) (Module 12: Figure amyloid
plasm, from where it can enter the nucleus to activate cascade hypothesis).
transcription. • LRP5 and LRP6 function as co-receptors in the ca-
8. β-Catenin binds to LEF-1 and TCF to reduce their nonical Wnt/β-catenin pathway (Module 2: Figure
repressor activity to initiate the transcription of the Wnt Wnt canonical pathway). Mutations in LRP5 can cause
genes. β-Catenin replaces HDAC with p300, which either extremely high or low bone mass traits. A high
facilitates transcription by acetylating histones to re- bone mass syndrome (HBM) is caused by gain-of-
model chromatin. function mutations of LRP5. On the other hand, loss-
9. Activation of transcription of the Wnt target genes res- of-function LRP5 mutations are linked to osteoporosis
ults in the activation of the developmental and prolifer- pseudoglioma (OPPG).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r111
Inhibitors of Wnt signalling of colorectal cancer (CRC) (Module 12: Figure colon
There are various extracellular molecules that can inhibit cancer).
Wnt signalling. Some of these, such as the Wnt inhibit- • The canonical Wnt pathway inhibits the differentiation
ory factor 1 (WIF-1) and secreted frizzled-related protein of white fat cells (Module 8: Figure white fat cell dif-
(sFRP), bind to Wnt and thus prevent it from activating ferentiation) and the differentiation of brown fat cells
the Fz receptor. There is another group, such as Dickkopf (Module 8: Figure brown fat cell differentiation).
(Dkk) and sclerostin (SOST) that interfere with the activ-
ity of the lipoprotein receptor-related protein (LRP) co- The adenomatous polyposis coli (APC) protein, which
receptor LRP5/6. These inhibitors play an important role contributes to the cytoplasmic complex that degrades β-
in preventing the proliferation of stem cells until they are catenin in the cytoplasm, is a potent tumour suppressor
required for tissue repair as occurs for the epidermal stem that is frequently mutated in cancer cells and particularly
cells used for the hair follicle cycle (Module 8: Figure epi- in those that develop within the intestine such as colorectal
dermal stem cell). cancer (CRC). Germline mutations of APC are responsible
for familial adenomatous polyposis (FAP). Mutation in the
Wnt inhibitory factor 1 (WIF-1)
LRP5 gene, which binds to the Wnt antagonist Dickkopf1
The Wnt inhibitory factor 1 (WIF-1) is a soluble extracel-
(DKK1), causes osteoporosis pseudoglioma (OPPG) syn-
lular factor that binds to Wnt and prevents it from inter-
drome.
acting with the frizzled receptor (Module 2: Figure Wnt
canonical pathway).
Wnt/planar cell polarity (PCP) pathway
Secreted frizzled-related protein (sFRP)
The Wnt/planar cell polarity (PCP) pathway has been
The secreted frizzled-related protein (sFRP) is a soluble
characterized in insects, where it functions to establish
inhibitor that binds to Wnt and prevents it from interacting
planar cell polarity (PCP) during development (Module
with the frizzled receptor (Module 2: Figure Wnt canonical
2: Figure Wnt signalling pathways). Just how this path-
pathway).
way functions is still unclear, but there are indications that
Dickkopf (Dkk) it relays information through the Rac signalling mechan-
Dickkopf (Dkk) binds to Kremen and the lipoprotein isms and the Rho signalling mechanism, both of which
receptor-related protein (LRP) co-receptor LRP5/6 and function in the remodelling of actin. The Rho pathway
this causes the complex to internalize and will thus inac- acts through the Rho kinase (ROK) to activate contrac-
tivate Wnt signalling. tion of the actin/myosin system (Module 2: Figure Rho
signalling). These effects on actin remodelling and con-
Sclerostin (SOST) traction may play an important role in planar cell polarity.
Sclerostin (SOST) inhibits Wnt signalling by binding to In vertebrates, there are similar PCP processes such as
the lipoprotein receptor-related protein (LRP) co-receptor neural tube closure, the orientation of hair cell stereociliary
LRP5/6 (Module 2: Figure Wnt canonical pathway). SOST bundles in the ear, mammalian hair follicle orientation and
is produced by the osteoclasts to inhibit the proliferation convergent extension (CE), during which there are large-
and differentiation of the osteoblasts (Module 8: Figure scale movements of cells that occur during gastrulation.
bone cell differentiation). Components of the insect planar cell polarity pathway
Van Buchem disease is caused by a mutation in SOST have also been described in vertebrates, where it includes
that results in excessive activation of the Wnt signalling signalling through Ca2 + and has thus been referred to as
pathway. the Wnt/Ca2 + signalling pathway.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r112
Mutations of the Fz4 receptor, which activates this it can also be activated by certain growth factors (insulin,
Wnt/Ca2 + pathway, have been linked to familial exud- IGF-I and EGF).
ative vitreoretinopathy (FEVR).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r113
Hh
Hh
HIP
PTC SMO SMO Hh
PTC
KIF7
SU X
SU GLI1
KIF7 SU GLI1
SUFU
KIF7
GLI1 SUFU
GLI1
miR-324-5p
Positive Negative
feedback feedback
Iguana + + MIM
GLI1, MIM
PTC, HIP
GLI1 Wnt, BMP
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r114
Hedgehog signalling functions sterile-20-like kinase type 1 and type 2 (MST1/2), which
The Hedgehog signalling pathway functions both dur- is the first protein kinase of the core kinase cascade.
ing development and during adult life. Its function dur- In the next of part of the cascade, MST1/2 phos-
ing development is wide-ranging in that it can control phorylates Large tumour suppressor-1 and -2 (Lats1/2).
cell proliferation, cell determination and pattern forma- The activity of Lats1/2 is modulated by Mps one binding
tion of the developing embryo and the final processes of protein (MOB1). The ability of MOB1 to activate Lats1/2
cell differentiation. Hedgehog signalling seems to play an is enhanced by its phosphorylation by MST1/2. The activ-
important role in controlling the development of organs ated Lat1/2 then carries out the final step by phosphorylat-
such as the skin, brain, digestive tract, pancreas and pro- ing the closely related transcription factors Yes-activated
state. Mutations of components of this signalling pathway protein (YAP) and transcriptional coactivator with PDZ–
result in congenital malformations such as holoprosen- binding motif (TAZ). Once they are phosphorylated, YAP
cephaly, which is a cranial defect that occurs when the and TAZ are inactivated and leave the nucleus (Module 2:
midline structures of the brain and face fail to separate. Figure hippo signalling pathway). In the case of TAZ, ex-
The most dramatic phenotype of such malformation is port from the nucleus is carried out by protein 14-3-3.
cyclopia where only one eye is formed. YAP can also be inactivated by a ubiquitination pathway
The function of Hedgehog continues in the adult or- that begins with its phosphorylation by casein kinase Iδ
ganism, where it plays a major role in the formation and (CKIδ) or casein kinase Iε (CKIε) that marks it out for
maintenance of the stem cell population. Since Hedgehog ubiquitin ligase by SCFβ-TRCP .
signalling plays such a major role in regulating cell prolif- The closely related transcription factors YAP and TAZ,
eration, it is not surprising that alterations in this signalling which have overlapping and distinct functions, operate to-
pathway have been detected in many cancers such as skin gether with other co-activators of which the TEA domain
cancer and some brain cancers. (TEAD) proteins are particulary important. This tran-
For example, patched (PTC) is a tumour suppressor that scriptional complex activates a number of target genes
is inactivated in basal cell carcinomas (BCCs), medullo- including amphiregulin (AR), cysteine-rich protein con-
blastomas, gliomas in the brain and prostate cancers. nective tissue factor (CTGF) and Baculoviral inhibitor of
Mutations of the PTC gene are responsible for Gorlin’s apoptosis repeat-containing 5 (BIRC5, also known as sur-
syndrome, which is also known as nevoid basal cell car- vivin). BIRC5 is a member of the inhibitor of apoptosis
cinoma syndrome (NBCC). The Hedgehog signalling (IAP) family.
pathway may also contribute to the growth of tumours Hippo signalling appears to have multiple functions in
by enhancing the activity of stromal cells that provide the mammalian cells. Many of these functions seem to be re-
tumour cell microenvironment that supports cancer cell lated to controlling cell proliferation and cell growth. For
survival and growth. Cancer cells release hedgehog that example, it can control the size of organs such as the liver.
then uses a paracrine mechanism to stimulate neighbouring Contact inhibition in cultured cells seems to require ac-
stromal cells such as the blood vessels, fibroblasts, immune tivation of this signalling cascade. Its role in cell prolifera-
cells and epithelial cells. These stromal cells assist cancer tion is apparent in numerous examples where uncontrolled
cell growth by providing both an extracellular matrix and growth occurs in many cancers when various compon-
essential growth factors such as insulin-like growth factor ents of the pathway are deleted. Hepatocellular carcinoma
(IGF) and Wnt. (HCC) can be induced by the overexpression of YAP.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r115
CD44
NF2/Merlin
MST1/2 hWW45/
Sav1
P
P
Lats1/2 MOB1/
Mats
P 14-3-3
YAP TAZ
CKI
P
P YAP
YAP P 14-3-3
P
Lats1/2 TAZ
Ubiquitination
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r116
Endosome
Delta
Jagged
1 2
S2 Notch 3
-secretase
S3 Proteasome
6 Ankyrin
repeats ADAM 4
NICD
PEST
UbUbUbUb
P
5 8 9
NICD SEL-10
CDK-8
P
Acetylation
p300 MAM Notch target genes HES1
SKIP HES2
CSL 7
HES7
HEY1
Gene repression 10 6 Gene activation HEY2
HEYL
ESR
Deacetylation HDAC
SMRT
CSL
SHARP
X NRARP
signal transduction process itself, whereas others play a 5. NICD released from the membrane diffuses into the
role in the modulation of Notch signalling, which regu- nucleus and binds to CSL (CBF-1, Suppressor of Hair-
lates the expression of the stimuli (Delta and Jagged) and less, Lag-1).
the Notch receptor at the cell surface. The operation of 6. CSL normally acts to repress Notch target genes.
the Notch signalling pathway depends upon the following Repression is enhanced by CSL providing a frame-
steps (Module 2: Figure Notch signalling): work to recruit co-repressors such as SMRT, SHARP,
SKIP and CIR. This repression complex also recruits
1. Delta or Jagged located on one cell interacts with histone deacetylase (HDAC) that deacetylates chro-
the Notch receptor on a neighbouring cell. The N- matin further shutting down transcriptional activity.
terminal DSL (Delta, Serrate and LAG-2) domain When NICD binds to CSL, the repression complex is
(yellow bar) on Delta/Jagged binds to the EGF- disassembled and this paves the way for the assembly
repeats 11 and 12 (red bar) on Notch. By itself, this of an activation complex. An important part of the
interaction with Notch seems to have little effect and complex is the co-activator Mastermind (MAM) and
only initiates the signal transduction sequence as a the histone acetyl transferase p300. The latter is re-
result of Delta/Jagged physically pulling on Notch. sponsible for protein acetylation of histones to open
2. The endocytosis of Delta/Jagged seems to be a crit- up the chromatin to facilitate gene transcription.
ical step for receptor activation. As Delta/Jagged are 7. Gene activation results in an increase in the transcrip-
drawn into the endosome, they pull on Notch, which tion of Notch target genes. Some of these such as the
undergoes a conformational change to expose site-2 hairy and enhancer of split (HES) family encode tran-
(S2). scriptional repressors responsible for suppressing the
3. S2 is cleaved by ADAM proteases such as ADAM-10 expression of tissue specific proteins, which accounts
and ADAM-17 (Module 1: Table ADAMs proteases). for the ability of the Notch signalling pathway to in-
The external domain is shed leaving behind a short hibit differentiation.
transmembrane region and the intracellular domain, 8. The inactivation of target gene transcription begins
which then becomes a substrate for γ-secretase. when NICD is phosphorylated in the N-terminal
4. The γ-secretase complex is an enzyme complex made PEST domain by kinases such as cyclin-dependent
up of presenilin, nicastrin, PEN2 and APH1 that kinase-8 (CDK-8).
cleaves the S3 site to release the Notch intracellular 9. The phosphorylated NICD becomes a substrate for
domain (NICD). The activity of γ-secretase may be nuclear ubiquitin ligases such as SEL-10 and is then
inhibited by Crumbs, which is an apical polarity pro- exported to the cytoplasm where it is degraded by the
tein. proteasome.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r117
10. Once NICD is removed from the activation com- • Proliferation of satellite cells in skeletal muscle is en-
plex and degraded, the different co-activators fall hanced by Notch signalling (Module 8: Figure Satellite
away and are replaced by the repressors that result cell activation).
in gene repression. Gene repression also depends on • The self renewal of haematopoietic stem cells (HSCs)
the recruitment of histone deacetylase (HDAC) that is facilitated by Notch signalling that acts by inhibiting
deacetylates chromatin further shutting down tran- differentiation (Module 8: Figure HSC regulation).
scriptional activity. • Notch signalling is responsible for the process of lat-
eral inhibition that inhibits tip cell formation during
angiogenesis (see Step 2 in Module 9: Figure angiogen-
esis signalling).
Notch signalling controls a number of developmental
events and continues to have a role during adulthood par- Alterations in Notch signalling have been implicated in a
ticular in maintaining the stem cell population: number of cancers. For example, overexpression of Notch
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r118
Ub
Ub
Ligand maturation Degredation
Ub 3
2
Ub
Epsin Recycling
1
r Ub
u b
Ne Mi Ub PtdIns4,5P2
Ub
Delta
Jagged
8
Notch
NAK
Numb 4
-adaptin Recycling
7
MVB
Receptor maturation
Endosome
Ub
Itch 6
5 Degredation
Deltex Ub
Ub
has been identified in both ovarian and medullablastomas. PtdIns4,5P2 regulation of membrane trafficking and en-
An up-regulation of Notch and a decrease in the inhib- docytosis.
itor Numb has been observed in breast cancer. Mutations 3. The endosome then has two paths: it can move down
in Notch have been linked to T cell acute lymphoblastic the lysosomal path resulting in degradation of Delta and
leukaemia. Jagged. Alternatively, it can recycle back to the plasma
membrane where the ligands are then able to activate
Notch.
Modulation of Notch signalling
The primary mechanism for modulating Notch signalling Different players function in the regulation of Notch
is to adjust the mechanisms responsible for regulating both trafficking as shown in the following steps (Module 2:
ligand (Delta and Jagged) and receptor (Notch) maturation Figure Notch modulation):
(Module 2: Figure Notch modulation). In both cases, the
ligands and the receptor on the cell surface are taken up 4. Entry of Notch into the endosome is dependent on the
into the endosomes and are then either recycled back to the protein Numb, which is a major inhibitor of Notch
cell surface or are degraded. The balance between recycling signalling. The Notch receptor interacts with Numb,
and degradation thus determines their level of membrane which also binds to α-adaptin. The latter is a component
expression and thus sets the sensitivity of the Notch sig- of the adaptor protein-2 (AP2) complex responsible for
nalling pathway. The ubiquitin-proteasome system plays endocytosis. A Numb-associated kinase (NAK) is also
a critical role in regulating the trafficking of these two a component of this complex. The Notch receptors in
signalling components. the endosome have two fates.
The trafficking of Delta and Jagged follows the fol- 5. Some of the Notch receptors are ubiquitinated by
lowing series of events (Module 2: Figure Notch mod- ubiquitin ligases such as Itch (a Hect domain E3 lig-
ulation): ase) and Deltex (a Ring finger E3 ligase).
6. Ubiquitinylated notch receptors are transferred to the
1. The cytoplasmic domain of Delta and Jagged are ubi- multivesicular body (MVB) en route to degradation by
quitinylated by Ring finger E3 ubiquitin ligases such as the lysosome.
Mind bomb (Mib) and Neutralized (Neur). 7. Some of the Notch receptors are recycled back to the
2. Endocytosis of these ubiquitylated proteins is facil- plasma membrane.
itated by the protein epsin that binds to ubiquitin- 8. These Notch receptors on the cell surface are then able
containing cargo proteins. In addition, epsin binds to interact with ligands such as Delta and Jagged to
to both clathrin and to phosphatidylinositol 4,5- initiate the Notch signalling pathway (Module 2: Figure
bisphosphate (PtdIns4,5P2 ), which functions in the Notch signalling).
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r119
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r120
2 3 Excess
6 protein
Caspase-12 7
IRE1 P P
NF-kB INFLAMMATORY
ATF-6 APOPTOSIS RESPONSES
Transcription
factors
5
PDI: GRP78:
GRP94; CHOP Interleukins
Calreticulin etc Cytokines
nature of the stress. The fact that the ER can up-regulate C/EBP (CCAAT/enhancer-binding protein)-homologous
chaperone levels results in the phenomenon of tolerance, protein 10 (CHOP). Another mechanism depends upon
whereby treatment of cells with low levels of stress stimuli the ER directly activating a subset of caspases during
can make cells much more tolerant to subsequent stressful ER stress. A critical component is caspase 12, which is
stimuli. associated with the ER membrane and is released by
proteolytic cleavage following ER stress. Several mech-
Unfolded protein response (UPR) anisms have been proposed for this activation process.
An accumulation of misfolded proteins induces an unfol- One suggestion is that the stress sensor molecule IRE1
ded protein response (UPR), which switches off ongoing recruits tumour-necrosis-factor-receptor-associated factor
protein synthesis and also activates various transcriptional (TRAF) which then binds to caspase 12, making it sens-
cascades that result in the up-regulation of many of the itive to the Ca2 + -responsive cysteine protease m-calpain.
key chaperones in an attempt to improve the defective Another suggestion is that the hydrolysis of caspase 12 is
protein packaging machinery (Module 2: Figure ER stress mediated by caspase 7, which is recruited to the membrane
signalling). Activating transcription factor 6 (ATF6) is one during ER stress. An interesting aspect of this mechanism
of the transcription factors activated by the UPR. is that glucose-regulated protein 78 kDa (GRP78) appears
to inhibit this activation process by forming a complex
with caspase 7 and caspase 12. Once caspase 12 is released
Endoplasmic reticulum (ER) overload into the cytosol, it activates a specific cascade involving
response (EOR)
caspase 9 and caspase 3 in a cytochrome c-independent
An excessive build-up of proteins, as occurs during viral in-
manner.
fections, switches on an endoplasmic reticulum (ER) over-
load response (EOR) that acts through the nuclear factor
κB (NF-κB) signalling cascade to stimulate the release of
interferons and cytokines as part of an inflammatory re- Metabolic messengers
sponse. There are a number of cellular metabolites that function as
metabolic messengers to integrate the activities of cellular
Activation of apoptosis metabolism and cell signalling (Module 2: Figure meta-
Endoplasmic reticulum (ER) stress signalling pathways bolic messengers). In this context, a metabolic messenger
can also contribute to apoptosis (Module 11: Figure ap- is defined fairly widely: it includes components that are
optosis). For example, one of the UPR pathways depends either a part of, or are derived from, cellular metabolism.
upon the release of the transcription factor activating Metabolism is regulated at many different levels. The most
transcription factor 6 (ATF6), which acts to switch on direct control depends upon feedback processes where
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r121
+
Ca 2+ K+ +
Ca 2+
ATP
TRPM2 P2Y P2X
K ATP
Ca 2+ + PLC Ca 2+
DAG InsP3
ADPR ATP
Cyclic AMP
NAD signalling
NADP HCO pathway
3
ADP ribosyl H S
cyclase Metabolic
messengers
cADPR AMP
AMP
signalling
+ NADH
NAADP pathway
NAD
Calcium +
signalling Gene
pathway transcription
certain substrates or products function as positive or neg- pathway has been described in cardiac myocytes, where the
ative regulators of the enzymes that synthesize or metabol- addition of pyruvate to increase metabolism has a marked
ize them. They are not signalling mechanisms in the strict effect on Ca2 + signalling (Module 2: Figure pyruvate and
sense, but are based on relatively straightforward mass ac- Ca2 + signalling).
tion reactions that ensure that metabolism proceeds in an
orderly and regulated manner. However, some of the meta-
bolic components can be considered to be metabolic mes- AMP signalling pathway
sengers because they activate or modulate clearly defined
signalling pathways. There are a number of such metabolic Adenosine monophosphate (AMP)
messengers: Cells have an AMP signalling pathway that is activated by
an increase in the AMP/ATP ratio, which results in the
• Adenosine triphosphate (ATP) activation of an AMP-activated protein kinase (AMPK).
• Adenosine monophosphate (AMP) AMP thus functions as a second messenger, since it is re-
• Fatty acids sponsible for activating the signalling pathway. The AMPK
• Bicarbonate (HCO3 − ) that responds to AMP has been referred to as the “fuel
• NAD + signalling pathways gauge” in that it responds to a decrease in the level of ATP.
This signalling cascade is sensitive to many stimuli, such as
The AMP signalling pathway is of major importance cell stress, oxidative damage, hypoxia and glucose depriva-
with regard to metabolic signalling systems. Components tion. Once activated, AMPK induces an up-regulation
of various redox signalling systems, such as the nitric ox- of ATP-generating systems (fatty acid oxidation, glyco-
ide signalling pathway, are also related to such metabolic lysis and mitochondrial biogenesis) while simultaneously
signalling pathways. down-regulating processes that consume energy (fatty acid
Signalling through metabolites is a highly integrated sys- synthesis and gluconeogenesis). One of its important ac-
tem because some of the signalling pathways activated by tions is to reduce protein synthesis when energy levels are
the metabolic messengers can feed back to regulate meta- low by regulating the activity of the target of rapamycin
bolism (Module 2: Figure metabolic signalling). An ex- (TOR) (Module 9: Figure target of rapamycin signalling).
ample of how a change in metabolism can affect a signalling Another of its actions is to regulate the transcription of
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r122
Metabolic messengers
Stimuli ROS/RNS Substrates Oxygen
1 3
+
NAD / NADH
+
NADP / NADPH
AMP/ATP
METABOLISM
_
9 HCO 3 8
SIGNALLING
PATHWAYS
NAADP
cADPR
7
4
Energy
6
CELLULAR
2 RESPONSES 5
Function of metabolic hormones in integrating the operation of cell metabolism and cell signalling pathways.
The signalling cascade begins with the arrival of an agonist (1) that recruits specific signalling pathways to activate a cellular response (2). Metabolism
uses oxygen and substrates (3) to provide the energy (4) that not only powers the cellular responses (5), but also drives signalling pathways (6). The
signalling pathways can also regulate the supply of energy by direct effects on metabolism (7). Superimposed on these more direct interactions, there
are a variety of metabolic messengers that form a complex signalling network (8 and 9) that integrate the activity of both the signalling and metabolic
cascades.
genes that function in the metabolism of glucose, fatty AMP-activated protein kinase (AMPK)
acids and cholesterol. The AMPK signalling pathway may AMP-activated protein kinase (AMPK) plays a critical role
also play a role in stimulating mitochondrial biosynthesis. in regulating the usage of fuels such as glucose and fatty
AMPK has also been implicated in cell growth control, acids. However, it can have additional functions such as
where it functions to regulate the protein kinase TOR that the regulation of insulin secretion by pancreatic β-cells,
controls protein synthesis. and may also play a role in controlling satiety centres in
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r123
GBD BD
I
C
Enzyme activation by
AMP and/or protein phosphorylation
by an AMPK kinase (LKB1)
GBD BD
2+ I
Ca + CaMKK +
P
AM
+ C P
LKB1
Protein +
Protein- P AMP
the hypothalamus. AMPK is a trimeric protein (Module 2: is a key transcriptional regulator of genes involved in
Figure AMPK structure) made up of multiple isoforms of a metabolism and particularly those that control mito-
catalytic α subunit (α1 and α2) associated with β-subunits chondrial biogenesis. PGC-1α activity is controlled
(β1 and β2) and γ-subunits (γ1--γ3). Cells express differ- both by its expression level and by post-translational
ent combinations of these different isoforms. mechanisms of which phosphorylation and acetyla-
AMPK carries out its function as a pleiotropic regulator tion are key processes. Phosphorylation of PGC-1α
of cell metabolism by regulating a large number of pro- by AMPK acts to prime it for subsequent deacylation
cesses (Module 2: Figure AMPK control of metabolism): by the deacetylase SIRT1. AMPK also acts to increase
the level of NAD + , which enhances the the activity of
1. One of the primary regulators of AMPK is AMP, SIRT1. The activity of PGC-1α is inhibited following
which is elevated when the level of ATP falls. Glycogen its acetylation by the acetyltransferase GCN5.
can inhibit the activity of AMPK by interacting with 4. One of the primary actions of PGC-1α is to stimulate
the glycogen-binding domain (GBD) of the β subunit the expression of genes that contribute to ATP genera-
(Module 2: Figure AMPK structure). tion, such as those that function in fatty acid oxidation,
2. Phosphorylation also plays a key role in regulating the glycolysis and mitochondrial biogenesis.
activity of AMPK. There are two major AMPK kinases- 5. AMPK phosphorylates TORC2 to prevent it from act-
LKB1 and Ca2 + /calmodulin-dependent protein kinase ing as a cofactor to activate genes responsible for gluc-
kinase β (CaMKKβ). The LKB1 is thought to be con- oneogenesis. For example, in the case of liver cells,
stitutively active, but there are indications that its activ- AMPK can phosphorylate transducer of regulated cyc-
ity might be regulated by acetylation. The activation lic AMP response element-binding protein 2 (TORC2),
through CaMKKβ may explain how adiponectin exerts which is then prevented from acting as a cofactor for the
its effects on metabolism. The adiponectin receptors cyclic AMP response element-binding protein (CREB)
(AdipoR1 and AdipoR2) are thought to act by promot- transcription factor, which can activate genes respons-
ing the entry of Ca2 + that then stimulates CaMKKβ to ible for gluconeogenesis (Module 7: Figure liver cell
phosphorylate and activate AMPK (Module 2: Figure signalling). AMPK can also inhibit the activity of vari-
AMPK control of metabolism). ous transcription factors such as the sterol regulatory
3. One of the important actions of AMPK is to regu- element-binding protein 1c (SREBp1c) and hepatocyte
late the activity of peroxisome-proliferator-activated nuclear factor 4α (HNF4α), which regulate lipogenic
receptor γ (PPARγ) coactivator-1α (PGC-1α), which and glycolytic genes respectively.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r124
Adiponectin Glucagon
Ca 2+
Glucose
AdipoR
Gluconeogenesis
Ac P Glucose
PGC-1
+
+
3
+ G-6-P
GCN5
SIRT1
+ NAD + 6 +
PFK-2
+ Acetyl-CoA 8
PGC-1 TORC P F-6-P
P F-2,6-P2 ase
ACC P
X
MDC
X
F-2,6-P2 PFK-1
TORC
5
F-1,6-P 2 ase
X
Malonyl-CoA +
Gluconeogenesis _
4 _
Glycolysis
Mitochondrial F-1,6-P2
biogenesis FFA
FFA CPT1 oxidation
Lipogenic and 7
glycolytic genes
Mitochondrion Pyruvate
6. Lipid metabolism is strongly influenced by AMPK, this by exerting rapid effects on processes such as gluc-
which acts to divert fatty acids away from lipid syn- ose entry and glycolysis, as well as longer-term effects,
thesis and directs them towards the mitochondrial oxid- by regulating the transcription of genes for mitochondrial
ative pathway to produce ATP. The AMPK-dependent biogensis and glycolytic and lipogenic hormones (Module
phosphorylation of acetyl-CoA carboxylase (ACC) re- 2: Figure AMPK control of metabolism). The AMPK sig-
duces the conversion of acetyl-CoA into malonyl-CoA. nalling pathway functions in many different cell types:
7. The fall in malonyl-CoA levels has two import con-
• In liver cells, AMPK inhibits gluconeogensis by redu-
sequences. First, fatty acid synthesis is reduced because
cing the activity of PGC-1α (Module 7: Figure liver cell
malonyl-CoA is an important precursor for lipid syn-
signalling)
thesis. Secondly, there is an increase in mitochondrial
• AMPK regulates insulin biosynthesis in insulin-
ATP formation because malonyl-CoA normally inhib-
secreting β1 cells (Module 7: Figure β-cell signalling)
its fatty acid oxidation.
• O2 -sensing by the glomus cells in the carotid body
8. AMPK can influence the balance between glycolysis
(Module 10: Figure carotid body chemoreception)
and gluconeogenesis by stimulating the formation of
• Control of Glut4 insertion during excitation--
fructose 2,6-bisphosphate (F-2,6-P2 ), which is a po-
metabolism coupling in skeletal muscle (see step 10 in
tent regulator of glycolysis through its ability to activ-
Module 7: Figure skeletal muscle E-C coupling)
ate 6-phosphofructo-1-kinase (PFK-1) and to inhibit
• AMPK plays an important role in cell growth control
fructose-1,6-bisphosphate 1-phosphatase. The forma-
by reducing protein synthesis when energy levels are
tion of F-2,6-P2 is regulated by two separate signalling
low by acting through TOR (Module 9: Figure target of
pathways. AMPK promotes glycolysis by stimulat-
rapamycin signalling).
ing the phosphofructokinase (PFK-2) of the bifunc-
• The AMP signalling pathway plays an important role
tional enzyme, which has both kinase and phosphatase
in the control of autophagy (Module 11: Figure auto-
activities. Cyclic AMP acting through the fructose-
phagy).
2,6-bisphosphate 2-phosphatase component lowers the
level of F-2,6-P2 , which reduces glycolysis and pro- The fact that AMPK plays such a central role in regu-
motes gluconeogenesis. lating energy metabolism has important implications for
9. AMPK stimulates the translocation of the glucose diabetes.
transporter (GLUT4) to the plasma membrane, where Glycogen storage disease in humans is caused by a muta-
it facilitates the entry of glucose in skeletal muscle and tion of the AMPK γ3-subunit.
heart cells.
LKB1
In summary, AMPK switches the cell away from energy- LKB1 is a serine/threonine protein kinase that functions
requiring processes towards energy conservation. It does to activate AMP-activated protein kinase (AMPK) by
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r125
phosphorylating Thr-172 on the α-subunit (Module 2: linoleic acid can activate the TREK subfamily of two-pore
Figure AMPK structure). The activation of AMPK is very domain K + (K2P ) channels.
dependent upon LKB1. Inactivation of the latter is re- The positive-feedback loop that free fatty acids (FFAs)
sponsible for Peutz-Jeghers syndrome. As such, LKB1 is exert on the process of lipogenesis (i.e. Step 7 in Module
considered to be one of the tumour suppressors. 7: Figure metabolic energy network) may exacerbate the
onset of obesity by enhancing fat storage.
The build-up of FFAs that occur during obesity play a
Adenosine triphosphate (ATP) critical role in inducing the insulin resistance (Module 12:
ATP is an important metabolic messenger in that it has Figure insulin resistance) that leads to the development of
a number of different actions both as an internal and an diabetes.
external signal (Module 2: Figure metabolic messengers).
With regard to the former, one of its main functions is
to regulate the activity of the ATP-sensitive K + (KATP ) Omega 3 fatty acids
channel, which is particularly important in regulating the The omega-3 fatty acids such as α-linolenic acid (ALA),
release of insulin (Module 7: Figure β-cell signalling). It eicosapentaenoic acid (EPA) and docosahexaenoic acid
also plays a role in regulating the activity of the ADP- (DHA) are typical polyunsaturated fatty acids (PUFAs).
ribosyl cyclase that generates the Ca2 + -mobilizing mes- These PUFAs are essential for normal cellular function.
sengers cyclic ADP-ribose (cADPR) and nicotinic acid-- ALA and α-linolenic acid, which are the precursors of
dinucleotide phosphate (NAADP) (Module 2: Figure arachidonic acid and DHA respectively, are not synthes-
cADPR/NAADP function). ATP is also released from ized de novo but are obtained from the diet. Arachidonic
the cell and can activate P2X receptors that activate Ca2 + acid is the precursor of the endocannabinoids, such as
entry or P2Y receptors that are coupled to phospholipase anandamide and 2-arachidonoylglycerol (2-AG), which
C (PLC) to generate inositol 1,4,5-trisphosphate (InsP3 ) have important signalling functions (Module 1: Figure
and diacylglycerol (DAG) (Module 2: Figure metabolic anandamide).
messengers). The first double bond of these omega-3 fatty acids is
located at the third carbon atom from the methyl (CH3 )
end of the molecule (see white arrow in Module 2: Fig-
Bicarbonate (HCO3 − ) ure omega-3 fatty acids). These omega-3 fatty acids have
The CO2 produced during cellular metabolism is rapidly a number of specific signalling functions as outlined in
converted into bicarbonate (HCO3 − ), which acts as a Module 2: Figure omega-3 fatty acids:
messenger to report the current state of metabolism. The
HCO3 − activates soluble adenylyl cyclase (Module 2: Fig-
ure cyclic AMP signalling) to generate cyclic AMP that has 1. When GPR120 was first identified, it was classed as
many signalling functions, including an effect on cellular an orphan receptor as there was no known ligand.
metabolism through its activation of glycogen metabolism. Subsequently, the omega-3 fatty acids were identified
as stimuli for this typical G-protein-coupled receptor
(GPCR).
Fatty acids 2. GPR120 is coupled through Gq/11 and phospholipase C
Fatty acids come in two main forms: saturated and poly- to activate the Inositol 1,4,5-trisphosphate (InsP3 ) and
unsaturated. There are two main types of polyunsaturated Ca2 + release signalling pathway.
fatty acid: omega-6 and omega-3 fatty acids. These are re- 3. One of the functions of the increase in Ca2 + might
ferred to as essential fatty acids since they are not made be to stimulate the release of glucagon-like peptide 1
by the body but are components of the diet: omega-6 (GLP-1).
fatty acids are derived mainly from vegetable oils, whereas 4. Another function of the GPR120 receptors is to activate
the omega-3 fatty acids are found in certain plants (li- the multifunctional adaptor protein arrestin-2.
nolenic acid) or from marine fish and shellfish (eicos- 5. The anti-inflammatory responses of omega-3 fatty
apentanoic acid and docosahexanoic acid). Fatty acids not acids might be carried out by arrestin-2 inactivating the
only provide an important energy source but can also TAK1-binding protein 1 (TAB1), which can inhibit the
be considered as metabolic messengers that contribute signalling pathways used by the Toll receptor signalling
to a number of metabolic control mechanisms. For ex- pathway (Module 2: Figure Toll receptor signalling)
ample, they control gluconeogenesis in liver cells by ac- or by the tumour necrosis factor α (TNFα) signalling
tivating the peroxisome-proliferator-activated receptor α pathway (Module 2: Figure NF-κB activation).
(PPARα) (Module 7: Figure liver cell signalling). Free fatty 6. Apart from the intracellular signalling pathways de-
acids are also responsible for activating the uncoupling scribed above, the omega-3 fatty acids are metabolized
protein 1 (UCP1) that provides the proton leak dur- by cyclooxygenase 2 (COX2) to form the resolvins and
ing noradrenaline-induced heat production by brown fat the protectins, which are potent anti-inflammatory and
cell mitochondria (Module 7: Figure brown fat cell). The immunoregulatory agents.
omega-3 fatty acids have a number of specific signalling 7. The anti-inflammatory action of the omega-3 fatty
functions. acids might have beneficial effects for coronary artery
Arachidonic acid (AA) and other polyunsaturated fatty disease, cardiac disease and for the insulin resistance
acids (PUFAs) such as docosahexenoic acid, linolenic and that results in metabolic syndrome.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r126
C20:6n-3
COOH Docosahexaenoic
CH3
acid (DHA)
LPS TNF
1
GLP-1
GPR120 TNF R
TLR4
PLC
DD
q/11
3 4 IRAK-1
TRAF2
2
+ TRAF6
-arrestin2 IRAK-4
InsP 3 P
-arrestin2
Ca 2+
+ _ 5 TAB1
TAK1
IKK
Inflammatory
responses
A decrease in dietary omega-3 fatty acids results in a NAD and NADP as precursors of metabolic
decline in the ability of anandamide to activate long-term messengers
depression (LTD) in neurons and this might be the cause • NAD + is a precursor of cyclic ADP-ribose (cADPR)
of various neuropsychiatric diseases such as depression. signalling pathway that functions in Ca2 + signalling.
• Metabolism of cADPR generates ADPR, which regu-
NAD signalling pathways lates transient receptor potential melastatin 2 (TRPM2),
As the name implies, the NAD signalling pathways en- a member of the transient receptor potential (TRP) ion
compass signalling systems that depend on nicotinamide-- channel family that controls the entry of external Ca2 +
adenine dinucleotide (NAD + ) and nicotinamide--adenine (Module 2: Figure cADPR/NAADP function).
dinucleotide phosphate (NADP + ). These two meta- • NADP + is a precursor of nicotinic acid–adenine dinuc-
bolic cofactors exist in the cell as NAD + /NADH and leotide phosphate (NAADP) signalling pathway that
NADP + /NADPH redox couples and have a number of functions in Ca2 + signalling.
important functions both as messengers and as precursors • NADPH is the substrate used to generate reactive oxy-
of other metabolic messengers. gen species (ROS), which function as second messen-
gers to regulate a number of cellular proteins (Module
2: Figure plasma membrane ROS formation).
NAD and NADP as metabolic messengers
• NAD + functions to regulate a number of cellular pro- Sterol sensing and cholesterol biosynthesis
cesses including energy metabolism, gene transcription, The level of cholesterol in cell membranes is regulated
DNA repair and perhaps ageing as well. by a signalling system that can sense the level of ster-
• NADH activates the C-terminal binding protein ols and then relay information to the nucleus to adjust
(CtBP), which is a transcriptional corepressor that func- the transcription of the genes responsible for cholesterol
tions during growth and development. biosynthesis. The signalling system is based on membrane-
• NADH and NADPH regulate the transcription factors bound transcription factors: the sterol regulatory element-
Clock/BMAL1 and NPAS2/BMAL1 that control gene binding proteins (SREBPs), which are integral membrane
expression during the operation of the circadian clock. proteins located in the endoplasmic reticulum (ER). They
• NADPH appears to regulate the ADP-ribosyl cy- have two membrane-spanning domains with the free ends
clase that is responsible for producing both cyclic projecting into the cytosol. The N-terminal region is
ADP-ribose (cADPR) and nicotinic acid--adenine di- the latent transcriptional regulator, which is cleaved by
nucleotide phosphate (NAADP) (Module 2: Figure a sterol-regulated system of proteases (Module 2: Fig-
cADPR/NAADP function). ure sterol sensing). Once released into the cytosol, these
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r127
transcription factors dimerize through a basic loop--helix-- Rossman, K.L., Der, C.J. and Sondek, J. (2005) GEF means go: turning
leucine zipper and enter the nucleus, where they bind to on Rho GTPases with guanine nucleotide-exchange factors. Nat. Rev.
Mol. Cell. Biol. 6:167–180.
sterol regulatory elements on the genes that code for the Somlyo, A.P. and Somlyo, A.V. (2003) Ca2 + sensitivity of smooth muscle
enzymes of lipid biosynthesis (cholesterol, unsaturated and nonmuscle myosin II: modulated by G proteins, kinases, and
fatty acids and triacylglycerols) and lipid-uptake mech- myosin phosphatase. Physiol. Rev. 83:1325–1358.
Tybulewicz, V.L.J. (2005) Vav-family proteins in T-cell signalling. Curr.
anisms. The sterol sensor is a SREBP cleavage-activating Opin. Immunol. 17:267–274.
protein (SCAP). When sterols build up in the membranes, Welch, H.C.E., Coadwell, W.J., Stephens, L.R. and Hawkins, P.T. (2003)
they bind to SCAP to inhibit the proteolytic cleavage Phosphoinositide 3-kinase-dependent activation of Rac. FEBS Lett.
546:93–97.
of the SREBPs. The ER thus plays a central role both
in sensing the level of sterols and then providing the
output signals that make the necessary adjustments to
lipid synthesis to maintain a constant level of membrane Cyclic AMP signalling pathway
cholesterol. Cooper, D.M. (2003) Regulation and organization of adenylyl cyclases
and cAMP. Biochem. J. 375:517–529.
Whorton, M.R. and Sunahara, R.K. (2003) Adenylyl cyclases. In
Handbook of Cell Signaling, Vol. 2 (Bradshaw, R.A. and Dennis, E.A.,
eds), pp. 419–426, Academic Press, San Diego.
References
Monomeric G proteins
Cullen, P.J. and Lockyer, P.J. (2002) Integration of calcium and Ras G proteins
signalling. Nat. Rev. Mol. Cell Biol. 3:339–348. Feig, L.A. (2003) Ral-GTPase: approaching their 15 minutes of fame.
Manser, E. (2003) Cytoskeletal regulation: small G-protein–kinase Trends Cell Biol. 13:419–425.
interactions. In Handbook of Cell Signaling, Vol. 1 (Bradshaw, R.A. Myers, K.R. and Casanova, J.E. (2008) Regulation of actin cytoskeleton
and Dennis, E.A., eds), pp. 499–503, Academic Press, San Diego. dynamics by Arf-family GTPases. Trend Cell Biol. 18:184–192.
Mitlin, N., Rossman, K.L. and Der, C.J. (2005) Signalling interplay in Ras Stenmark, H. (2009) Rab GTPases as coordinators of vesicle traffic. Nat.
superfamily function. Curr. Biol. 15:R563–R574. Rev. Mol. Cell Biol. 10:513–525.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r128
Ca2 + signalling Pendaries, C., Tronchère, H., Racaud-Sultan, C., Gaits-Iaconvani, F.,
Berridge, M.J., Bootman, M.D. and Roderick, H.L. (2003) Calcium Coronas, S., Manenti, S., Gratacap, M.-P., Plantavid, M. and Payrastre,
signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. B. (2005) Emerging roles of phosphatidylinositol monophosphates in
Cell Biol. 4:517–529. cellular signalling and trafficking. Adv. Enzyme Regul. 45:201–214.
Maravall, M., Mainen, Z.F., Sabatini, B.L. and Svoboda, K. (2000) Takenawa, T. and Itoh, T. (2001) Phosphoinositides, key regulatory
Estimating intracellular calcium concentration and buffering without molecules for regulation of actin cytoskeleton and membrane traffic
wavelength ratioing. Biophys. J. 78:2655–2667. from the plasma membrane. Biochim. Biophys. Acta 1533:190–206.
Vicinanza, M., D’Angelo, G., Di Campli, A. and De Matteis, M.A. (2008)
Function and dysfunction of the PI system in membrane trafficking.
EMBO J. 27:2457–2470.
Cyclic ADP-ribose (cADPR)
Galione, A. and White, A. (1994) Ca2 + release induced by cyclic
ADP-ribose. Trends Cell Biol. 4:431–436.
Hua, S.-Y., Tokimasa, T., Takasawa, S., Furuya, S., Nohmi, M., Okamoto, PtdIns 3-kinase signalling
H. and Kuba, K. (1994) Cyclic ADP-ribose modulates Ca2 + release Hawkins, P.T., Anderson, K.E., Davidson, K. and Stephens, L.R. (2006)
channels for activation by physiological Ca2 + entry in bullfrog Signalling through Class I PI3Ks in mammalian cells. Biochem Soc.
sympathetic neurons. Neuron 12:1073–1709. Trans. 34:647–662.
Lee, H.C. (1997) Mechanisms of calcium signalling by cyclic ADP-ribose Leslie, N.R. and Downes, C.P. (2004) PTEN function: how normal cells
and NAADP. Physiol. Rev. 77:1133–1164. control it and tumour cells lose it. Biochem. J. 382:1–11.
Lukyanenko, V., Györke, I., Wiesner, T.F. and Györke, S. (2001) Woodgett, J.R. (2005) Recent advances in the protein kinase B
Potentiation of Ca2 + release by cADP-ribose in the heart is mediated signalling pathway. Curr. Opin. Cell Biol. 17:150–157.
by enhanced SR Ca2 + uptake into the sarcoplasmic reticulum. Circ. Wymann, M.P. and Marone, R. (2005) Phosphoinositide 3-kinase in
Res. 89:614–622. disease: timing, location, and scaffolding. Curr. Opin. Cell Biol.
17:141–149.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r129
Dröge, W. (2002) Free radicals in the physiological control of cell Hla, T., Lee, M.-J., Ancellin, N., Paik, J.H. and Kluk, M.J. (2001)
function. Physiol. Rev. 82:47–95. Lysophospholipids: receptor revelations. Science 294:1875–1878.
Lambeth, J.D. (2004) NOX enzymes and the biology of reactive oxygen. Hannun, Y.A. and Obeid, L.M. (2008) Principles of bioactive lipid
Nat. Rev. Immunol. 4:181–189. signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol.
Mikkelsen, R.B. and Wardman, P. (2003) Biological chemistry of reactive 9:139–150.
oxygen and nitrogen and radiation-induced signal transduction Le Stunff, H., Peterson, C., Liu, H., Milstien, S. and Spiegel, S. (2002)
mechanisms. Oncogene 22:5734–5754. Sphingosine-1-phosphate and lipid phosphohydrolases. Biochim.
Rhee, S.G., Kang, S.W., Jeong, W., Chang, T.-S., Yang, K.-S. and Woo, Biophys. Acta 1582:8–17.
H.A. (2005) Intracellular messenger function of hydrogen peroxide and Spiegel, S., English, D. and Milstien, S. (2002) Sphingosine-1-phosphate
its regulation by peroxyredoxins. Curr. Opin. Cell Biol. 17:183–189. signaling: providing cells with a sense of direction. Trends Cell Biol.
Singh, D.K., Kumar, D., Siddiqui, Z., Basu, S.K., Kumar, V. and Rao, 12:236–242.
K.V.S. (2005) The strength of receptor signaling is centrally controlled
through a cooperative loop between Ca2 + and an oxidant signal. Cell
121:281–293.
Janus kinase (JAK)/signal transducer and
activator of transcription (STAT) signalling
Mitogen-activated protein kinase (MAPK) pathway
signalling Chen, X., Vinkemeier, U., Zhao, Y., Jeruzalmi, D., Darnell, Jr, J.E. and
Davis, R.J. (2000) Signal transduction by the JNK group of MAP kinases. Kuriyan, J. (1998) Crystal structure of a tyrosine phosphorylated
Cell 103:239–252. STAT-1 dimer bound to DNA. Cell 93:827–839.
Hattori, K., Naguro, I., Runchel, C. and Ichijo, H. (2009) The roles of ASK
family proteins in stress responses and disease. Cell Commun.
Signal. 7:9.
Johnson, G.L. and Lapadat, R. (2002) Mitogen-activated protein kinase
pathways mediated by ERK, JNK, and p38 protein kinases. Science Smad signalling pathway
298:1911–1912. Derynck, R. and Zhang, Y.E. (2003) Smad-dependent and
Morrison, D.K. and Davis, R.J. (2003) Regulation of MAP kinase Smad-independent pathways in TGF-β family signalling. Nature
signalling modules by scaffold proteins in mammals. Annu. Rev. Cell 425:577–584.
Dev. Biol. 19:91–118. Shi, Y. and Massagué, J. (2003) Mechanisms of TGF-β signalling from
Pouysségur, J. and Lenormand, P. (2003) Fidelity and spatio-temporal cell membrane to the nucleus. Cell 113:685–700.
control of MAP kinase (ERKs) signalling. Eur. J. Biochem. ten Dijke, P. and Hill, C.S. (2004) New insights into TGF-β-Smad
270:3291–3299. signalling. Trends Biochem. Sci. 29:265–273.
Wellbrock, C., Karasarides, M. and Marais, R. (2004) The Raf proteins
take centre stage. Nat. Rev. Mol. Cell Biol. 5:875–885.
C
2012 Portland Press Limited www.cellsignallingbiology.org
Cell Signalling Biology Michael J. Berridge r Module 2 r Cell Signalling Pathways 2 r130
Metabolic messengers Rutter, G.A., da Silva Xavier, G. and Leclerc, I. (2003) Roles of
Zima, A.V., Kockskämper, J., Meijia-Alvarez, R. and Blatter, L.A. (2003) 5’-AMP-activated protein kinase (AMPK) in mammalian glucose
Pyruvate modulates cardiac sarcoplasmic reticulum Ca2 + release in homoeostasis. Biochem. J. 375:1–16.
rats via mitochondria-dependent and -independent mechanisms.
J. Physiol. 550:765–783.
C
2012 Portland Press Limited www.cellsignallingbiology.org